000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1530|3182|lyfalmen|||1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1530||1530|3182||1
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|31679|41640|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||31679||31679|41640||2
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|47602|61623|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||47602||47602|61623||2
000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|10219|15068|lyfalmen|V0457|7883|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10219||10219|15068||2
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|29784|40209|lyfalmen|V0475|15386|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||29784||29784|40209||2
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|38734|51441|lyfalmen|V0540|20065|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||38734||38734|51441||2
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|20835|28978|lyfalmen|V0456|15580|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20835||20835|28978||2
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4833|6975|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4833||4833|6975||1
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7311|14211|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7311||7311|14211||1
000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|12946|18130|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||12946||12946|18130||1
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|15602|22411|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||15602|22411||1
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|30986|41717|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||30986|41717||1
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4401|7110|lyfalmen|V0621|1772|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4401||4401|7110||1
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139||1
000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2584|4624|lyfalmen|V0628|4624|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||||2584|4624||1
000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|26985|36696|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||26985||26985|36696||2
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1722|3445|lyfalmen|V0075|3445|1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1722||1722|3445||1
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4697|7515|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4697||4697|7515||1
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3173|5430|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3173||3173|5430||1
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||||1
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15035|20751|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||15035||15035|20751||2
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2961|5140|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2961||2961|5140||1
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3646|6077|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3646||3646|6077||1
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|131262|166616|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||131262||131262|166616||2
000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|21598|28988|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||21598||21598|28988||1
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|5512|7955|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||5512||5512|7955||1
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1407|3014|lyfalmen|V0037|1990|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1407||1407|3014||1
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6144|9494|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6144||6144|9494||1
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16289|23273|lyfalmen|||1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||16289||16289|23273||1
001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2139|4015|lyfalmen|V0050|2909|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2139||2139|4015||1
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|27558|36468|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||27558||27558|36468||1
001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2547|1585|lyfalmen|V0278|1416|2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||362||362|1585||1
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5900|9160|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5900||5900|9160||1
001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3796|6282|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||3796||3796|6282||1
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|2184|lyfalmen|V0038|2184|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||800||800|2184||1
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|4021|lyfalmen|V0039|3825|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2143||2143|4021||1
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21238|28536|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||21238||21238|28536||2
001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|14619|21177|lyfalmen|V0637|18829|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||14619||14619|21177||1
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30947|40721|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||30947||30947|40721||2
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2342|3380|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2342||2342|3380||1
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3804|6293|lyfalmen|V0444|6293|0|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||3804||3804|6293||1
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|805|2191|lyfalmen|V0004|614|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||805||805|2191||1
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1946|3483|lyfalmen|V0291|3004|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3483||1
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6936|10577|lyfalmen|V0297|7929|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10577||1
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|4123|6729|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||4123||4123|6729||2
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3353|5676|lyfalmen|V0292|4783|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5676||1
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4191|6822|lyfalmen|V0004|2457|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4191||4191|6822||1
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5263|8289|lyfalmen|V0296|6848|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8289||1
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8321|12472|lyfalmen|V0011|3061|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8321||8321|12472||1
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1321|2896|lyfalmen|V0005|597|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1321||1321|2896||1
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5865|9112|lyfalmen|V0005|2389|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5865||5865|9112||1
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4702|7521|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4702|7521||2
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5135|8114|lyfalmen|V0011|2733|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5135||5135|8114||1
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25001|33259|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||25001||25001|33259||2
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000|28.02.2014|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12064|7210|lyfalmen|||1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4474||4474|7210||1
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9353|13884|lyfalmen|V0012|2669|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9353||9353|13884||1
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3022|5223|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3022||3022|5223||1
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000|28.02.2014|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14709|21290|lyfalmen|||1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||14709||14709|21290||1
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|16579|23637|lyfalmen|V0492|8074|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||16579||16579|23637||1
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|89939|114756|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||89939|114756||2
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|45844|59417|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||45844|59417||2
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|23339|31173|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||23339|31173||2
002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3288|5587|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3288|5587|31.3.2014|2
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2103|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2312||1
002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3327|5804|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3327||3327|5804||2
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1221|2760|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1221||1221|2760||2
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|25556|33955|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||25556||25556|33955||1
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13702|15012|lyfalmen|V0089|2749|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10178||10178|15012||1
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|10128|14944|lyfalmen|V0515|5264|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10128||10128|14944||1
003099|L01DB0104|Myocet|irţ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|TBV|0|0|0|100|DKK|238236|300869|lyfsjukr|||1|2|0||Vistor hf|Teva Pharma B.V.|Doxórúbicín||238236||238236|300869||2
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|17227|24450|lyfalmen|V0253|9925|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17227||17227|24450||1
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|33431|44786|lyfalmen|V0516|8565|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||33431||33431|44786||1
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|9901|14633|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||9901||9901|14633||1
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|14719|21302|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||14719||14719|21302||1
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|194274|245696|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||194274||194274|245696||2
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|8512|12733|lyfalmen|V0356|11626|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||8512||8512|12733||1
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|7627|11523|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||7627||7627|11523||1
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3132|5374|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3132||3132|5374||1
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000|31.03.2014|R|1|1|0|0|G|0|TPA|0|0|0|100|SEK|14883|11242|lyfalmen|||1|98|0|49,0000|Vistor hf|Takeda Pharma A/S|Píóglítazón||7422||7422|11242||1
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000|31.03.2014|R|1|1|0|0|G|0|TPA|0|0|0|100|SEK|21951|24521|lyfalmen|||1|98|0|98,0000|Vistor hf|Takeda Pharma A/S|Píóglítazón||17284||17284|24521||1
003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|849|2251|lyfalmen|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Pseudóefedrín í blöndum||849||849|2251||1
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1017|1617|lyfalmen|V0151|1617|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||386||386|1617||1
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|572|1872|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||572||572|1872||1
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2564|lyfalmen|V0322|2542|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2564||1
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2071|3922|lyfalmen|V0469|1910|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||2071||2071|3922||1
004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|21230|28526|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21230||21230|28526||1
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7706|11631|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7706||7706|11631||1
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4063|6647|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4063||4063|6647||1
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|577|1879|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||577||577|1879||1
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1152|2665|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1152||1152|2665||1
004184|L03AC0101|Proleukin|stl/irs|||1|hgl|1|pakki||L03AC01|01.10.2013||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|31801|41793|lyfsjukr|||1|1|0|5,5000|Vistor hf|Novartis Healthcare A/S|Aldesleukín||31801||31801|41793||1
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5329|8379|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5329||5329|8379||1
004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6869|10486|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||6869||6869|10486||1
004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|9767|14450|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||9767||9767|14450||1
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001|31.03.2014|R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|621|1939|lyfalmen|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||621||621|1939||1
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|20511|27624|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||20511||20511|27624||1
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001|31.03.2014|R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1620|3305|lyfalmen|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1620||1620|3305||1
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|ţpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|5381|4900|lyfalmen|V0381|3946|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||2786||2786|4900||1
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4156|6775|lyfalmen|V0458|3731|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4156||4156|6775||1
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4669|9138|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4669||4669|9138||1
004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3162|5415|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3162||3162|5415||2
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|616|1932|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||616||616|1932||1
004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|4217|6858|lyfalmen|V0226|2764|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4217||4217|6858||2
004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|5956|9237|lyfalmen|V0227|4031|1|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||5956||5956|9237||2
004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|7927|11933|lyfalmen|V0228|5121|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7927||7927|11933||2
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2153|4035|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||2153||2153|4035||1
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3192|2773|lyfalmen|V0494|2762|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1231||1231|2773||1
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2556|3346|lyfalmen|V0318|3141|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1650||1650|3346||1
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|34621|45332|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||34621||34621|45332||2
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1381|2978|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1381||1381|2978||1
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3179|5438|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||3179||3179|5438||1
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4843|5152|lyfalmen|V0320|4783|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2970||2970|5152||1
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|776|1920|lyfalmen|V0062|1719|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||607||607|1920||1
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1921|3196|lyfalmen|V0317|3004|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1540||1540|3196||1
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|926|1920|lyfalmen|V0067|1719|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||607||607|1920||1
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1851||1
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|ABP|0|0|0|100|DKK|37107|48452|lyfsjukr|||1|4,69|0|7,0000|Vistor hf|Swedish Orphan Biovitrum AB (publ)|Anakinra||37107||37107|48452||1
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1778|3522|lyfalmen|V0318|1759|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3522||1
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||||1
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|173104|219128|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||173104||173104|219128||2
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|9469|14042|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9469||9469|14042||1
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|632|1954|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||632||632|1954||1
004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|14905|2868|lyfalmen|V0282|2397|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||1300||1300|2868||1
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5273|7610|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5273||5273|7610||1
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|364|1587|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||364||364|1587||1
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|639|1963|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||639||639|1963||1
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1209|2743|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1209||1209|2743||1
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1744|3475|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1744||1744|3475||1
005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3538|5929|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||3538||3538|5929||2
005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8560|7051|lyfalmen|V0148|3046|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4358||4358|7051||1
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2158|4041|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2158||2158|4041||1
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2485|4489|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2485||2485|4489||1
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3084|5308|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3084||3084|5308||1
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|25537|34879|lyfalmen|V0356|34878|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||25537||25537|34879||1
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|49332|64742|lyfalmen|V0287|45087|1|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||49332||49332|64742||1
005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|3235|5515|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3235||3235|5515||1
005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|1096|2589|lyfalmen|||1|2,4|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||1096||1096|2589||1
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|57512|75008|lyfalmen|V0451|70710|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||57512||57512|75008||1
005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1742|3472|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1742||1742|3472||1
005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003|31.03.2014|R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|34527|46161|lyfalmen|||1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||34527||34527|46161||2
005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||||1
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5933|9205|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||5933||5933|9205||1
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6236|9620|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6236||6236|9620||1
005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|BAX|0|0|0|100|USD|3823|6319|lyfalmen|||1|0,5|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||3823||3823|6319||2
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1819|3578|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1819||1819|3578||2
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3639|6067|lyfalmen|V0020|4691|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3639||3639|6067||2
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|9492|14074|lyfalmen|V0020|14074|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||9492||9492|14074||2
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4746|7582|lyfalmen|V0020|7037|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4746||4746|7582||2
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1742|3472|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1742||1742|3472||1
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6468|8976|lyfalmen|V0324|1773|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5765||5765|8976||1
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3071|4970|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2837||2837|4970||1
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|17521|30565|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||17521||17521|30565||1
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6105|9441|lyfalmen|||1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6105||6105|9441||1
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|10285|13964|lyfalmen|V0325|2243|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9412||9412|13964||1
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|4933|7427|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4633||4633|7427||1
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2680|4755|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2680||2680|4755||2
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15924|20662|lyfalmen|V0326|2526|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14209||14209|20662||1
005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3474|5842|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3474||3474|5842||1
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6301|8680|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5549||5549|8680||1
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12347|18326|lyfalmen|||1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12347||12347|18326||1
005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|ţpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|XEU|1901|2018|lyfalmen|V0169|2018|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||679||679|2018||2
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|81914|104685|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||81914||81914|104685||1
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5627|8787|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5627||5627|8787||1
006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|101592|129380|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||101592||101592|129380||1
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5459|8557|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5459||5459|8557||1
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|152538|193318|lyfsjukr|||1|3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||152538||152538|193318||1
006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|77585|99252|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||77585||77585|99252||1
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2475|4475|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2475||2475|4475||1
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|7659|14879|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||7659|14879||1
006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6438|9896|lyfalmen|||1|5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6438||6438|9896||1
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13935|20318|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13935||13935|20318||1
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|473635|596294|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||473635||473635|596294||1
006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14253|20718|lyfalmen|V0099|3780|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14253||14253|20718||1
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4374|7073|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4374||4374|7073||1
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|24732|47662|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim Danmark|||24732||24732|47662||1
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13223|19425|lyfalmen|V0117|10527|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13223||13223|19425||1
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6596|10112|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6596||6596|10112||1
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|19528|27338|lyfalmen|V0118|15425|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||19528||19528|27338||1
007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|ţpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1883|3665|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1883||1883|3665||1
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8289|12428|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8289||8289|12428||1
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|24483|33556|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||24483||24483|33556||1
007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|161822|204969|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||161822||161822|204969||2
007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|308808|389437|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||308808||308808|389437||2
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|2892|5045|lyfalmen|V0377|4246|1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||2892||2892|5045||1
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|95646|121918|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||95646||95646|121918||1
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983|31.03.2014|L|1|0|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||||1
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|241346|304772|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||241346||241346|304772||1
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|3144|5390|lyfalmen|V0374|4344|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3144||3144|5390||1
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|8313|11998|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8313||8313|11998||2
007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|115491|146824|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||115491||115491|146824||3
007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|22753|30438|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||22753||22753|30438||1
007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1916|3342|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||1916||1916|3342||2
007505|G04BD0702|Detrusitol Retard|forđahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6079|9405|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||6079||6079|9405||1
007538|R03BA0701|Asmanex Twisthaler|innönddu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003|28.02.2014|R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|4919|7818|lyfalmen|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mometasón||4919||4919|7818||1
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4373|6311|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4373||4373|6311||1
007549|R03BA0701|Asmanex Twisthaler|innönddu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003|28.02.2014|R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|5495|8606|lyfalmen|||1|60|0|60,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mometasón||5495||5495|8606||1
007760|G04BD0702|Detrusitol Retard|forđahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6241|9627|lyfalmen|V0618|6145|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||6241||6241|9627||1
007769|G04BD0702|Detrusitol Retard|forđahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|21188|29421|lyfalmen|V0589|8289|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||21188||21188|29421||1
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1691|3210|lyfalmen|V0290|3210|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3210||1
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3895|6418|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3895||3895|6418||1
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.02.2006||L|0|0|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1215|2751|lyfalmen|||0|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1215||1215|2751||1
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|20029|27019|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||20029||20029|27019||5
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|ţpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|2087|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|2087||3
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|384|1615|lyfalmen|V0502|1088|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||384||384|1615||2
008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|22926|30655|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||22926||22926|30655||2
008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|28444|37580|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||28444||28444|37580||2
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5359|8420|lyfalmen|V0620|8420|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5359||5359|8420||1
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003|30.04.2014|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|126890|161129|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||126890||126890|161129||1
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1490|3128|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1490||1490|3128||1
008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|283|1476|lyfalmen|||1|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||283||283|1476||1
008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|35471|46399|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||35471||35471|46399||2
008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|27775|36740|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||27775||27775|36740||2
008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|553|1846|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||553||553|1846||1
008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|32454|42612|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||32454||32454|42612||2
008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|871|2133|lyfalmen|||2|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||763||763|2133||1
008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1247|2795|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1247||1247|2795||1
008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|2812|4936|lyfalmen|V0226|4936|2|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2812||2812|4936||1
008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|4466|7199|lyfalmen|V0227|7199|2|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4466||4466|7199||1
008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|ACA|0|0|1|100|XEU|6288|9144|lyfalmen|V0228|9144|2|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||5888||5888|9144||1
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|149991|190121|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||149991||149991|190121||1
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|525|1808|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||525||525|1808||2
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|690|2024|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||683||683|2024||
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|USD|4684|8171|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||4684||4684|8171||2
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|10532|20396|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||10532||10532|20396||2
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998|30.04.2014|L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|3773|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||3773||2
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998|30.04.2014|L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2813|4937|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2813||2813|4937||1
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|106226|135196|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||106226||106226|135196||2
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|104415|132923|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||104415||104415|132923||2
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1885|3668|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1885||1885|3668||1
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6370|9803|lyfalmen|V0145|9289|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6370|9803||2
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12548|18578|lyfalmen|V0145|18578|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12548|18578||2
008959|R01AA0706|Naso-ratiopharm|nefúđi|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2
009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1711|2947|lyfalmen|V0064|2870|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||1358||1358|2947||2
009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|ţpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4424|5740|lyfalmen|V0064|5740|2|60|0|60,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||3400||3400|5740||2
009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8557|12350|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8557||8557|12350||2
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4211|5051|lyfalmen|V0063|5051|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||2896||2896|5051||2
009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8557|12350|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8557||8557|12350||2
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|13914|20292|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13914||13914|20292||1
009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8557|12350|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8557||8557|12350||2
009270|R01AA0706|Naso-ratiopharm|nefúđi|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|50757|65583|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||50757||50757|65583||1
009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1899||2
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5317|8363|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5317||5317|8363||1
009340|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1110|2608|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1110||1110|2608||1
009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1225|2765|lyfalmen|V0130|1594|1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1225||1225|2765||1
009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1416|3026|lyfalmen|V0131|2386|1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1416||1416|3026||1
009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1774|3516|lyfalmen|V0132|2643|1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1774||1774|3516||1
009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6944|10022|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6944||6944|10022||2
009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7237|10445|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7237||7237|10445||2
009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6944|10022|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6944||6944|10022||2
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|193757|245048|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||193757||193757|245048||1
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5138|8118|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5138||5138|8118||1
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|57980|74647|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||57980||57980|74647||2
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9216|13696|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9216||9216|13696||1
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9751|14428|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9751||9751|14428||1
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7853|11832|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7853||7853|11832||1
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9751|14428|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9751||9751|14428||1
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8017|12056|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8017||8017|12056||1
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8577|12822|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8577||8577|12822||1
009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1206|2104|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1206||1206|2104||2
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2114|3981|lyfalmen|V0329|2115|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2114||2114|3981||1
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003|30.04.2014|R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4031|6604|lyfalmen|||1|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4031||4031|6604||1
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5752|8958|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5752||5752|8958||1
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|204752|258846|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||204752||204752|258846||2
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|7069|10202|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7069||7069|10202||1
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|12494|18510|lyfalmen|V0331|3552|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12494||12494|18510||1
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|17617|24939|lyfalmen|V0304|8713|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||17617||17617|24939||1
010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dćluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|13925|20306|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13925|20306||1
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|22574|31160|lyfalmen|V0605|10746|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||22574||22574|31160||1
010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1995||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7200|10939|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||7200||7200|10939||2
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12213|18157|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12213||12213|18157||1
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|6351|9777|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||6351|9777||2
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7006|10111|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7006||7006|10111||2
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8968|12943|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8968||8968|12943||2
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1226|2766|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1226||1226|2766||2
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5749|8297|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5749||5749|8297||2
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8842|12761|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8842||8842|12761||2
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3911|5645|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3911||3911|5645||2
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2242|3236|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2242||2242|3236||2
010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|8515|12737|lyfalmen|V0377|12737|1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8515||8515|12737||1
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7284|10513|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7284||7284|10513||2
010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2850|lyfalmen|V0006|2219|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2850||2
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5229|7547|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5229||5229|7547||2
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3174|4581|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3174||3174|4581||2
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|13086|5500|lyfalmen|V0207|2315|1|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3224||3224|5500||1
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1709|2467|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1709||1709|2467||2
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACT|0|1|0|100|DKK|344217|433875|lyfsjukr|||1|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||344217||344217|433875||3
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACL|0|1|0|100|DKK|344217|433875|lyfsjukr|||1|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||344217||344217|433875||3
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|47232|61159|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||47232||47232|61159||2
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|2945|4250|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||2945||2945|4250||1
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|19713|27570|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19713||19713|27570||1
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|19483|27281|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19483||19483|27281||1
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|33564|44953|lyfalmen|||1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33564||33564|44953||1
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|33335|44665|lyfalmen|||1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33335||33335|44665||1
011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|17883|25273|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||17883||17883|25273||1
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4403|7112|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4403||4403|7112||1
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4575|7348|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4575||4575|7348||1
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19809|26155|lyfalmen|V0327|2311|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18586||18586|26155||1
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1168|2687|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1168||1168|2687||1
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1040|2512|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1040||1040|2512||1
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2867|3377|lyfalmen|V0069|3212|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1672||1672|3377||1
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|8553|12789|lyfalmen|V0357|12207|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||8553||8553|12789||1
011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6385|9824|lyfalmen|||1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6385||6385|9824||1
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2373|3425|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2373||2373|3425||1
011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|8319|10059|lyfalmen|V0624|10059|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6557||6557|10059||1
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1887|3754|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1887||1887|3754||2
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4837|6981|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4837||4837|6981||1
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|G|0|OYL|0|0|0|100|DKK|1192|2720|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1192||1192|2720||1
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|79138|101201|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||79138||79138|101201||2
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2726|5407|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2726||2726|5407||2
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1796|2082|lyfalmen|V0152|2082|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|2082||1
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4738|3905|lyfalmen|V0323|3883|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3905||1
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|4274|6168|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4274||4274|6168||1
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2473|3569|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2473||2473|3569||1
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7798|11757|lyfalmen|V0604|4269|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7798|11757||1
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|39643|51634|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||39643||39643|51634||1
012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1284|1769|lyfalmen|V0551|1769|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||497||497|1769||2
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3875|6390|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||3875||3875|6390||1
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6370|9803|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6370||6370|9803||2
012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1827|1769|lyfalmen|V0556|1769|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||497||497|1769||2
012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|10374|11757|lyfalmen|V0622|11203|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7798||7798|11757||1
012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|3852|3129|lyfalmen|V0552|3059|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1491||1491|3129||2
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003|30.04.2014|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|436519|549714|lyfsjukr|||1|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||436519||436519|549714||2
012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|2072|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|2072||1
012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4534|7292|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4534||4534|7292||1
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|6397|9840|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6397||6397|9840||2
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2732|4128|lyfalmen|V0250|4039|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2221||2221|4128||2
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3577|4773|lyfalmen|V0251|4641|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2693||2693|4773||2
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|5524|8646|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5524||5524|8646||1
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6802|13233|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6802||6802|13233||2
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|8919|13290|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8919||8919|13290||1
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1712|3405|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1712||1712|3405||2
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|21706|29124|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||21706||21706|29124||5
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|6797|9810|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6797||6797|9810||2
013259|B02BD0901|BeneFIX|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|28856|38097|lyfsjukr|||1|1|0|0,5600|Icepharma hf|Pfizer Limited|Storkuţáttur IX||28856||28856|38097||1
013270|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|48842|63179|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||48842||48842|63179||1
013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|3291|4725|lyfalmen|V0042|4725|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2658||2658|4725||1
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4467|8750|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4467||4467|8750||2
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|10424|20188|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||10424||10424|20188||2
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1094|2176|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1094||1094|2176||2
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|137596|174565|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||137596|174565||3
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|0|0|100|SEK|394520|388684|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||308208||308208|388684||1
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|24207|32262|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||24207|32262||3
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|89940|114757|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||89940|114757||3
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|45844|59417|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||45844|59417||3
013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010|30.04.2014|R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5300|8339|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5300||5300|8339||1
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003|30.04.2014|R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18046|25478|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||18046||18046|25478||1
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1284|2846|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1284||1284|2846||2
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1620||1
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|746|1627|lyfalmen|V0562|1627|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||393||393|1627||2
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2456|4449|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2456||2456|4449||2
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|395|1630|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||395||395|1630||1
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4584|7360|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||4584||4584|7360||1
013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009|30.04.2014|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|944|2381|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||||944|2381||1
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2751|lyfalmen|V0168|2668|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2751||1
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6057|9375|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6057||6057|9375||1
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2523|4541|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2523||2523|4541||1
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4525|7279|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4525||4525|7279||1
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|166258|210536|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||166258||166258|210536||1
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|337466|425402|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||337466||337466|425402||1
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2442|4430|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2442||2442|4430||1
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7769|11213|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7769||7769|11213||1
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|17715|25062|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||17715||17715|25062||1
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|66265|85993|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||66265||66265|85993||2
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29254|38596|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||29254||29254|38596||2
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|26925|36621|lyfalmen|V0357|36621|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||26925||26925|36621||1
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1589|3263|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1589||1589|3263||2
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|19432|26270|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||19432||19432|26270||2
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25438|33807|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||25438||25438|33807||2
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|359|1357|lyfalmen|V0563|1357|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||196||196|1357||2
014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2342|4293|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2342||2342|4293||1
014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2243|4462|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2243|4462||2
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|80778|103259|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||80778|103259||2
014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|5575|10877|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5575||5575|10877||2
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|905|1760|lyfalmen|V0564|1760|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||490||490|1760||2
014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1235|2779|lyfalmen|V0596|2712|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||1235||1235|2779||2
014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1147|2375|lyfalmen|V0558|1773|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||940||940|2375||2
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|61522|79093|lyfsjukr|||1|2,5|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||61522||61522|79093||1
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|98432|125415|lyfsjukr|||1|2,5|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||98432||98432|125415||1
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1338|2300|lyfalmen|V0559|2300|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||885||885|2300||2
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|18851|26488|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||18851||18851|26488||1
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|56883|74218|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||56883||56883|74218||1
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|37863|50348|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||37863||37863|50348||1
015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2
015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998|30.04.2014|R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|751|2117|lyfalmen|||1|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||751||751|2117||1
015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2671|4743|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2671||2671|4743||1
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8399|12579|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8399||8399|12579||1
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1082|2548|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1066||1066|2548||1
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4865|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4865||3
015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1064|2545|lyfalmen|V0129|1662|1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1064||1064|2545||1
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1899|2565|lyfalmen|V0234|1963|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1079||1079|2565||1
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2712|2565|lyfalmen|V0233|2258|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1079||1079|2565||1
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|10007|14778|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10007||10007|14778||1
015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|310549|391621|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||310549||310549|391621||3
015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|89720|114481|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||89720||89720|114481||3
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5189|8188|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5189||5189|8188||1
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13192|19386|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13192||13192|19386||1
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5189|8188|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5189||5189|8188||1
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|14260|20726|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14260||14260|20726||1
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|68822|88254|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68822||68822|88254||1
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5189|8188|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5189||5189|8188||1
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13052|19210|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13052||13052|19210||1
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|68822|88254|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68822||68822|88254||1
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|22069|30527|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||22069||22069|30527||1
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|45968|60520|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||45968||45968|60520||1
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3129|5458|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||3129||3129|5458||2
015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5140|8966|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5140||5140|8966||2
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2334|4072|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2334||2334|4072||2
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3256|5680|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3256||3256|5680||2
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|4436|7158|lyfalmen|V0200|5448|1|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4436||4436|7158||3
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4918|8579|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4918||4918|8579||2
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1966|3779|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1966|3779||1
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2208|4110|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2208||2208|4110||1
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1539|3195|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1539||1539|3195||2
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3131|5462|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||3131||3131|5462||2
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|1964|3776|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1964||1964|3776||1
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14342|20829|lyfalmen|V0117|10742|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14342||14342|20829||1
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1143|2653|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1143||1143|2653||2
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|21475|29781|lyfalmen|V0118|15740|1|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21475||21475|29781||1
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1212|2747|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1212||1212|2747||2
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2672|4745|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2672||2672|4745||1
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6964|10616|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6964||6964|10616||1
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4867|7747|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4867|7747||2
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10558|15532|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10558||10558|15532||1
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1764|3502|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1764||1764|3502||1
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15345|22088|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||15345||15345|22088||1
016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8644|12914|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||8644||8644|12914||1
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|94065|119934|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||94065||94065|119934||1
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|4165|6011|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4165||4165|6011||1
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2747|4847|lyfalmen|||1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2747||2747|4847||1
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|17182|24393|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17182||17182|24393||1
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7751||1
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|33563|44952|lyfalmen|||1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33563||33563|44952||1
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|1885|lyfalmen|V0169|1730|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||582||582|1885||1
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|180949|228973|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||180949||180949|228973||2
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|7054|10739|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7054||7054|10739||1
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2999|5192|lyfalmen|V0240|5192|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2999||2999|5192||3
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5534|8660|lyfalmen|V0433|8660|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5534||5534|8660||3
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|59874|77972|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||59874||59874|77972||1
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|88224|113551|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||88224||88224|113551||1
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|28511|38611|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||28511||28511|38611||1
016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|70359|90183|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||70359||70359|90183||1
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3480|5850|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3480|5850||1
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|XEU|39030|50865|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||39030||39030|50865||2
016979|N02AE0103|Norspan|forđapl|5|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|3082|5305|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3082||3082|5305||2
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|18414|35530|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||18414||18414|35530||2
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25151|33447|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||25151||25151|33447||2
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1499|3140|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1499||1499|3140||1
017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|1|0|0|0|G|0|DSG|0|0|0|100|XEU|1410|3018|lyfalmen|||1|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1410||1410|3018||2
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|258871|326766|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||258871||258871|326766||2
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|AGT|0|0|0|100|XEU|5933|9205|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||5933||5933|9205||1
017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|AGT|0|0|0|100|SEK|5994|9289|lyfalmen|||2|500|0|500,0000|Actavis Group hf|Actavis Group hf|Zópíklón||5994||5994|9289||1
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|149363|189333|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||149363||149363|189333||1
017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|33498|43922|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||33498||33498|43922||2
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003|30.04.2014|R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|1033|2502|lyfalmen|||2|100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1033||1033|2502||1
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|120656|153306|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||120656||120656|153306||2
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|46957|61761|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||46957||46957|61761||2
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|145821|185835|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||145821||145821|185835||2
017266|N02AE0103|Norspan|forđapl|10|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|5544|8673|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5544||5544|8673||2
017326|N02AE0103|Norspan|forđapl|20|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|10189|15027|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10189||10189|15027||2
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003|30.04.2014|R|1|0|0|0|G|0|NYC|0|0|0|100|DKK|2648|4712|lyfalmen|||2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2648||2648|4712||1
017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|8854|12779|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8854||8854|12779||1
017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|ţpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|872|2282|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||872||872|2282||1
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|2905|5063|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2905||2905|5063||1
017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2668|lyfalmen|V0168|2668|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2668||1
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6572|12792|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6572||6572|12792||1
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10229|15082|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10229||10229|15082||1
017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|42099|55664|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||42099||42099|55664||1
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9342|13869|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9342||9342|13869||1
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|3908|6435|lyfalmen|||1|0,25|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3908||3908|6435||2
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4210|6848|lyfalmen|||1|0,5|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4210||4210|6848||2
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1030|1716|lyfalmen|V0243|1375|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||458||458|1716||1
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8126|12205|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8126||8126|12205||1
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|13421|18726|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13421||13421|18726||2
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|19924|27835|lyfalmen|V0441|22525|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||19924||19924|27835||1
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|938|2372|lyfalmen|V0414|2083|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||938||938|2372||2
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5755|8962|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5755||5755|8962||1
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|16222|23189|lyfalmen|V0440|18855|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16222||16222|23189||1
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|33765|45205|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||33765||33765|45205||1
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|100705|128267|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||100705||100705|128267||1
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|58930|75840|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||58930||58930|75840||1
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|414|1656|lyfalmen|V0633|1600|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||414||414|1656||1
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1186|2359|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1186||1186|2359||2
018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|9907|14642|lyfalmen|V0221|7582|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||9907||9907|14642||1
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19313|26120|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||19313||19313|26120||2
019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|7081|10776|lyfalmen|V0220|5889|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7081||7081|10776||1
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21796|29236|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21796||21796|29236||2
019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3926|6460|lyfalmen|V0219|3482|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3926||3926|6460||1
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|30260|39859|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||30260||30260|39859||2
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|31027|40821|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||31027||31027|40821||2
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37911|49461|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||37911||37911|49461||2
019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|7747|11687|lyfalmen|V0223|8237|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7747||7747|11687||1
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13654|19966|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||13654||13654|19966||1
019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|50908|65772|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||50908||50908|65772||1
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|729755|917725|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||729755||729755|917725||1
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|4134|8110|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||4134||4134|8110||1
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|415|1600|lyfalmen|V0633|1600|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||373||373|1600||1
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|28947|55755|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||28947||28947|55755||2
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6712|10271|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6712||6712|10271||2
019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|46312|60004|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||46312||46312|60004||2
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6712|10271|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6712||6712|10271||2
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|472|1735|lyfalmen|V0601|1589|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||472||472|1735||1
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3675|5304|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3675||3675|5304||2
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|16145|22144|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16145||16145|22144||2
019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|177814|225039|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||177814||177814|225039||2
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|175941|222688|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||175941||175941|222688||2
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12516|18538|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12516||12516|18538||2
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12516|18538|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12516||12516|18538||2
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|46785|61545|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||46785|61545||1
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12516|18538|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12516||12516|18538||2
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12516|18538|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12516||12516|18538||2
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12516|18538|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12516||12516|18538||2
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|769702|967859|lyfsjukr|||1|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||769702||769702|967859||1
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|389|1621|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||389|1621||1
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|66778|85689|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||66778||66778|85689||1
020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|4635|5788|lyfalmen|||2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Diltíazem||3435||3435|5788||2
020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2862|5004|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2862||2862|5004||1
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|26037|35506|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||26037||26037|35506||1
020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2524|4542|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2524||2524|4542||3
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020305|C08DB0109|Dilmin|forđatfl|90|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|7531|4445|lyfalmen|||2|100|0|37,5000|Medical ehf|ratiopharm GmbH|Diltíazem||2453||2453|4445||2
020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6682|10230|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6682||6682|10230||1
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|52156|68286|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||52156||52156|68286||1
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4741|4398|lyfalmen|||1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2419||2419|4398||1
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|10761|5102|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2933||2933|5102||1
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|23537|32369|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||23537||23537|32369||1
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|592|1899|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||592||592|1899||1
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|5574|8714|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5574||5574|8714||2
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1805|3558|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1805||1805|3558||1
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|16235|23205|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16235||16235|23205||2
020647|J01CA0415|Amoxicillin ratiopharm|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.08.2013||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1821|3580|lyfalmen|||2|100|1|5,0000|Parlogis hf|Parlogis - óskráđ lyf|Amoxicillín||||1821|3580||2
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005|30.04.2014|L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
020685|C08DB0109|Dilmin|forđatfl|120|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|12398|10234|lyfalmen|V0599|10234|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Diltíazem||6685||6685|10234||2
020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2181|3805|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2181||2181|3805||1
020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2551|4450|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2551||2551|4450||2
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1975|3394|lyfalmen|V0174|2954|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1685||1685|3394||2
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2947|5121|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2947||2947|5121||2
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2409|4385|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2409||2409|4385||2
021057|J01CR0203|Augmentine (Lyf og heilsa)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|HOL|0|0|1|100|IKR|827|2059|lyfalmen|||3|12|0|6,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín og ensímblokkar||709||709|2059|30.4.2014|2
021149|J01CR0203|Augmentine (Lyf og heilsa)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|HOL|0|0|1|100|IKR|1025|2319|lyfalmen|V0169|1730|3|12|0|10,5000|Lyf og heilsa|Lyf og heilsa|Amoxicillín og ensímblokkar||899||899|2319||2
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1601|lyfalmen|V0188|1526|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1601||1
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1248|2797|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1248||1248|2797||1
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2433|lyfalmen|V0189|2056|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||982||982|2433||1
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|8737|13041|lyfalmen|V0437|13041|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||8737||8737|13041||
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|16772|23879|lyfalmen|V0490|4037|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||16772||16772|23879||1
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|6664|10205|lyfalmen|V0436|10205|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||6664||6664|10205||
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004|31.03.2014|L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
021417|R01AD0504|Rhinocort (Lyf og heilsa)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|15.12.2004||R|0|0|0|0|G|0|HOL|0|0|1|100|SEK|1585|3258|lyfalmen|V0443|3258|3|120|0|38,4000|Lyf og heilsa|Lyf og heilsa|Búdesóníđ||1585||1585|3258||
021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17038|24213|lyfalmen|V0491|9289|1|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17038||17038|24213||1
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1547|2233|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1547||1547|2233||2
021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4299|6970|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4299||4299|6970||1
021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13159|19345|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13159||13159|19345||1
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14021|20426|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14021||14021|20426||1
021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6954|10602|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6954||6954|10602||1
021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|14777|21375|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14777||14777|21375||1
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15470|21297|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||15470||15470|21297||2
021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|22152|30631|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||22152||22152|30631||1
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15470|21297|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||15470||15470|21297||2
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23812|32714|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23812||23812|32714||1
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4371|7069|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4371||4371|7069||1
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8895|12838|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||8895||8895|12838||2
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4489|6479|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4489||4489|6479||1
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19063|26754|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19063||19063|26754||1
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|3976|6528|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3976||3976|6528||2
021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21117|28384|lyfsjukr|||1|2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||21117||21117|28384||2
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6276|9675|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6276||6276|9675||2
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|19137|26847|lyfalmen|||1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||19137||19137|26847||2
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|79970|102245|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||79970||79970|102245||3
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19063|26754|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19063||19063|26754||1
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|82088|104903|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||82088||82088|104903||2
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|119892|152347|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||119892||119892|152347||2
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||||1
022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8256|12383|lyfalmen|V0616|12383|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8256||8256|12383||1
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|21687|30047|lyfalmen|V0615|30047|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||21687||21687|30047||1
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4925|7826|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4925||4925|7826||1
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|287277|362415|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||287277||287277|362415||2
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|304876|384502|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||304876||304876|384502||2
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12376|21589|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||12376||12376|21589||2
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|23891|32813|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||23891||23891|32813||1
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2221|3874|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2221||2221|3874||2
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1270|2827|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1270||1270|2827||1
022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1404|2449|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1404|2449||2
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3752|2787|lyfalmen|V0056|1999|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1241||1241|2787||1
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6596|3783|lyfalmen|V0057|1999|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1969||1969|3783||1
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2104|3670|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||2104||2104|3670||2
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|617|1933|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||617||617|1933||1
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1852|3623|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1852||1852|3623||1
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1362|2376|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1362||1362|2376||2
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4583|7359|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||4583||4583|7359||1
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3103|lyfalmen|V0321|3103|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3103||1
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2156|lyfalmen|V0321|1862|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2156||1
022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4813||2
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|25617|34979|lyfalmen|||1|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||25617||25617|34979||1
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|12808|18904|lyfalmen|||1|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12808||12808|18904||1
022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|19233|26967|lyfalmen|||1|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19233||19233|26967||1
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2951||2
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|2942|lyfalmen|V0124|2937|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1354||1354|2942||1
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|4309|lyfalmen|V0125|4307|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2354||2354|4309||1
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|78376|100244|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||78376||78376|100244||2
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|25200|34456|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25200||25200|34456||3
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|39345|52208|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||39345||39345|52208||3
023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|NEL|0|0|0|100|DKK|19924|27835|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19924||19924|27835||1
023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|14000|20400|lyfalmen|V0256|20400|2|100|0|44,4400|Medical ehf|ratiopharm GmbH|Gabapentín||14000||14000|20400||2
023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|7500|11349|lyfalmen|V0254|11349|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Gabapentín||7500||7500|11349||2
023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|NEL|0|0|0|100|DKK|20126|28088|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20126||20126|28088||1
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2639|4039|lyfalmen|V0250|4039|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||2156||2156|4039||
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3530|4641|lyfalmen|V0251|4641|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2596||2596|4641||2
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|19234|26969|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||19234||19234|26969||1
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|132384|168024|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||132384||132384|168024||1
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|24247|28750|lyfalmen|V0029|6915|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||20653||20653|28750||1
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3062|5278|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3062||3062|5278||2
023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|142043|180146|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||142043||142043|180146||2
023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2320|lyfalmen|V0066|2067|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2320||2
023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2526|lyfalmen|V0449|1920|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2526||2
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|55511|71549|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||55511||55511|71549||2
023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2047|lyfalmen|V0448|1678|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2047||2
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|72835|93290|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||72835||72835|93290||1
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2873|5019|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2873||2873|5019||1
024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2392|4361|lyfalmen|V0222|3903|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2392||2392|4361||1
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|18988|26660|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||18988||18988|26660||1
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1455|2100|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1455||1455|2100||2
024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22346|29927|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||22346||22346|29927||2
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|62628|81428|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||62628||62628|81428||1
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23812|32714|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||23812||23812|32714||1
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7496|11343|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7496||7496|11343||1
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|422|1667|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||422||422|1667||1
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7496|11343|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7496||7496|11343||1
024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12630|18681|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12630||12630|18681||1
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12652|18708|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12652||12652|18708||1
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12781|18870|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12781||12781|18870||1
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5405|8483|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5405||5405|8483||1
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|68670|89011|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||68670||68670|89011||1
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12781|18870|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12781||12781|18870||1
024603|V04CL0001|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1539|3195|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1539||1539|3195||1
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5405|8483|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5405||5405|8483||1
024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7496|11343|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7496||7496|11343||1
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7496|11343|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7496||7496|11343||1
024681|V04CL0002|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1539|3195|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1539||1539|3195||1
024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|ţpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2341|3415|lyfalmen|V0106|3415|2|100|0|66,6660|Medical ehf|ratiopharm GmbH|Metóprólól||1700||1700|3415||2
024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|1|0|0|0|G|0|OPF|0|0|1|100|XEU|371|1597|lyfalmen|V0563|1357|2|30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||371||371|1597||1
025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|1|0|0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||||1
025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|G|0|OPF|0|0|1|100|XEU|744|1981|lyfalmen|V0562|1627|2|100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||652||652|1981||1
025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3193|5457|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3193||3193|5457||2
025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4879|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4879||2
025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3825|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3825||2
025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|1|0|0|0|G|0|OPF|0|0|1|100|XEU|893|2301|lyfalmen|V0564|1760|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||886||886|2301||1
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|626|1946|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||626||626|1946||1
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19063|26754|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19063||19063|26754||1
025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1480|2184|lyfalmen|V0051|2184|2|100|0|33,3333|Medical ehf|ratiopharm GmbH|Metóprólól||800||800|2184||2
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19063|26754|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19063||19063|26754||1
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|82420|105320|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||82420||82420|105320||1
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|76984|98497|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||76984||76984|98497||1
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|9446|18310|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||9446||9446|18310||1
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|16352|23352|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||16352||16352|23352||1
025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2515|4200|lyfalmen|V0462|2869|2|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||2274||2274|4200||1
025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2737|4475|lyfalmen|V0471|2869|2|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||2475||2475|4475||1
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|5173|8166|lyfalmen|V0205|1255|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5173||5173|8166||2
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|13862|20227|lyfalmen|V0205|3766|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13862||13862|20227||2
025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2942|3552|lyfalmen|V0472|3552|2|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1800||1800|3552||1
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|52526|68750|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||52526||52526|68750||1
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7191|10378|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7191||7191|10378||1
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23812|32714|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||23812||23812|32714||1
025895|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1519|2498|lyfalmen|V0597|2498|2|28|0|3,7300|Medical ehf|ratiopharm GmbH|Oxýcódon||1030||1030|2498||2
025906|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|3880|5118|lyfalmen|V0598|5118|2|98|0|13,0700|Medical ehf|ratiopharm GmbH|Oxýcódon||2945||2945|5118||2
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|51885|66998|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||51885|66998||2
025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13191|10608|lyfalmen|V0492|8074|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||6958||6958|10608||1
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|4650|8112|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||4650||4650|8112||1
025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13493|5111|lyfalmen|V0490|4037|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||2940||2940|5111||1
025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||||1
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1928|3835|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1928||1928|3835||1
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2211|lyfalmen|V0447|2211|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2211||1
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|9160|15979|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||9160||9160|15979||1
026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|23430|15450|lyfalmen|V0475|15386|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||10498||10498|15450||1
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19063|26754|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19063||19063|26754||1
026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|42047|54651|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||42047||42047|54651||1
026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|210260|265759|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||210260||210260|265759||1
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1791|3539|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1791|3539||1
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6788|10375|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6788|10375||1
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3539|5931|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3539|5931||1
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|14017|20421|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14017|20421||1
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|21004|29190|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21004|29190||1
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|27993|37961|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||27993|37961||1
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1414|3024|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1414||1414|3024||1
026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
026702|C10AA0505|Atorvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|4560|3907|lyfalmen|||2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||2060||2060|3907|30.4.2014|2
026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|ţpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4765|3857|lyfalmen|V0099|3857|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Lósartan||2023||2023|3857||2
026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1426|3040|lyfalmen|V0160|3040|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1426||1426|3040||2
026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1152|2215|lyfalmen|||3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||823||823|2215|28.2.2014|2
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|420|1664|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||420||420|1664||1
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|2662|4731|lyfalmen|V0199|3462|1|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2662||2662|4731||3
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2159|4043|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2159||2159|4043||1
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6910|10542|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||6910||6910|10542||2
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|16410|7999|lyfalmen|V0341|7999|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||5051||5051|7999||1
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|18839|7999|lyfalmen|V0342|7999|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||5051||5051|7999||1
027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2777|4008|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2777||2777|4008||2
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|7138|10854|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7138||7138|10854||1
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|9124|13571|lyfalmen|V0139|13571|1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9124||9124|13571||1
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|595|1903|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||595||595|1903||1
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|691|2035|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||691||691|2035||1
027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2683|lyfalmen|V0284|2541|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1165||1165|2683||1
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|94790|120844|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||94790||94790|120844||1
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|20216|28201|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20216||20216|28201||1
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|31559|41489|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||31559|41489||2
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|23365|32153|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23365||23365|32153||1
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|46503|60244|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||46503||46503|60244||2
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|58580|75400|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||58580|75400||2
028045|G03AB0801|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|5236|8252|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5236||5236|8252||2
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|22390|30929|lyfalmen|V0387|30929|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||22390||22390|30929||1
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||||2
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|22720|31344|lyfalmen|V0386|31344|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||22720||22720|31344||1
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|49892|64497|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||49892||49892|64497||1
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2728|4821|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2728||2728|4821||2
028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|44592|58793|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||44592||44592|58793||2
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|37036|49310|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||37036||37036|49310||2
028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|10116|14928|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaćđi, dauđ veira||10116||10116|14928||2
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1844|3612|lyfalmen|V0202|3612|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1844||1844|3612||2
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2067|3917|lyfalmen|V0428|3346|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||2067||2067|3917||2
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1278|2838|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2838||1
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|5812|3880|lyfalmen|V0245|3481|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2040||2040|3880||1
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|10358|8695|lyfalmen|V0232|7770|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5560||5560|8695||1
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|787|2166|lyfalmen|V0266|2165|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||787||787|2166||1
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7840|15227|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7840||7840|15227||2
028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4534|7292|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4534||4534|7292||1
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3815|5677|lyfalmen|V0267|5189|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||3354||3354|5677||1
028739|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2399|4371|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||2399|4371||2
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1910|lyfalmen|V0551|1769|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||600||600|1910||1
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3434|lyfalmen|V0552|3278|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||1714||1714|3434||1
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól|||||||1
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1859|lyfalmen|V0555|1859|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1859||1
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1910|lyfalmen|V0556|1769|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||600||600|1910||1
029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1121|2457|lyfalmen|V0625|1747|1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1000||1000|2457||1
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|7483|11326|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||7483||7483|11326||2
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|18727|26332|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||18727||18727|26332||2
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2856|4996|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2856||2856|4996||1
029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|ţpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1093|2585|lyfalmen|||0|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1093||1093|2585||1
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|253|1435|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||253|1435||1
029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|63375|81418|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||63375||63375|81418||1
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|22288|29854|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22288||22288|29854||1
029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|4228|6102|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||4228||4228|6102||1
029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4427|6389|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4427||4427|6389||1
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15725|22565|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||15725|22565||1
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15725|22565|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||15725|22565||1
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|6370|9803|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6370||6370|9803||2
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|98990|126115|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||98990||98990|126115||1
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|197979|250346|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||197979||197979|250346||1
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
030108|R06AX2701|Aerius|filmhtfl|5|mg|10|stk|1|ţpakki||R06AX27|01.11.2012|31.03.2014|R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|621|1939|lyfalmen|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||621||621|1939||1
030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|4739|3046|lyfalmen|V0148|3046|2|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||1430||1430|3046||1
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|21398|29685|lyfalmen|V0138|29685|1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||21398||21398|29685||1
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|9111|13553|lyfalmen|V0277|13553|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||9111||9111|13553||1
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2884|5035|lyfalmen|||1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2884||2884|5035||1
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|15953|27829|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15953|27829||2
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1366|2820|lyfalmen|V0051|2184|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||1265||1265|2820||2
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2158|4041|lyfalmen|V0106|3415|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||2158||2158|4041||2
031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2753||1
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2986|5174|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2986||2986|5174||2
031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2934|5103|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2934||2934|5103||2
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|2073|3925|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2073||2073|3925||1
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5863|9110|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5863||5863|9110||1
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|22964|30702|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||22964||22964|30702||1
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1978|3795|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1978||1978|3795||2
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|20844|28989|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20844||20844|28989||1
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|14683|25614|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||14683||14683|25614||1
032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|ţpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1198|1773|lyfalmen|V0558|1773|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||500||500|1773||2
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|21126|29343|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||21126|29343||1
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|42136|55711|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||42136|55711||1
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|1213|2116|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1213||1213|2116||2
033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|3045|5255|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3045||3045|5255||2
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9079|17606|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9079|17606||2
033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|10375|15282|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||10375||10375|15282||2
033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6093|9424|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6093||6093|9424||2
033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|17985|25401|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||17985||17985|25401||2
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|ACK|0|0|1|100|USD|1174|2695|lyfalmen|||0|5|0||Vistor hf|Alcon Denmark A/S|Dexametasón||1174||1174|2695||1
033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1988|2056|lyfalmen|V0189|2056|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Díklófenak||707||707|2056||2
033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|870|1526|lyfalmen|V0188|1526|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Díklófenak||319||319|1526||2
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|18596|16040|lyfalmen|V0185|16040|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||10929||10929|16040||2
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|95966|122320|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||95966||95966|122320||1
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2451|4875|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2451|4875||2
034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|ţpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|ROY|0|0|0|100|XEU|1941|2450|lyfalmen|V0098|2450|2|100|0|100,0000|Medical ehf|ratiopharm Oy|Enalapríl og ţvagrćsilyf||995||995|2450||2
034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|740|2102|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||740||740|2102||2
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|17487|23829|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||17487||17487|23829||2
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|8058|12112|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8058|12112||2
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|8058|12112|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8058|12112||2
034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|75868|97097|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||75868||75868|97097||1
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1741|3471|lyfalmen|V0367|3471|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1741||1741|3471||1
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2913|5074|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2913||2913|5074||1
034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|171201|216740|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||171201||171201|216740||2
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|7379|10650|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7379||7379|10650||1
035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2241|3234|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2241||2241|3234||2
035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|15817|22680|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15817||15817|22680||1
035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1330|2909|lyfalmen|V0050|2909|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1330||1330|2909||2
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2315|lyfalmen|V0244|2139|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||896||896|2315||1
035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1322|2898|lyfalmen|V0048|2898|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1322||1322|2898||2
035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2361|4319|lyfalmen|V0049|4319|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2361||2361|4319||2
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9564|14172|lyfalmen|V0080|5583|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9564||9564|14172||1
035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5159|7490|lyfalmen|V0054|7490|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4679||4679|7490||2
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|NOK|27440|34450|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||25195||25195|34450||1
036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|140375|178053|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||140375||140375|178053||2
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|5865|9112|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||5865||5865|9112||1
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8011|12048|lyfalmen|V0081|4816|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8011||8011|12048||1
036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|1|0|0|1|0|1|ABV|0|0|0|100|DKK|6005|8667|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||6005||6005|8667||1
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|194776|246326|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||194776||194776|246326||1
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|354292|446519|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||354292||354292|446519||1
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|708560|891125|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||708560||708560|891125||1
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|802|2186|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||802||802|2186||1
036502|N06DA0301|Exelon|forđapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|20338|28354|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||20338||20338|28354||1
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1411|3020|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1411||1411|3020||1
036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4400|7676|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||4400||4400|7676||1
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2784|4898|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2784||2784|4898||1
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|844|2244|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||844||844|2244||1
037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|9291|7616|lyfalmen|V0532|6642|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4771||4771|7616||1
037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|18877|13077|lyfalmen|V0533|11286|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||8763||8763|13077||1
037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|33526|25067|lyfalmen|V0534|21745|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||17719||17719|25067||1
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2488|4493|lyfalmen|V0434|4493|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2488||2488|4493||2
037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1138|2646|lyfalmen|V0627|2646|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1138||1138|2646||1
037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1773|lyfalmen|V0151|1733|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1773||2
037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2594|lyfalmen|V0322|2594|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1100||1100|2594||2
037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3962|lyfalmen|V0323|3962|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2100||2100|3962||2
037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2349||1
037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3731||1
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8260|12389|lyfalmen|V0102|3176|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8260|12389||1
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|0|0|GSK|0|0|0|100|IKR|664|1609|lyfalmen|||1|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1609||1
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2667|3266|lyfalmen|V0321|3103|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3266||1
038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2134|lyfalmen|V0110|2134|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2134||2
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|1030|2498|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1030||1030|2498||2
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|172793|218738|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||172793||172793|218738||1
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|16296|23282|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||16296|23282||2
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|40254|52401|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||40254||40254|52401||2
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6870|10487|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||6870||6870|10487||1
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|4190|6821|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||4190|6821||1
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|19376|27147|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||19376|27147||1
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3527|5680|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3356||3356|5680||2
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|470|1642|lyfalmen|V0541|1583|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||404||404|1642||2
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|633|1690|lyfalmen|V0542|1251|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||439||439|1690||2
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1276|2835|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1276||1276|2835||1
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1840|3606|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1840||1840|3606||1
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1307|1886|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1307||1307|1886||2
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2134|lyfalmen|V0110|2091|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2134||1
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|7654|8022|lyfalmen|V0182|8022|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||5068||5068|8022||1
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3276|4728|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3276||3276|4728||2
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|1828|2059|lyfalmen|V0033|2059|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||709||709|2059||1
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6535|9432|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||6535||6535|9432||2
040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1293|2318|lyfalmen|V0366|2318|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||898||898|2318||1
040475|C09DA0603|Candesartan/Hydrochlorothiazide Aspen|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3724|5602|lyfalmen|V0095|5602|2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan og ţvagrćsilyf||3299||3299|5602||1
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1834||1
040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|ţpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1555|2954|lyfalmen|V0174|2954|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1363||1363|2954||1
041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|ţpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|10313|15197|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||10313||10313|15197||2
041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|ţpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|10313|15197|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||10313||10313|15197||2
041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006|30.04.2014|R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3481|5851|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3481||3481|5851||2
041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2521|3141|lyfalmen|V0318|3141|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1500||1500|3141||2
041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|27652|48238|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||||27652|48238||2
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4330|7553|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4330||4330|7553||1
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1165|2683|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1165|2683||2
041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|IKR|2903|2389|lyfalmen|V0005|2389|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||950||950|2389||1
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||||1
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1498|3139|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1498||1498|3139||1
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|12607|17704|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||12607||12607|17704||1
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2500|3608|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2500||2500|3608||2
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3022|4362|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3022||3022|4362||2
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4279|6176|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4279||4279|6176||2
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4385|6329|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4385||4385|6329||2
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5587|8063|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5587||5587|8063||2
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6895|9951|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6895||6895|9951||2
042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3736|5392|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3736||3736|5392||2
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2860|4128|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2860||2860|4128||2
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2186|3155|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2186||2186|3155||2
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2736|3949|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2736||2736|3949||2
042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3590|5181|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3590||3590|5181||2
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2452|3539|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2452||2452|3539||2
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2072|2990|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2072||2072|2990||2
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5995|8652|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5995||5995|8652||2
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2346|3386|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2346||2346|3386||2
042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2502|4512|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||2502||2502|4512||2
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3237|4672|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3237||3237|4672||2
042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|14592|21143|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14592||14592|21143||2
042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1322|2630|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1322||1322|2630||2
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1970|3919|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1970||1970|3919||2
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2641|5244|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2641||2641|5244||2
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5283|10317|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5283||5283|10317||2
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6075|11837|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||6075||6075|11837||2
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2385|3442|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2385||2385|3442||2
042669|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|3758|6230|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||3758||3758|6230||2
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|563|1859|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||563||563|1859||2
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3123|4507|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3123||3123|4507||1
043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|18620|9932|lyfalmen|V0516|8565|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||6464||6464|9932||1
043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4037|6612|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4037||4037|6612||1
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5773|8332|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5773||5773|8332||1
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|555|1849|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||555||555|1849||1
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|1207|2740|lyfalmen|||1|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1207||1207|2740||1
043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
043935|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1
044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|0|0|0|G|0|LVR|0|0|1|100|CHF|12748|18829|lyfalmen|V0637|18829|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12748||12748|18829||3
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|375322|472912|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||375322|472912||1
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|529646|666588|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||529646|666588||1
044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|16878|24012|lyfalmen|V0635|20651|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||16878||16878|24012||1
044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|49236|64621|lyfalmen|V0636|60560|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||49236||49236|64621||1
044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2637|4697|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2637||2637|4697||1
044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2055|4088|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2055||2055|4088||2
045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7295|11069|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7295||7295|11069||2
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1803|lyfalmen|V0109|1767|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1803||1
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1675|lyfalmen|V0108|1642|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1675||1
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|2637|3806|lyfsjukr|||1|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2637||2637|3806||3
045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|5273|7610|lyfsjukr|||1|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5273||5273|7610||3
045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|409|1649|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||409||409|1649||1
045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1602|3281|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||1602||1602|3281||1
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|20830|40169|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||20830||20830|40169||2
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1612|3294|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1612||1612|3294||1
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1015|2478|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1015||1015|2478||1
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|3873|6387|lyfalmen|V0382|6387|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3873||3873|6387||2
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|668|1895|lyfalmen|||2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||589||589|1895||1
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|791|2171|lyfalmen|V0022|2171|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||791||791|2171||1
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1013|2475|lyfalmen|V0023|2475|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1013||1013|2475||1
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|6450|9913|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6450||6450|9913||2
046724|R01AD0802|Nasofan|nefúđi|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2184|lyfalmen|V0625|2184|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||800||800|2184||2
046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|10558|2327|lyfalmen|V0283|1637|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||905||905|2327||1
046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|5525|3766|lyfalmen|V0205|3766|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3766||1
046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3407|1772|lyfalmen|V0279|1548|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||499||499|1772||1
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|999|2456|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||999||999|2456||2
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684||5
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564||5
047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|12451|4385|lyfalmen|V0420|4385|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||2409||2409|4385||1
047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|14951|10872|lyfalmen|V0421|9506|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||7151||7151|10872||1
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5049|7287|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||5049||5049|7287||2
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8618|12438|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8618||8618|12438||2
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8191|11822|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||8191||8191|11822||2
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2667|2497|lyfalmen|V0324|1773|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1029||1029|2497||1
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2477|4478|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2477||2477|4478||1
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7689|2243|lyfalmen|V0325|2243|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||843||843|2243||1
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7554|3842|lyfalmen|V0326|2526|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2012||2012|3842||1
048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3875|6390|lyfalmen|||2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3875||3875|6390||1
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|15105|3418|lyfalmen|V0327|2311|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1702||1702|3418||1
048183|C09CA0603|Candesartan Aspen|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3780|5697|lyfalmen|V0080|5697|2|100|0|200,0000|Artasan ehf|Navamedic ASA|Candesartan||3368||3368|5697||1
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1227|2768|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1227||1227|2768||1
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13702|20026|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||13702||13702|20026||1
048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1768|3508|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1768||1768|3508||1
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|60757|75739|lyfalmen|V0187|14027|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||58095||58095|75739||2
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|896955|1127561|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||896955||896955|1127561||1
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|475|1739|lyfalmen|V0230|1652|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||475||475|1739||1
048770|B05ZB0001|Hemosol BO|blóđ.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|4744|6847|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóđsölt og stuđpúđalausn||4744||4744|6847||1
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2415|4393|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2415||2415|4393||1
049033|C08DB0108|Cardil|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4722|7549|lyfalmen|V0599|6140|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||4722||4722|7549||1
049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6129|9474|lyfalmen|V0376|5108|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||6129|9474||1
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|16410|23425|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||16410||16410|23425||2
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2362|4320|lyfalmen|V0122|4320|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2362||2362|4320||1
049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|6037|9348|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||6037||6037|9348||1
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|6508|9992|lyfalmen|||1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6508||6508|9992||2
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|1979|lyfalmen|V0109|1767|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||650||650|1979||1
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2389|lyfalmen|V0110|2134|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||950||950|2389||1
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|IKR|8006|5110|lyfalmen|V0123|3371|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2939||2939|5110||1
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1181|2690|lyfalmen|V0496|2687|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1170||1170|2690||1
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2433|3717|lyfalmen|||2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1921||1921|3717||1
049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1
049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1
049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1527||1
049894|N02BG1001|Sativex|munnhúđi|52|mg|10|ml|3|úđagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|80267|103565|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||80267||80267|103565||1
049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|152993|193889|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||152993||152993|193889||2
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|60757|79080|lyfalmen|V0470|75549|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||60757||60757|79080||2
049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|8236|11887|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8236||8236|11887||2
049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|20590|27723|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||20590||20590|27723||2
049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|38249|49885|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||38249||38249|49885||2
049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|76497|97886|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||76497||76497|97886||2
050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.12.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3256|3401|lyfalmen|V0445|3401|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríđ||1690||1690|3401||2
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4240|5554|lyfalmen|V0550|5554|2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||3264||3264|5554||2
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|1|0|100|DKK|566381|712691|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||566381||566381|712691||2
050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29813|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29813||2
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|70742|90664|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||70742|90664||1
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3109|5342|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3109||3109|5342||1
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13113|19287|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13113||13113|19287||1
050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5425|5212|lyfalmen|V0042|4725|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3014||3014|5212||1
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|5357|lyfalmen|V0002|5357|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5357||1
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3962|lyfalmen|V0006|3962|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2100||2100|3962||1
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|10567|4408|lyfalmen|V0001|3985|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2426||2426|4408||1
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1682|3390|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1682||1682|3390||1
051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1713|3433|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1713||1713|3433||1
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3802|5475|lyfalmen|V0365|5475|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||3206||3206|5475||2
051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|29904|39412|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||29904||29904|39412||1
051686|N05AE0402|Zeldox (Lyf og heilsa)|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|26716|26759|lyfalmen|V0611|26759||56|0|56,0000|Lyf og heilsa|Lyf og heilsa|Ziprasidon||19067||19067|26759||
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1556|2052|lyfalmen|V0056|1999|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||704||704|2052||1
051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2612|2515|lyfalmen|V0057|1999|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1042||1042|2515||1
051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|933|2366|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||933||933|2366||1
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|210|1377|lyfalmen|V0047|1377|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||210||210|1377||2
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|494|1765|lyfalmen|V0305|1037|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||494||494|1765||2
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|338401|426576|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||338401||338401|426576||1
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|350|1552|lyfalmen|V0439|1552|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||338||338|1552||2
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|863|2248|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||847||847|2248||2
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|720|2074|lyfalmen|V0305|2074|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||720||720|2074||2
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|706919|889066|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||706919||706919|889066||1
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|571813|719508|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||571813||571813|719508||1
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3700|6151|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3700||3700|6151||1
052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|36598|47813|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||36598||36598|47813||2
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29752|39221|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||29752||29752|39221||2
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31409|41301|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||31409||31409|41301||2
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26278|34861|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||26278||26278|34861||2
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|35551|46499|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||35551||35551|46499||2
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007|31.03.2014|R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33011|43311|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||33011||33011|43311||2
052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|14787|21388|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||14787||14787|21388||1
052997|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|30|stk|1|ţpakki||N05CF02|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|477|1608|lyfalmen|V0060|1608|2|30|0|30,0000|Icepharma hf|Mylan AB|Zolpidem||379||379|1608||2
053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2358|3943|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||2086||2086|3943|30.4.2014|
053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2159|4043|lyfalmen|V0134|3197|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2159||2159|4043||2
053043|J05AR1001|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AR10|01.11.2006|30.04.2014|R|1|0|0|1|0|1|ABT|0|0|0|100|DKK|61622|79218|lyfsjukr|||1|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopínavír og ritónavír||61622||61622|79218||1
053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|5067|8021|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5067||5067|8021||1
053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11969|17462|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||11969||11969|17462||2
053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|35648|47568|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||35648||35648|47568||2
053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5968|9253|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5968||5968|9253||2
053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1750|3476|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1745||1745|3476||2
053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6093|9424|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||6093||6093|9424||1
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|35753|47700|lyfalmen|V0453|43313|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||35753||35753|47700||1
053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|635|1468|lyfalmen|||2|20|0|20,0000|Icepharma hf|Mylan AB|Zolpidem||277||277|1468|31.3.2014|2
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|15567|22367|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15567||15567|22367||2
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1531|3184|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1531||1531|3184||1
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1141|2650|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1141||1141|2650||1
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7743|5045|lyfalmen|V0490|4119|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||2892||2892|5045||1
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4157|6776|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||4157||4157|6776||2
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2698|4780|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2698||2698|4780||1
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3720|6178|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3720||3720|6178||1
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|53279|68748|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||53279||53279|68748||2
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|1073|2557|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1073||1073|2557||1
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1685|3394|lyfalmen|V0061|3394|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1685||1685|3394||1
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|ALS|0|0|0|100|DKK|4747|9288|vetalmen|||0|10|0||Icepharma hf|Alstoe Limited|Buprenorphinhýdróklóríđ||||4747|9288||2
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|7686|13408|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||7686||7686|13408||2
054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|XEU|5500|8613|lyfalmen|||1|60|0|30,0000|Vistor hf|Almirall S.A.|Aclídínumbrómíđ||5500||5500|8613||1
055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|20275|25183|lyfalmen|V0470|25183|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||17811||17811|25183||2
055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|ţpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|19884|11338|lyfalmen|V0187|4676|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||7492||7492|11338||2
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|ACK|0|0|1|100|USD|1624|3311|lyfalmen|||1|5|0||Vistor hf|Alcon Denmark A/S|Moxífloxacín||||1624|3311||1
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|766|2137|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||766||766|2137||1
055257|G03AA0903|Benidette|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1329|2429|lyfalmen|V0065|2320|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||979||979|2429||1
055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|9208|13685|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9208||9208|13685||1
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|2064|2457|lyfalmen|V0467|2457|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2457||1
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4539|3887|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||2045||2045|3887|30.4.2014|1
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6185|3896|lyfalmen|V0113|3896|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||2052||2052|3896||1
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|7867|3899|lyfalmen|V0114|3899|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||2054||2054|3899||1
056308|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|32109|43127|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||32109||32109|43127||2
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|27011|47119|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27011||27011|47119||2
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1247|2795|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1247||1247|2795||1
056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3724|5428|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3172||3172|5428||1
056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3724|5428|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3172||3172|5428||1
056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2926|5092|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2926||2926|5092|30.4.2014|1
056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|223525|282406|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||223525||223525|282406||2
057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3518|5902|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3518||3518|5902||1
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10646|15653|lyfalmen|V0095|5490|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||10646||10646|15653||1
057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|11740|16616|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||11740||11740|16616||1
057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3911|5645|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3911||3911|5645||2
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|6751|9743|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||6751||6751|9743||1
057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|22873|31536|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||22873||22873|31536||1
057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4884|7049|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4884||4884|7049||2
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|3722|5372|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||3722||3722|5372||1
057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|347677|438217|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||347677||347677|438217||1
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|1|0|100|SEK|474171|596967|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||474171||474171|596967||1
057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|23288|22930|lyfalmen|V0607|22437|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||16016||16016|22930||2
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|20143|28109|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20143|28109||1
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|426|1672|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||426||426|1672||1
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|GGL|0|1|0|100|GBP|128441|163076|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||128441||128441|163076||1
058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|162284|283096|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||162284|283096||2
058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|246525|430051|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||246525|430051||2
058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007|28.02.2014|R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|16606|23671|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16606||16606|23671||2
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1008|2468|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1008||1008|2468||1
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|100171|127597|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||100171||100171|127597||1
058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|40929|54196|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||40929||40929|54196||1
058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5749|8297|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5749||5749|8297||2
058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1144|2654|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1144||1144|2654||1
058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2134|4009|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2134||2134|4009||1
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2850|lyfalmen|V0006|2219|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2850||1
059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|11811|17246|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11811||11811|17246||3
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|99105|127207|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||99105||99105|127207||1
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|32907|44128|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||32907||32907|44128||1
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|39972|46453|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||34759||34759|46453||1
059803|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5654|8824|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5654|8824||2
059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8948|13330|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8948||8948|13330||1
059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|44743|58982|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||44743||44743|58982||1
060114|N02AB0305|Fentanyl ratiopharm|forđapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2715|3482|lyfalmen|V0219|3482|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1749||1749|3482||2
060123|N02AB0305|Fentanyl ratiopharm|forđapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4313|5889|lyfalmen|V0220|5889|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3509||3509|5889||2
060132|N02AB0305|Fentanyl ratiopharm|forđapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5591|7582|lyfalmen|V0221|7582|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4746||4746|7582||2
060141|N02AB0305|Fentanyl ratiopharm|forđapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|6519|8237|lyfalmen|V0223|8237|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||5225||5225|8237||2
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|339735|429197|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||339735||339735|429197||1
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|188136|238941|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||188136||188136|238941||1
061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2743|5440|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2743|5440||2
061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1437|2858|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1437|2858||2
061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|8491|16477|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8491|16477||2
061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|6974|10629|lyfalmen|V0133|10629|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||6974||6974|10629||2
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|6975|10631|lyfalmen|V0133|10629|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||6975||6975|10631||1
061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1699|2964|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1699||1699|2964||2
061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|4432|6396|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||4432||4432|6396||1
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|15826|21744|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||15826||15826|21744||1
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|22281|29845|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22281||22281|29845||1
062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|458|1716|lyfalmen|V0307|1579|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||458||458|1716||1
062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6685|5178|lyfalmen|V0604|4574|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||2989||2989|5178||1
062250|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|30|ml|1|túpa||A01AA01|01.03.2014||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|5102|8069|lyfalmen|||1|30|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||5102||5102|8069||2
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|9458|14027|lyfalmen|V0187|14027|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9458||9458|14027||1
062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1646|3341|lyfalmen|V0634|1685|1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1646||1646|3341||1
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|924|2353|lyfalmen|V0308|2076|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||924||924|2353||1
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|2007|3835|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2007||2007|3835||1
062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|17971|31350|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||17971||17971|31350||2
062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011|30.04.2014|R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|37677|49167|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||37677||37677|49167||1
062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011|30.04.2014|R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|41869|54428|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||41869||41869|54428||1
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|14575|16261|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11091||11091|16261||1
062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|145754|185751|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||145754||145754|185751||1
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|4202|6837|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||4202||4202|6837||1
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3054||1
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2537|3371|lyfalmen|V0123|3371|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1668||1668|3371||1
063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|4158|6349|lyfalmen|V0458|3731|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3845||3845|6349||2
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7766|11208|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7766||7766|11208||1
063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2536|4424|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2536||2536|4424||2
063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|971|2418|lyfalmen|V0309|2007|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||971||971|2418||1
063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2034|3872|lyfalmen|V0310|3011|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2034||2034|3872||1
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1085188|1363793|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1085188|1363793||2
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|434075|546647|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||434075|546647||2
064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2136|4011|lyfalmen|V0311|3011|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2136||2136|4011||1
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4340755|5449530|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4340755|5449530||2
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|2170378|2725707|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2170378|2725707||2
064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3464|3801|lyfalmen|V0009|3664|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1982||1982|3801||2
064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|8220|6915|lyfalmen|V0029|6915|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||4259||4259|6915||2
064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1181|2349|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1181||1181|2349||1
064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2097|3958|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2097||2097|3958||1
064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|1043|2516|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||1043||1043|2516||2
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|58419|75198|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||58419||58419|75198||1
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|TAS|0|0|1|100|DKK|829|2223|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||829||829|2223||1
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|TAS|0|0|1|100|DKK|477|1742|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||477||477|1742||1
065029|A03FA0102|Afipran|eţ-stíll|20|mg|5|stk|1|ţpakki||A03FA01|01.03.2013|30.04.2014|R|0|0|0|0|G|0|TAS|0|0|1|100|DKK|244|1423|lyfalmen|||2|5|0|3,3300|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||244||244|1423||1
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1948|3754|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1948||1948|3754||1
065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5869|11442|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5869||5869|11442||2
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|14055|19522|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||14055||14055|19522||2
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2498|3828|lyfalmen|V0376|1703|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2002||2002|3828||1
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|57512|70744|lyfalmen|V0451|70710|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||54115||54115|70744||3
065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6129|9474|lyfalmen|V0376|5108|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||6129||6129|9474||1
065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|998|1864|lyfalmen|V0163|1864|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||566||566|1864||2
065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4359|6291|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4359||4359|6291||2
065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|621|1939|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||621||621|1939||1
065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1876|3656|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1876||1876|3656||1
065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|3488|5861|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3488||3488|5861||1
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4483|8781|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4483||4483|8781||2
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6236|9620|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6236||6236|9620||1
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33053|43364|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33053||33053|43364||2
066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|845|2245|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||845||845|2245||2
066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066593|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3962|lyfalmen|V0006|3962|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2100||2100|3962||3
066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|1098|2591|lyfalmen|V0036|2591|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||1098||1098|2591||2
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|15294|21076|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15294||15294|21076||1
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8619|12439|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8619||8619|12439||2
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1487|3123|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1487||1487|3123||1
067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|1020|2485|lyfalmen|V0376|1703|2|2,5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1020||1020|2485||1
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1771|lyfalmen|V0551|1769|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||498||498|1771||1
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3278|lyfalmen|V0552|3278|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3278||1
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998|28.02.2014|R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|664|1879|lyfalmen|||2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1879||1
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1859|lyfalmen|V0555|1859|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1859||1
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1910|lyfalmen|V0556|1769|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1910||1
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|13547|lyfalmen|V0419|13547|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13547||1
068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|106512|135555|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||106512||106512|135555||1
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|1|0|100|GBP|78351|100213|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||78351||78351|100213||1
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1752|3486|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1752||1752|3486||1
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|5515|8634|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||5515||5515|8634||1
068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|18462|10573|lyfalmen|V0342|7839|2|98|0|130,6700|Medical ehf|Medical ehf|Dónepezíl||6933||6933|10573||2
068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|ţpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín|||||||2
068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3553|5950|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3553||3553|5950||2
068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2514|3628|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2514||2514|3628||1
068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|3129|4516|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3129||3129|4516||1
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14120|20551|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14120||14120|20551||1
069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|44569|58764|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||44569||44569|58764||1
069707|G04BD0705|Tolterodine Sandoz|forđahlk|4|mg|98|stk|1|ţpakki||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|10281|8123|lyfalmen|V0589|8123|2|98|0|98,0000|Artasan ehf|Sandoz A/S|Tólteródín||5142||5142|8123||1
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|430|1678|lyfalmen|V0448|1678|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||430||430|1678||2
070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|16900|24040|lyfalmen|V0645|24040|1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||16900|24040||1
070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|24371|33416|lyfalmen|V0646|33416|1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||24371|33416||1
070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|31363|42191|lyfalmen|V0647|42191|1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||31363|42191||1
070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1
070142|G04BD0704|Tolterodin Actavis|forđahlk|4|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|9129|8813|lyfalmen|V0589|8289|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||5646||5646|8813||1
070493|N05AH0314|Olanzapine Mylan|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|5836|2397|lyfalmen|V0282|2397|2|56|0|56,0000|Icepharma hf|Generics UK Ltd|Olanzapín||956||956|2397||2
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|12276|18236|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12276||12276|18236||1
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|65136|83628|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||65136||65136|83628||1
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|325684|410616|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||325684||325684|410616||1
071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2061|3139|lyfalmen|V0247|3139|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1498||1498|3139||2
071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|6236|7922|lyfalmen|V0249|7922|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||4995||4995|7922||2
071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|13435|19691|lyfalmen|V0252|19691|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||13435||13435|19691||2
071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|8467|12672|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8467|12672||1
071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10868|7668|lyfalmen|V0144|7459|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4809||4809|7668||2
071844|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|50|stk|1|ţpakki||M01AE01|01.03.2013||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Portfarma|Íbúprófen|||||||1
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|85930|109725|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||85930||85930|109725||1
072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|3151|3991|lyfalmen|V0009|3926|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||2121||2121|3991||1
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|7005|13623|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||7005||7005|13623||1
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|8220|6915|lyfalmen|V0029|6915|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||4259||4259|6915||1
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|639|922|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||639||639|922||1
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|XEU|16512|23553|lyfalmen|||1|1,2|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||16512||16512|23553||2
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|XEU|16512|23553|lyfalmen|||1|2,4|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||16512||16512|23553||2
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|73192|93738|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||73192||73192|93738||1
073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8865|11159|lyfalmen|V0286|10480|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||7361||7361|11159||1
073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|758345|953605|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||758345||758345|953605||2
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3763|6237|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3763||3763|6237||1
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|18596|16326|lyfalmen|V0185|16040|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||11138||11138|16326||1
073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|715|2067|lyfalmen|V0066|2067|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||715||715|2067||2
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|304|1505|lyfalmen|V0047|1377|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||304||304|1505||1
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|956|2397|lyfalmen|V0305|2074|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||956||956|2397||1
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|514|1792|lyfalmen|V0439|1552|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||514||514|1792||1
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1397|3000|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1397||1397|3000||1
073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|ţpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|3113|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1479||1479|3113||2
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3720|6489|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3720||3720|6489||2
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APT|0|0|0|100|GBP|1337|2918|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1337||1337|2918||1
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|3579|5985|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3579||3579|5985||1
074083|B03BB0106|Folic Acid (Lyf og heilsa)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|GBP|403|1635|lyfalmen|V0391|1635|3|28|0|350,0000|Lyf og heilsa|Lyf og heilsa|Fólínsýra||399||399|1635||2
074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|24148|33136|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||24148||24148|33136||1
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|478|1743|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||478||478|1743||1
074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Medical ehf|ratiopharm GmbH|Paracetamól|||||||2
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|661|1994|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||661||661|1994||1
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|1074|2559|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1074||1074|2559||1
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|22451|39165|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||22451||22451|39165||2
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|410|1634|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||398||398|1634||1
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|708|2058|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||708||708|2058||1
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|953|2393|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||953||953|2393||1
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|508|1784|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||508||508|1784||1
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APT|0|0|0|100|GBP|2351|4305|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2351||2351|4305||1
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4874|7757|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4874||4874|7757||1
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14621|21179|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14621||14621|21179||1
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4874|7757|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4874||4874|7757||1
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1718|2728|lyfalmen|||1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1198||1198|2728||1
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14621|21179|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14621||14621|21179||1
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|XEU|3152|5401|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||3152||3152|5401||1
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|NOK|4535|7293|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||4535||4535|7293||1
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2601|4647|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2601|4647||1
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4099|3842|lyfalmen|V0445|3401|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||2012||2012|3842||1
075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|28474|37617|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||28474||28474|37617||1
075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|77627|99304|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||77627||77627|99304||1
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1052|2093|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1052||1052|2093||1
075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|12769|18855|lyfalmen|V0440|18855|2|90|0|90,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||12769||12769|18855||1
075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5752|8302|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5752||5752|8302||2
075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5752|8302|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5752||5752|8302||2
075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6055|8739|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6055||6055|8739||2
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|441|1693|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||441||441|1693||1
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|449|1704|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||449||449|1704||1
075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|892|1920|lyfalmen|V0449|1920|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||607||607|1920||2
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6532|10025|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6532||6532|10025||1
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|21788|30174|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||21788|30174||1
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|ţpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|22755|31388|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||22755||22755|31388||1
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|22769|31405|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||22769||22769|31405||1
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1698|lyfalmen|||2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1698|28.2.2014|1
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|3210|lyfalmen|V0290|3210|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3210||1
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1946|3483|lyfalmen|V0291|3004|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3483||1
076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1722|3445|lyfalmen|V0075|3445|1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1722||1722|3445||1
076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2
076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|492|1762|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||492||492|1762||1
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|368|1593|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||368||368|1593||1
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1044|2517|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1044||1044|2517||1
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|788|2167|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||788||788|2167||1
078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12717|lyfalmen|V0419|12644|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12717||1
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|520|1801|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||520||520|1801||1
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|792|2173|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||792||792|2173||1
078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1392|2994|lyfalmen|V0560|2994|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1392||1392|2994||2
078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1990|3812|lyfalmen|V0561|3812|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1990||1990|3812||2
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|0|0|0|1|0|1|SAG|0|0|0|100|DKK|124402|158007|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||124402||124402|158007||2
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8857|6175|lyfalmen|V0069|3212|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3718||3718|6175||1
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998|31.03.2014|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3068|4428|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||3068||3068|4428||2
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998|31.03.2014|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6135|8854|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||6135||6135|8854||2
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998|31.03.2014|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|12307|17328|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||12307||12307|17328||2
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3630|6055|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3630||3630|6055||2
079269|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|18337|25843|lyfalmen|V0639|25843|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||18337||18337|25843||1
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3549|5944|lyfalmen|V0315|5944|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3549||3549|5944||1
079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|ţpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|7382|lyfalmen|V0184|7382|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||4600||4600|7382||2
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|2059|2972|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2059||2059|2972||1
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1627|lyfalmen|V0176|1627|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1627||1
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1962|lyfalmen|V0418|1962|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1962||1
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1974|lyfalmen|V0177|1974|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1974||1
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2687|lyfalmen|V0411|2687|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2687||1
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745||2
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3995|7844|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3995|7844||2
080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14951|9506|lyfalmen|V0421|9506|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||6153||6153|9506||2
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|10818|18871|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10818||10818|18871||2
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|16511|7692|lyfalmen|V0170|7692|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||4827||4827|7692||2
080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|18596|16326|lyfalmen|V0185|16040|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||11138||11138|16326||2
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2233|4144|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2233||2233|4144||1
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5915|9181|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||5915||5915|9181||1
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2642|2769|lyfalmen|V0143|2012|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1228||1228|2769||1
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3071|5290|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3071||3071|5290||1
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7466|6190|lyfalmen|V0143|6036|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||3729||3729|6190||1
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2916|2970|lyfalmen|V0144|2486|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1375||1375|2970||1
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|14862|20534|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14862||14862|20534||1
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10869|7668|lyfalmen|V0144|7459|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4809||4809|7668||1
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|29299|38653|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||29299||29299|38653||1
081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|758345|953605|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||758345||758345|953605||2
081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|8002|5264|lyfalmen|V0515|5264|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3052||3052|5264||1
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4579|7353|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4579||4579|7353||1
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1715|2320|lyfalmen|V0590|2320|2|84|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel||900||900|2320||2
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1814|2618|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1814||1814|2618||2
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|5354|8413|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5354||5354|8413||1
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|7540|11404|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7540||7540|11404||1
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16974|9233|lyfalmen|V0184|7234|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5953||5953|9233||1
082040|D07XC0101|Diprosalic|húđlausn|||100|ml|1|glas||D07XC01|01.01.1987||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2228|4137|lyfalmen|V0640|4137|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2228||2228|4137||1
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5
082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostţurrkađ stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|8579|14966|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||8579||8579|14966||1
082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostţurrkađ stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|39490|68888|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||39490||39490|68888||1
082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|844|2244|lyfalmen|V0629|2244|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||844||844|2244||1
082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|ţpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|DKK|735|2080|lyfalmen|V0229|2080|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Paracetamól||724||724|2080||2
082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3060|5275|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3060||3060|5275||1
082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5516|8635|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5516||5516|8635||1
082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1
082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3868|6381|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3868||3868|6381||1
082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4211|6850|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4211||4211|6850||1
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8937|6777|lyfalmen|V0080|5697|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||4158||4158|6777||1
082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|13017|19166|lyfalmen|V0354|16564|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||13017||13017|19166||1
083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|18501|26049|lyfalmen|V0186|2382|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||18501||18501|26049||1
083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|13595|19892|lyfalmen|V0344|15713|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||13595||13595|19892||1
083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5716|8909|lyfalmen|||1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5716||5716|8909||1
083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|6136|11955|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||6136||6136|11955||2
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|75974|97230|lyfsjukr|||1|450|0|30,0000|Vistor hf|AbbVie Ltd.|Ritonavír||75974||75974|97230||1
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|29501|39854|lyfalmen|V0346|33539|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||29501||29501|39854||1
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1297|2864|lyfalmen|V0231|2635|1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1297||1297|2864||1
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|266|1453|lyfalmen|V0642|1453|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||266||266|1453||1
084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|2017|3011|lyfalmen|V0311|3011|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1405||1405|3011||2
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|513|1791|lyfalmen|V0643|1791|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||513||513|1791||1
084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|68666|88058|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||68666||68666|88058||1
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|60562|77888|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||60562||60562|77888||2
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|78951|100966|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||78951||78951|100966||2
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|97673|124462|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||97673||97673|124462||2
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|20188|27218|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20188||20188|27218||2
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|31530|41453|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||31530||31530|41453||2
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|40374|52552|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||40374||40374|52552||2
084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|12504|17575|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12504|17575||2
084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|47663|61700|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||47663|61700||2
084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|146799|186115|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||146799|186115||2
084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|0|0|100|GBP|265034|334500|lyfsjukr|||1|28|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||265034||265034|334500||1
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|922|2351|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||922||922|2351||1
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|10942|16057|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||10942||10942|16057||1
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|35608|47518|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||35608||35608|47518||1
084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|50301|65010|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||50301||50301|65010||1
084936|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013|30.04.2014|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|149059|188952|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||149059||149059|188952||1
085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|12592|18633|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||12592||12592|18633||1
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|39744|52709|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||39744||39744|52709||2
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2600|4646|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2600||2600|4646||2
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|29501|39854|lyfalmen|V0345|33539|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||29501||29501|39854||1
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|756|2124|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||756||756|2124||1
085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6339|9149|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6339||6339|9149||2
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|17738|25091|lyfalmen|V0412|22797|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||17738|25091||1
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|34074|45593|lyfalmen|V0412|45593|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||34074|45593||1
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|93268|118934|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||93268||93268|118934||2
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|21234|29479|lyfalmen|V0579|29479|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||21234||21234|29479||1
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|39412|52292|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||39412||39412|52292||1
085830|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|5375|7757|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||5375||5375|7757||1
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|2886|5037|lyfalmen|V0465|4252|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2886||2886|5037||1
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|8528|12755|lyfalmen|V0465|12755|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8528||8528|12755||1
085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|ţpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|425|1671|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||425||425|1671||1
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1989|3810|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1989||1989|3810||1
086018|N02CC0404|Rizatriptan Actavis|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3746|3401|lyfalmen|V0621|1772|2|6|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Rizatriptan||1690||1690|3401||1
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|5056|5669|lyfalmen|V0365|5475|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3348||3348|5669||1
086142|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|64219|83425|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||64219||64219|83425||2
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8203|11839|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8203||8203|11839||1
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8904|12851|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8904||8904|12851||1
086324|A02BC0501|Nexium|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14317|20798|lyfalmen|V0012|5338|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||14317||14317|20798||1
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|29099|39349|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||29099|39349||1
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|58370|76084|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||58370|76084||1
086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|51866|66974|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||51866||51866|66974||1
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|17992|25410|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||||17992|25410||2
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|49650|64193|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||49650||49650|64193||2
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998|30.04.2014|R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|2949|5123|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||2949||2949|5123||1
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|394|1628|lyfalmen|V0060|1608|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||394||394|1628||1
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|158952|201367|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||158952||158952|201367||1
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|267|1455|lyfalmen|V0312|453|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||267||267|1455||1
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|235|1411|lyfalmen|V0312|1359|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||235||235|1411||1
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1979|3797|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1979||1979|3797||1
087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|49325|19652|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||13404||13404|19652||1
087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|49325|19652|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||13404||13404|19652||1
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3697||1
087727|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2584|4624|lyfalmen|V0628|4624|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2584||2584|4624||1
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|859|2264|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||859||859|2264||2
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3465|3664|lyfalmen|V0009|3664|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1882||1882|3664||1
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|6642|5579|lyfalmen|V0420|4385|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||3282||3282|5579||1
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|31138|54319|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||31138||31138|54319||2
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1
087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3742|7358|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3742||3742|7358||1
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|27438|47864|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27438||27438|47864||2
088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|3269|5561|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3269||3269|5561||2
088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|GGL|0|0|1|100|GBP|1243|2790|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1243||1243|2790||1
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1496|3136|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1496||1496|3136||1
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|5773|8987|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5773||5773|8987||1
088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12845|7861|lyfalmen|V0342|7839|2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4950||4950|7861||2
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|5003|7933|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5003||5003|7933||1
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|9665|14311|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9665||9665|14311||1
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|14828|21439|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14828||14828|21439||1
088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|14951|10872|lyfalmen|V0421|9506|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||7151||7151|10872||1
088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2938|5108|lyfalmen|V0376|5108|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||2938||2938|5108||1
088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1459|3085|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1459||1459|3085||1
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|23180|31921|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||23180||23180|31921||2
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5784||1
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|158952|201367|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||158952||158952|201367||1
089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYD|0|0|0|100|SEK|3923|6456|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan dura GmbH|Mebeverín||3923||3923|6456||2
089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2
089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2103|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2103||2
089533|V03AE0401|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE04|01.10.2012||R|1|0|0|0|0|0|FMC|0|0|0|100|XEU|6605|10125|lyfalmen|||1|180|0|30,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||6605||6605|10125||2
089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|24445|33509|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24445||24445|33509||1
089913|B03AC0001|Monofer|irl|100|mg/ml|5|ml|5|hgl||B03AC|01.10.2012|30.04.2014|R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|132129|156438|lyfalmen|||1|25|0|25,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||122397||122397|156438||1
089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|97780|125544|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||97780||97780|125544||1
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2069|3920|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2069||2069|3920||2
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|4139|6751|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||4139||4139|6751||2
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|936|2370|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||936||936|2370||2
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|5733|8274|lyfsjukr|||1|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5733||5733|8274||2
090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1629|3318|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1629||1629|3318||1
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|ACK|0|0|0|100|USD|15290|21071|lyfsjukr|||1|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||15290|21071||1
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2813|4060|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2813||2813|4060||1
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4863|7019|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4863||4863|7019||1
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|14268|19789|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14268||14268|19789||1
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|3312|5620|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3312||3312|5620||1
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6466|9935|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6466||6466|9935||1
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|7256|10472|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7256|10472||1
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3908|6435|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3908||3908|6435||1
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1151|1828|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||540||540|1828|30.4.2014|1
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1994|2211|lyfalmen|V0022|2171|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||820||820|2211||1
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|616|1932|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||616||616|1932||1
092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009|30.04.2014|R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|3813|6305|lyfalmen|||1|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3813|6305||1
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|9024|17500|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9024||9024|17500||2
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|7252|10059|lyfalmen|V0009|3664|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||6557||6557|10059||1
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092554|N06DX0105|Memantine Mylan|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|12025|8271|lyfalmen|V0606|7776|2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Memantín||5250||5250|8271||2
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2236|4148|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2236||2236|4148||1
092750|N05AH0203|Leponex (Lyf og heilsa)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|9111|13553|lyfalmen|V0277|13553|3|100|0|33,3333|Lyf og heilsa|Lyf og heilsa|Klózapín||9111||9111|13553||2
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|494|1765|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||494||494|1765||1
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|874|2285|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||874||874|2285||1
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|3306|3679|lyfalmen|V0203|3679|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1893||1893|3679||2
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|981|2431|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||981||981|2431||2
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2251|4169|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2251||2251|4169||2
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|4377|7077|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||4377||4377|7077||2
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6260|9653|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6260||6260|9653||1
093284|G04BD1201|Betmiga|forđatfl|50|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|6044|9357|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||6044||6044|9357||1
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1443|3063|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1443||1443|3063||1
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|26007|45368|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||26007||26007|45368||2
093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|ţpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|38276|50866|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||38276||38276|50866||2
093736|L02AE0305|Zoladex LA (Lyf og heilsa)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|G|0|HOL|0|0|0|100|SEK|57512|70710|lyfalmen|V0451|70710|3|1|0|83,7209|Lyf og heilsa|Lyf og heilsa|Góserelín||54088||54088|70710||2
093747|C09AA0503|Ramipril Actavis (Lyf og heilsa)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|XEU|1170|2687|lyfalmen|V0496|2687|3|100|0|200,0000|Lyf og heilsa|Lyf og heilsa|Ramipríl||1168||1168|2687||2
093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|9410|13962|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||9410||9410|13962||2
093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|24392|33442|lyfalmen|V0588|29383|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||24392||24392|33442||2
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|406106|511546|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||406106||406106|511546||1
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|458476|577270|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||458476||458476|577270||1
094099|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.06.2013||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|2453|4445|lyfalmen|V0236|3737|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2453||2453|4445||1
094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4993|7920|lyfalmen|V0236|7474|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||4993||4993|7920||1
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|7399|11211|lyfalmen|V0236|11211|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7399||7399|11211||1
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1752|3485|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1752||1752|3485||1
094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|1043|2366|lyfalmen|V0044|2366|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||933||933|2366||2
094652|B01AC0602|Hjarta-Aspirín|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2
094757|N04BC0406|Ropinirole Portfarma|forđatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|30720|25007|lyfalmen|||2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||17671||17671|25007|31.3.2014|1
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|79963|102236|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||79963||79963|102236||1
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|46683|61417|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||46683|61417||1
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6369|11110|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6369||6369|11110||2
095005|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|50908|65772|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||50908||50908|65772||1
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3247|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3247||1
095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|4976|4545|lyfalmen|V0143|4024|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2526||2526|4545||2
095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|5993|9287|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5993||5993|9287||1
095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|17451|24731|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17451||17451|24731||1
095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|17451|24731|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17451||17451|24731||1
095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1890|2728|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1890||1890|2728||1
095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2960|4272|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2960||2960|4272||1
095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|17451|24731|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17451||17451|24731||1
095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2480|3579|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2480|3579||1
095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3433|4955|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3433|4955||1
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|983|1605|lyfalmen|V0225|1605|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||377||377|1605||1
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8153|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8153||2
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11181|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11181||2
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18479|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18479||2
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|31767|41750|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||31767||31767|41750||2
096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|12569|17657|lyfsjukr|||1|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12569||12569|17657||1
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|93597|119347|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||93597||93597|119347||1
096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2359|2456|lyfalmen|V0088|2456|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||999||999|2456||2
096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2456|2771|lyfalmen|V0089|2749|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1229||1229|2771||2
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2014|3844|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2014||2014|3844||1
096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14813|21420|lyfalmen|V0347|18747|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14813||14813|21420||1
096438|J01CA0413|Amoxin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CA04|01.05.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1704|3420|lyfalmen|||2|60|0|6,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1704||1704|3420|28.2.2014|2
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|675510|849648|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||675510||675510|849648||2
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|716077|900559|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||716077||716077|900559||2
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|753137|947069|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||753137||753137|947069||2
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|786181|988540|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||786181||786181|988540||2
096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|15804|22664|lyfalmen|V0349|19923|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15804||15804|22664||1
096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1457|3082|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1457||1457|3082||2
096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|31609|42499|lyfalmen|||1|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||31609||31609|42499||1
096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|16949|24101|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||16949||16949|24101||1
097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|26528|35175|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||26528||26528|35175||1
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|72064|125712|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||72064||72064|125712||2
097080|R06AX2701|Aerius|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2012|31.03.2014|R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1620|3305|lyfalmen|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1620||1620|3305||1
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7958|15453|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7958|15453||2
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2139|4015|lyfalmen|V0461|4015|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2139||2139|4015||2
097498|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|566|1864|lyfalmen|V0333|784|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||566||566|1864||1
097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10898|15997|lyfalmen|V0334|4218|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10898||10898|15997||1
097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|20692|28798|lyfalmen|V0335|4218|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||20692|28798||1
097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2380|4345|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2380||2380|4345||1
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2862|2520|lyfalmen|V0023|2475|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1046||1046|2520||1
097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|2738|2264|lyfalmen|V0233|2258|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||859||859|2264||
097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|1917|1969|lyfalmen|V0234|1963|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||643||643|1969||
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1081|2568|lyfalmen|V0329|2115|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1081||1081|2568||1
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4510|3099|lyfalmen|V0072|3099|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1469||1469|3099||1
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|6056|3658|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1878||1878|3658||1
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|667|2002|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||667||667|2002||2
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|667|2002|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||667||667|2002||2
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1063|1637|lyfalmen|V0243|1637|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||400||400|1637||2
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|1910|lyfalmen|V0244|1910|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||600||600|1910||2
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3552|lyfalmen|V0245|3552|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3552||2
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|7929|lyfalmen|V0232|7929|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5000||5000|7929||2
098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|18349|24910|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||18349||18349|24910||1
098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|16299|23285|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16299||16299|23285||2
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|77735|99440|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||77735||77735|99440||1
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3204|2541|lyfalmen|V0284|2541|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||1061||1061|2541||2
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6680|5357|lyfalmen|V0285|5080|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||3120||3120|5357||2
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|10383|10982|lyfalmen|V0286|10480|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||7232||7232|10982||2
099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2887|3538|lyfalmen|V0247|3139|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1790||1790|3538||1
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3992|6102|lyfalmen|V0248|6102|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3664||3664|6102||1
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8108|9320|lyfalmen|V0249|7922|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6017||6017|9320||1
099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|ţpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|181792|230031|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||181792||181792|230031||1
099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|ţpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|330673|416877|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||330673||330673|416877||1
099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|ţpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|661323|831843|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||661323||661323|831843||1
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|696|2041|lyfalmen|V0414|2041|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||696||696|2041||1
100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|5897|9621|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||5897||5897|9621||1
100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12922|19047|lyfalmen|||1|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12922|19047||2
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|11561|16904|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11561|16904||2
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1975|3786|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1971||1971|3786||1
100482|J01DH0202|Merinfec|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.08.2013||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|10258|14756|lyfsjukr|||2|5000|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||10258|14756||1
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11245|13172|lyfalmen|V0254|11349|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8833||8833|13172||1
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|17014|24183|lyfalmen|V0256|20400|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17014||17014|24183||1
101148|QI10AB0301|Alpha Ject  5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|74387|121362|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||74387||74387|121362||1
101195|N06DX0105|Memantine Mylan|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|6439|4342|lyfalmen|V0604|4269|2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Memantín||2378||2378|4342||2
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1332|2911|lyfalmen|V0330|2389|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1332||1332|2911||1
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2736|4396|lyfalmen|V0331|3552|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2417||2417|4396||1
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2902|2712|lyfalmen|V0088|2506|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1186||1186|2712||1
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3986|2805|lyfalmen|V0089|2805|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1254||1254|2805||1
101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007|28.02.2014|R|1|0|1|0|G|0|DAC|0|0|1|100|DKK|5135|8114|lyfalmen|||3|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5135||5135|8114||2
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|SEK|16853|32533|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||||16853|32533||1
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|6964|10616|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6964||6964|10616||2
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|20891|29048|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||20891||20891|29048||2
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1051|2527|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1051||1051|2527||1
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1637|3329|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1637||1637|3329||1
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|ţpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|411|1652|lyfalmen|V0230|1652|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||411||411|1652||1
102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|ţpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|7126|10837|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||7126||7126|10837||1
102743|L01XA0303|Oxaliplatin Actavis|irţ|5|mg/ml|40|ml|1|hgl||L01XA03|01.05.2013||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|10103|14562|lyfsjukr|||2|40|0||Actavis Group hf|Actavis Group PTC ehf|Oxalíplatín||10103||10103|14562||1
102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3636|6063|lyfalmen|V0041|2907|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3636||3636|6063||1
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|1822|2630|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||1822||1822|2630||1
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|2962|4275|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||2962||2962|4275||1
102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|15693|22525|lyfalmen|V0441|22525|2|90|0|180,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||15693||15693|22525||1
103610|L01DB0105|Doxorubicin Actavis|irţ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|9018|13015|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||9018||9018|13015||1
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2997|2742|lyfalmen|V0088|2456|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1208||1208|2742||1
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4280|3325|lyfalmen|V0089|2749|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1634||1634|3325||1
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2992|3511|lyfalmen|V0069|3212|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1770||1770|3511||1
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|2514|2059|lyfalmen|V0033|2059|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||709||709|2059||1
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|7248|7691|lyfalmen|V0182|7640|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||4826||4826|7691||1
103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4454|4714|lyfalmen|V0334|4304|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||2650||2650|4714||1
103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7148|4714|lyfalmen|V0335|4304|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||2650||2650|4714||1
103806|N02AB0305|Fentanyl ratiopharm|forđapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2057|3903|lyfalmen|V0222|3903|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||2057||2057|3903||2
103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|335620|423086|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||335620||335620|423086||2
103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|120799|153485|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||120799||120799|153485||1
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3902|7665|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||3902||3902|7665||1
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2002||1
103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|12411|17458|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||12411||12411|17458||2
104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|3058|5273|lyfalmen|||2|98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||2000||3058|5273|28.2.2014|2
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3083|5307|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3083||3083|5307||1
104489|H01BA0201|Minirin|nefúđi|0,1|mg/ml|5|ml|1|úđagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6672|10216|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6672||6672|10216||1
104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|8128|12208|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8128||8128|12208||1
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|4564|7333|lyfalmen|V0017|7333|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4564||4564|7333||1
104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|5165|8155|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5165||5165|8155||1
104856|R03AK1101|Flutiform|innúđal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4466|7199|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4466||4466|7199||2
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|108307|137808|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||108307|137808||1
105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|DAC|0|0|0|100|DKK|1268|2820|lyfalmen|V0545|2820|3|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og ethinylestradíól||1265||1265|2820||2
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|13474|19740|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13474||13474|19740||1
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|15541|22334|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15541||15541|22334||1
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2364|4323|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2364||2364|4323||1
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2795|4913|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2795||2795|4913||1
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1809|3564|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1809||1809|3564||2
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3617|6037|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3617||3617|6037||2
106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3460|5822|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3460||3460|5822||2
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|18480|25075|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18480||18480|25075||1
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|10220|14709|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10220||10220|14709||1
106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|9126|5118|lyfalmen|V0572|5115|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||2945||2945|5118||2
107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|1995|1805|lyfalmen|V0278|1416|2|28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||523||523|1805||1
107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|1536|3191|lyfalmen|||2|100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1536||1536|3191||1
107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1543|3200|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1543||1543|3200||1
107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|4537|7296|lyfalmen|||2|30|0|30,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||4537||4537|7296|30.4.2014|1
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1517|2646|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1517||1517|2646||1
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|910|2334|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||910||910|2334||1
108103|M05BA0804|Zoledronic acid medac|irl|4|mg/glasi|100|ml|1|glas|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|49488|63990|lyfsjukr|||2|100|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||49488||49488|63990||2
108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|ţpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2685|4762|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2685||2685|4762||2
108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|53743|69330|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||53743||53743|69330||1
108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3236|5516|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3236||3236|5516||1
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|9606|14230|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9606||9606|14230||1
108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|85634|110301|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||85634||85634|110301||3
108741|QP52AC1304|Panacur PetPaste|pasta|187,5|mg|4,8|g|1|sk-dćl||QP52AC13|01.05.2014||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|812|1416|vetorma|||0|4,8|0||Vistor hf|Intervet International BV|||812||812|1416||1
108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1586|3259|lyfalmen|V0443|3258|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1586||1586|3259||1
109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23812|32714|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23812||23812|32714||1
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19063|26754|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19063||19063|26754||1
109569|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|2964|4646|lyfalmen|V0584|4646|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||2600||2600|4646||2
109578|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|7370|10261|lyfalmen|V0585|10261|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||6705||6705|10261||2
109588|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|4987|7450|lyfalmen|V0586|7450|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||4650||4650|7450||2
109597|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|14399|19711|lyfalmen|V0587|19711|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||13451||13451|19711||2
109615|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|22106|29383|lyfalmen|V0588|29383|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||21158||21158|29383||2
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|510|1787|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||510||510|1787||2
110094|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|12|stk|1|ţpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|10867|7668|lyfalmen|V0144|7459|2|12|0|24,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||4809||4809|7668||1
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|3004|lyfalmen|V0291|3004|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1400||1400|3004||2
110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|4783|lyfalmen|V0292|4783|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||2700||2700|4783||2
110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|6848|lyfalmen|V0296|6848|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4210||4210|6848||2
110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|7929|lyfalmen|V0297|7929|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|7929||2
110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1510|3155|lyfalmen|V0065|2320|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1510||1510|3155||1
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3861|6371|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3861||3861|6371||1
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|94900|120982|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||94900||94900|120982||1
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|5183|7327|lyfalmen|V0373|7327|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4560||4560|7327||1
111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|SLU|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumpicosúlfat|||||||1
111889|C07AB1201|Nebivolol Portfarma|töflur|5|mg|98|stk|1|ţpakki||C07AB12|01.08.2013||R|1|0|0|0|0|0|POF|0|0|0|100|XEU|3636|6063|lyfalmen|||2|98|0|98,0000|Portfarma ehf|Portfarma|Nebivolól||||3636|6063||1
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|735|2095|lyfalmen|V0229|2080|1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||735||735|2095||1
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|21335|29605|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21335||21335|29605||1
112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|XEU|16501|23539|lyfalmen|||1|180|0|90,0000|Vistor hf|Almirall S.A.|Aclídínumbrómíđ||16501||16501|23539||1
113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||||2
113247|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.03.2014||R|0|1|0|1|G|0|AUL|0|0|0|100|DKK|128480|164072|lyfalmen|V0140|164072|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Auxilium UK Limited|Clostridíum||128480||128480|164072||3
113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1915|3709|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1915||1915|3709||2
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8345|12505|lyfalmen|V0024|11321|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8345||8345|12505||1
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|24806|33962|lyfalmen|V0024|33962|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||24806||24806|33962||1
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8454|12654|lyfalmen|V0025|9939|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8454||8454|12654||1
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2279|3289|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2279||2279|3289||2
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|3208|5478|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3208||3208|5478||1
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|21504|29818|lyfalmen|V0025|29818|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||21504||21504|29818||1
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5510|8627|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5510||5510|8627||1
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|496538|625038|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||496538||496538|625038||1
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|650|1979|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||650||650|1979||1
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|823|2215|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||823||823|2215||1
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1355|2943|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1355||1355|2943||1
114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|949|2388|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||949||949|2388||1
114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|ţpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|23339|31173|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||23339|31173||2
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|34759|45505|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||34759|45505||2
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4053|6634|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4053||4053|6634||1
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999|30.04.2014|R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2315|4256|lyfalmen|||1|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2315||2315|4256||1
114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2176|4066|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2176||2176|4066||2
114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10665|15679|lyfalmen|V0594|15679|1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10665||10665|15679||1
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|6059|9378|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6059||6059|9378||2
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2445|1705|lyfalmen|V0278|1416|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||450||450|1705||2
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3197|1606|lyfalmen|V0279|1548|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||378||378|1606||2
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11094|1637|lyfalmen|V0280|1637|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||400||400|1637||2
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11674|2433|lyfalmen|V0282|2397|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||982||982|2433||2
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|7255|7883|lyfalmen|V0457|7883|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4966||4966|7883||2
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|14207|15580|lyfalmen|V0456|15580|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10593||10593|15580||2
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23237|15386|lyfalmen|V0475|15386|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10451||10451|15386||2
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|35825|20065|lyfalmen|V0540|20065|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|20065||2
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1868|3645|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1868||1868|3645||1
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|8711|12572|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||8711||8711|12572||1
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1526|2604|lyfalmen|V0158|2604|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1107||1107|2604||2
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11206|16419|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11206||11206|16419||1
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1868|3645|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1868||1868|3645||1
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11206|16419|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11206||11206|16419||1
115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|54842|71657|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||54842||54842|71657||1
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1861|3635|lyfalmen|V0369|3056|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1861||1861|3635||1
115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|3671|6111|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3671||3671|6111||1
115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|3687|5321|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3687||3687|5321||1
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|1927|2781|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1927||1927|2781||1
116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1999|lyfalmen|V0056|1999|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1999||2
116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1999|lyfalmen|V0057|1999|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1999||2
116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||||2
116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2492|4498|lyfalmen|V0630|4498|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2492||2492|4498||1
116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2928|5095|lyfalmen|V0632|5095|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2928||2928|5095||1
116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|19375|13501|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||9073||9073|13501||1
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|746|1981|lyfalmen|V0562|1627|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||652||652|1981||1
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|371|1582|lyfalmen|V0563|1357|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||360||360|1582||1
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|893|2290|lyfalmen|V0564|1760|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||878||878|2290||1
116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|17370|24629|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17370||17370|24629||1
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7427|5813|lyfalmen|V0081|4914|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3453||3453|5813||1
116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5919|9186|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5919||5919|9186||1
116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6356|9784|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6356||6356|9784||1
116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|18765|26380|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18765||18765|26380||1
116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|ţpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|12137|18062|lyfalmen|||2|56|0|56,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||12137||12137|18062||1
116841|D07AC1302|Ovixan|húđlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|990|2444|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||990|2444||1
116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|0|1|0|0|0|0|IPI|0|0|0|100|DKK|8096|12164|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8096||8096|12164||1
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|10035|19441|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum međ D-vítamíni/eđa öđrum efnum||10035||10035|19441||2
117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|2948|5122|lyfalmen|||1|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||2948||2948|5122||1
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4447|7173|lyfalmen|V0435|7070|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4447||4447|7173||2
117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|14407|18559|lyfalmen|V0275|18559|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||12533||12533|18559||1
117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|25462|30631|lyfalmen|V0273|30631|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||22152||22152|30631||1
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1576|3245|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1576||1576|3245||2
117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4403|7112|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4403|7112||1
117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|40864|47448|lyfalmen|V0272|47448|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||35552||35552|47448||1
117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|50924|66740|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||50924|66740||1
117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|58003|74676|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||58003||58003|74676||1
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9535|16633|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9535||9535|16633||2
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|6712|13061|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||6712||6712|13061||2
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|11772|22777|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||11772||11772|22777||2
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1780|1426|lyfalmen|V0278|1416|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||246||246|1426||1
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2919|1552|lyfalmen|V0279|1548|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||338||338|1552||1
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|10483|2561|lyfalmen|V0282|2397|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1076||1076|2561||1
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1721|2125|lyfalmen|V0283|1637|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||757||757|2125||1
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2196|4093|lyfalmen|||1|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2196||2196|4093||1
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728||5
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|17026|2433|lyfalmen|V0280|1637|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||982||982|2433||1
118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|22685|31300|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||22685||22685|31300||1
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|481|1747|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||481||481|1747||1
119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|75893|97128|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||75893||75893|97128||1
119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1352|2939|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1352||1352|2939||1
119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|947|2007|lyfalmen|V0309|2007|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||671||671|2007||2
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||||1
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|402917|507543|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||402917||402917|507543||1
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|402917|507543|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||402917||402917|507543||1
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|908|2331|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||908||908|2331||1
120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|47346|61302|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||47346||47346|61302||2
120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|30659|40360|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||30659||30659|40360||1
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5480|8586|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5480||5480|8586||1
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|8061|11634|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||8061||8061|11634||1
121302|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|467|1728|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1728||1
121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|8128|5266|lyfalmen|||2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5266|31.3.2014|1
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|403|1638|lyfalmen|V0391|1635|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||401||401|1638||1
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1729|3455|lyfalmen|V0314|3010|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1729||1729|3455||1
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|269|1457|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||269||269|1457||1
122301|R01AD0802|Nasofan|nefúđi|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón|||||||2
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9961|17376|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9961||9961|17376||1
122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|682|2022|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||682||682|2022||2
122577|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3070|3946|lyfalmen|V0381|3946|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2088||2088|3946||2
122588|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|15143|12550|lyfalmen|||2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||8378||8378|12550||2
122610|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3505|3574|lyfalmen|V0384|3574|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1816||1816|3574||2
122643|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|15143|12550|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||8378||8378|12550||2
122753|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN05|01.08.2013|31.03.2014|L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
122786|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN05|01.08.2013|31.03.2014|L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
122797|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN05|01.08.2013|31.03.2014|L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
122819|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir ţrýstingi|V03AN05|01.08.2013|31.03.2014|L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|822|2214|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||822||822|2214||1
123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1110|2608|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1110||1110|2608||1
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|24908|43451|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||24908||24908|43451||2
123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|ţpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|20983|29164|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||20983||20983|29164||1
123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|31277|54561|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||31277||31277|54561||2
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|241|1419|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||241|1419||1
123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2324|3004|lyfalmen|V0317|3004|2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1400||1400|3004||2
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|0|G|0|AVS|0|0|0|100|NOK|26239|35760|lyfalmen|V0579|29479|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||26239||26239|35760||1
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1791|3563|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1791|3563||2
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|34775|46473|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||34775|46473||1
124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|10236|15092|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||10236||10236|15092||2
124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1879|1963|lyfalmen|V0234|1963|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||639||639|1963||2
124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2683|2258|lyfalmen|V0233|2258|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||854||854|2258||2
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|981|2431|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||981||981|2431||1
124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|503|1777|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||503||503|1777||1
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|8878|13234|lyfalmen|V0464|13234|0|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||8878||8878|13234||1
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|827|2221|lyfalmen|V0066|2067|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||827||827|2221||1
125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|12799|18893|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||12799||12799|18893||1
125973|D01BA0206|Terbinafin Bluefish|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|XEU|2439|3371|lyfalmen|V0123|3371|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||1668||1668|3371||2
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|112098|142565|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||112098|142565||1
126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|28768|37986|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||28768|37986||1
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|24934|33175|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||24934||24934|33175||2
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|8311|11995|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||8311||8311|11995||2
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|34975|45776|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||34975||34975|45776||2
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|69949|89668|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||69949||69949|89668||2
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|139898|177454|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||139898||139898|177454||2
126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|133100|168923|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||133100||133100|168923||2
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38652|51338|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||38652|51338||2
126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|2934|5103|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||2934|5103||1
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|1006|2465|lyfalmen|V0447|2211|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1006||1006|2465||1
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
127542|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|4|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1831|2879|lyfalmen|V0144|2486|2|4|0|8,0000|Icepharma hf|Mylan AB|Síldenafíl||1308||1308|2879||2
127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Icepharma hf|Orifarm Generics A/S|Nikótín|||||||2
128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|8571|6225|lyfalmen|V0279|1548|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3754||3754|6225||2
128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|14180|27400|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||14180||14180|27400||1
128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|ţpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4905|7799|lyfalmen|||2|56|0|28,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||4905||4905|7799||1
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1209|2743|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1209||1209|2743||1
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3872|5588|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3872||3872|5588||2
129024|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|1684|lyfalmen|V0003|1673|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||435||435|1684||2
129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|30899|29888|lyfalmen|V0280|1637|1|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21560||21560|29888||2
129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|33584|23120|lyfalmen|V0282|2397|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16167||16167|23120||2
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|226|1398|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||226||226|1398||1
129483|J01DH0202|Merinfec|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.08.2013||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|18109|24609|lyfsjukr|||1|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||18109|24609||1
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3260||1
129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3425|5775|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||3425||3425|5775||1
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|18023|22567|lyfalmen|V0285|5080|1|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||15727||15727|22567||1
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|28529|34072|lyfalmen|V0286|10480|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||24894||24894|34072||1
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2266|4189|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2266||2266|4189||2
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|13712|26502|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||13712||13712|26502||1
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3921|6453|lyfalmen|V0644|6453|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||3921||3921|6453||1
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1771|3512|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1771||1771|3512||2
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|11156|16350|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11156|16350||1
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|58822|95968|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||58822|95968||1
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|3247|5531|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríđ||||3247|5531||2
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|458|1716|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||458||458|1716||1
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|721|2076|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||721||721|2076||1
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|961|2404|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||961||961|2404||1
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1064|2545|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||1064||1064|2545||1
131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5483|8590|lyfalmen|V0132|8590|1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5483||5483|8590||1
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|3855|6363|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||3855||3855|6363||2
131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|11564|16908|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||11564||11564|16908||2
131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38395|51016|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||38395||38395|51016||2
132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|7750|11691|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7750||7750|11691||1
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7162|2531|lyfalmen|V0581|2457|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1054||1054|2531||1
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4119|2531|lyfalmen|V0580|2457|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||1054||1054|2531||1
132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|11896|17362|lyfalmen|||1|28|0||Vistor hf|Almirall S.A.|Linaclotídum||11896||11896|17362||1
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1439|3058|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1439||1439|3058||1
132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6759|10335|lyfalmen|||1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6759||6759|10335||1
132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|9463|18343|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||9463||9463|18343||2
132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1035|2505|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1035||1035|2505||1
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1
132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1340|2922|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1340||1340|2922||1
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|27394|36262|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||27394||27394|36262||1
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|36439|47613|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||36439||36439|47613||1
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|47613|61637|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||47613|61637||1
133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|VIO|0|0|0|100|DKK|268318|338622|lyfsjukr|||1|2|0||Williams & Halls efh|ViroPharma SPRL|C1 hemill||268318||268318|338622||2
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|8440|12181|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||8440||8440|12181||1
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6635|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6635||1
133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|2115|lyfalmen|V0329|2115|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||750||750|2115||2
133974|N06AX1610|Venlafaxine Bluefish|forđahlk|37,5|mg|30|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3362|lyfalmen|V0333|3362|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3362||2
134019|N06AX1610|Venlafaxine Bluefish|forđahlk|75|mg|100|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|4304|lyfalmen|V0334|4304|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||2350||2350|4304||2
134085|N06AX1610|Venlafaxine Bluefish|forđahlk|150|mg|100|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|4304|lyfalmen|V0335|4304|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||2350||2350|4304||2
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998|28.02.2014|R|0|0|0|0|0|0|ABS|0|0|1|100|DKK|1493|3132|lyfalmen|||1|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1493||1493|3132||1
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3928|6463|lyfalmen|V0378|5732|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3928||3928|6463||2
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|11774|17196|lyfalmen|V0378|17196|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11774||11774|17196||2
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4639|6695|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4639||4639|6695||1
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|58811|75690|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||58811||58811|75690||1
134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|MBV|0|0|1|100|DKK|||lyfalmen|V0362|2103|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||9041||1
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|118054|150040|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||118054||118054|150040||2
134906|A02BC0307|Gasterix|sţ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4200|4372|lyfalmen|V0007|4372|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2400||2400|4372||2
134939|A02BC0307|Gasterix|sţ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3100|5056|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2900||2900|5056||2
135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|51836|66937|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||51836||51836|66937||1
135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|2590|4632|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2590||2590|4632||1
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|979|2429|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||979||979|2429||2
135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1340|2922|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1340||1340|2922||1
135559|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|4|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|5259|7590|lyfsjukr|||2|4|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||5259||5259|7590||1
136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1613|3296|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1613||1613|3296||1
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|6720|10282|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6720||6720|10282||1
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|68666|88058|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||68666||68666|88058||1
136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|450|1579|lyfalmen|V0307|1579|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||358||358|1579||2
136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2301|3321|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2301||2301|3321||2
136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|7204|10397|lyfsjukr|||2|16,7|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7204||7204|10397||2
136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5309|7662|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5309||5309|7662||2
136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|8276|11944|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8276||8276|11944||2
137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5819|8398|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5819||5819|8398||2
137218|G03AC0902|Gestrina|filmhtfl|75|mcg|168|stk|1|ţpakki|6x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|3288|4082|lyfalmen|||2|168|0|168,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||2188||2188|4082||1
137340|N04BC0506|Pramipexole Accord|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.04.2014||R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|9655|14297|lyfalmen|V0269|14297|2|100|0|28,0000|Portfarma ehf|Accord Healthcare Limited|Pramipexól||9655||9655|14297||1
137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|21174|28456|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21174||21174|28456||2
137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|6156|8885|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6156||6156|8885||2
137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|5376|7759|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||5376||5376|7759||2
137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|6076|8769|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6076||6076|8769||2
137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|729|1052|lyfsjukr|||2|1|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||729||729|1052||2
138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|1028|1484|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1028||1028|1484||2
138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3149|5397|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3149||3149|5397||2
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1681|3389|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1681||1681|3389||2
138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|ţpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16805|23920|lyfalmen|||1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||16805||16805|23920||1
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|4625|7327|lyfalmen|V0373|7327|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4560||4560|7327||1
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||5085||1
140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|133882|169904|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||133882||133882|169904||1
140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|334597|421802|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||334597||334597|421802||1
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1418|3029|lyfalmen|V0266|2165|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1418||1418|3029||1
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|11470|16277|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11470||11470|16277||1
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|DES|0|0|0|100|DKK|621|896|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||621||621|896||3
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|1|0|0|100|NOK|85211|163790|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||85211||85211|163790||1
140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1211|2746|lyfalmen|V0413|2471|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1211||1211|2746||1
141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|2934|5103|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||2934|5103||1
141153|R01AB0601|Otrivin Comp|nefúđi|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008|28.02.2014|R|0|0|0|0|0|1|DAC|0|0|0|100|DKK|4403|6183|lyfsjukr|||3|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4284||4284|6183||2
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3760|5427|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3760||3760|5427||2
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|16845|23971|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||16845|23971||2
141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|VIO|0|0|1|100|DKK|51229|67122|lyfalmen|||1|50|0|8,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||51229||51229|67122||2
141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4084|6676|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||4084|6676||2
141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|13124|9289|lyfalmen|V0492|8074|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||5994||5994|9289||2
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|8400|12580|lyfalmen|V0267|5189|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8400||8400|12580||1
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1910|3605|lyfalmen|V0127|3587|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1839||1839|3605||2
142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||L|0|0|0|0|0|0|LEV|1|0|0|100|XEU|1624|2833|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||||1624|2833||2
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|901|2322|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||901||901|2322||1
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2791|4907|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2791||2791|4907||1
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1409|3017|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1409||1409|3017||1
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2213|3194|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2213||2213|3194||1
143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|3767|6242|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3767||3767|6242||1
143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|573|1549|lyfalmen|V0542|1277|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||336||336|1549||1
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|855|2259|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||855||855|2259||1
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1438|3056|lyfalmen|V0173|2561|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1438||1438|3056||1
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6449|9911|lyfalmen|V0387|8837|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6449||6449|9911||1
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1296|2862|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1296||1296|2862||1
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|8223|12338|lyfalmen|V0386|8955|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||8223||8223|12338||1
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|592|1899|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||592||592|1899||1
143800|N05AN0101|Litarex|forđatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2214|4118|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2214||2214|4118||1
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1684|3393|lyfalmen|V0174|2954|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1684||1684|3393||1
144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2038|3877|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2038||2038|3877||1
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|22410|30955|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22410||22410|30955||1
144107|N06DX0104|Memantine LEK|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.08.2013|30.04.2014|R|1|0|0|0|G|0|SHR|0|0|0|100|DKK|17769|13454|lyfalmen|||2|98|0|49,0000|Artasan ehf|Pharmathen S.A.|Memantín||9039||9039|13454||1
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|78702|100654|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||78702||78702|100654||1
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|58822|75704|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||58822||58822|75704||1
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|36549|47751|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||36549||36549|47751||1
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|639|1963|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||639||639|1963||1
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|77262|98846|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||77262||77262|98846||1
145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1757|3495|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1757||1757|3495||1
145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2665|5290|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2665||2665|5290||1
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977|30.04.2014|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2168|4055|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2168||2168|4055||1
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1
145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4100|8045|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4100||4100|8045||1
145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5718|11152|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5718||5718|11152||1
145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998|28.02.2014|R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|20215|20022|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13699||13699|20022||2
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|30111|39672|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||30111|39672||1
146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2972|4289|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||2972||2972|4289||2
146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6038|8714|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6038||6038|8714||2
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|ţpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|17286|24524|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||17286||17286|24524||2
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|796|2178|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||796||796|2178||1
147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2465|3558|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2465||2465|3558||2
147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1527|2204|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1527||1527|2204||2
148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|110324|141287|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||110324||110324|141287||2
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1180|2389|lyfalmen|V0577|2389|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||950||950|2389||1
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1755|3490|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1755||1755|3490||1
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|6291|8947|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||5744||5744|8947||1
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|81422|105015|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||81422||81422|105015||1
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|81422|105015|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||81422||81422|105015||1
148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|447|1589|lyfalmen|V0601|1589|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||365||365|1589||1
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|834|2230|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||834||834|2230||1
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814||5
148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6413|9256|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6413||6413|9256||2
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|13443|18753|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13443||13443|18753||2
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|XEU|28758|37974|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28758||28758|37974||2
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3553|6995|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3553||3553|6995||2
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2045|3887|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2045||2045|3887||1
149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1020|2485|lyfalmen|V0376|1703|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1020||1020|2485||1
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|5112|8082|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||5112||5112|8082||1
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|43321|56250|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||43321|56250||1
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6423|9876|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6423||6423|9876||1
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1074|2559|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1074||1074|2559||1
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|15597|22404|lyfalmen|V0606|7776|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15597|22404||1
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|48159|60391|lyfalmen|V0607|22437|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||45865||45865|60391||1
151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|414|1656|lyfalmen|V0633|1600|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||414||414|1656||1
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4867|7747|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4867|7747||2
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5208|3829|lyfalmen|V0148|3046|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||2003||2003|3829||2
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1541|3197|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1541||1541|3197||1
151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3962|lyfalmen|V0006|3962|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2100||2100|3962||2
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1965|2836|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1965||1965|2836||1
152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|DAC|0|0|0|100|XEU|2537|3371|lyfalmen|V0123|3371|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||1668||1668|3371||2
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3157|5408|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3157||3157|5408||1
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5247|8267|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5247||5247|8267||1
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|9565|14174|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||9565||9565|14174||1
152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|18472|14302|lyfalmen|V0269|14297|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||9659||9659|14302||2
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1213|2749|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1213||1213|2749||1
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1738|3467|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1738||1738|3467||1
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|32492|42660|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||32492|42660||1
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2194|4091|lyfalmen|V0561|3812|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2194||2194|4091||1
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1535|3189|lyfalmen|V0560|2994|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1535||1535|3189||1
153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|3773|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3855||1
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|224109|283139|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||224109||224109|283139||2
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|535|1821|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||535|1821||1
153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|31884|42844|lyfalmen|V0452|42844|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||31884||31884|42844||1
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4189|6820|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4189||4189|6820||1
153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|315|1520|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||315||315|1520||1
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|522|1803|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||522||522|1803||1
154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|1195|2724|lyfalmen|V0366|2318|2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||1195||1195|2724||2
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|9228|13713|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9228||9228|13713||1
154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|24148|33136|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||24148||24148|33136||1
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1035|2505|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1035||1035|2505||1
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26063|34592|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||26063||26063|34592||2
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32479|42644|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||32479||32479|42644||2
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|41112|53478|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||41112||41112|53478||2
154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29408|38790|lyfsjukr|||1|7389|0||Icepharma hf|Fresenius Kabi|Blöndur||29408||29408|38790||2
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30429|40071|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||30429||30429|40071||2
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|37431|48858|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||37431||37431|48858||2
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26815|35535|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||26815||26815|35535||2
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3228|5505|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3228||3228|5505||1
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|34964|45762|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||34964||34964|45762||2
154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1496|3136|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1496||1496|3136||1
154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4254|4638|lyfalmen|V0334|4218|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||2594||2594|4638||1
154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6827|4638|lyfalmen|V0335|4218|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||2594||2594|4638||1
154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|440777|556005|lyfalmen|||1|252|0|28,0300|Vistor hf|InterMune Europe Ltd.|Pírfenidon||440777||440777|556005||1
155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5600|4574|lyfalmen|V0604|4574|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Memantín||2547||2547|4574||2
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10665|15679|lyfalmen|V0594|15679|1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10665||10665|15679||1
155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2175|3538|lyfalmen|V0247|3139|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||1790||1790|3538||1
155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3665|6103|lyfalmen|V0248|6102|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3665||3665|6103||1
155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6589|9320|lyfalmen|V0249|7922|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6017||6017|9320||1
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1491|3129|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1491||1491|3129||1
155410|A02BC0403|Rabeprazol Krka|sţ-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|1684|lyfalmen|V0466|1673|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||435||435|1684||2
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|638|1962|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||638||638|1962||1
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1644|2586|lyfalmen|V0590|2320|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1094||1094|2586||1
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|6541|10037|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6541||6541|10037||1
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5558|8692|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5558||5558|8692||2
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5806|9032|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5806||5806|9032||2
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|421|1665|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||421||421|1665||1
156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2310|3334|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2310||2310|3334||2
156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1354|1954|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1354||1354|1954||2
156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6327|9131|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6327||6327|9131||2
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9273|13774|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9273||9273|13774||2
156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|8475|12232|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8475||8475|12232||2
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|845|2245|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||845||845|2245||1
156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|11550|22350|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|||11550||11550|22350||2
156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775||2
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|2718|2177|lyfalmen|||2|28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||795||795|2177|28.2.2014|1
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1494|3133|lyfalmen|V0239|3133|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1494||1494|3133||1
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|6913|10546|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6913||6913|10546||1
158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|1133|1635|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||1133|1635||1
158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1532|3185|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1532|3185||1
158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|28223|38250|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||28223|38250||1
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|931|2363|lyfalmen|V0239|1567|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||931||931|2363||1
158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|101356|129084|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||101356|129084||1
158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|185887|235171|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||185887|235171||1
158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|574789|723243|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||574789|723243||1
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|51931|67056|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||51931|67056||1
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|74082|94855|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||74082||74082|94855||1
158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|0|0|0|0|G|0|DES|0|0|0|100|DKK|803|2188|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||803||803|2188||3
158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1001|1999|lyfalmen|V0469|1910|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||665||665|1999||2
159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|2072|3482|lyfalmen|V0219|3482|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1749||1749|3482||1
159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3553|5889|lyfalmen|V0220|5889|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3509||3509|5889||1
159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5101|7584|lyfalmen|V0221|7582|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4748||4748|7584||1
159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5701|8237|lyfalmen|V0223|8237|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5225||5225|8237||1
159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2457|lyfalmen|V0581|2457|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1000||1000|2457||2
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5082|4708|lyfalmen|V0318|1759|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2645||2645|4708||1
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13032|12234|lyfalmen|V0320|2678|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8147||8147|12234||1
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1843|2723|lyfalmen|V0062|1719|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1194||1194|2723||1
159565|J01CR0501|Piperacillin/Tazobactam Actavis|irs|||12|hgl|1|pakki|4 g/ 0,5 g|J01CR05|01.10.2013||R|0|1|0|0|0|1|APC|0|0|0|100|XEU|17135|23387|lyfsjukr|||1|12|0|3,4200|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||17135||17135|23387||1
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3190|3757|lyfalmen|V0067|1719|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1950||1950|3757||1
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6574|4950|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2822||2822|4950||1
159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|513|1791|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||513||513|1791||2
159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1555|3217|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1555||1555|3217||2
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|98800|125877|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||98800||98800|125877||1
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4132|8107|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4132||4132|8107||2
160164|M01AE0219|Alpoxen|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.05.2014||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen|||||||1
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5305|2457|lyfalmen|V0010|2330|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2457||1
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|7387|4501|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||3119||3119|4501||1
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|909|2333|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||909||909|2333||1
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2366|4326|lyfalmen|||1|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2366||2366|4326|28.2.2014|1
160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1179|2702|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1179||1179|2702||1
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|583|1887|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||583||583|1887||1
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|904|1305|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||904||904|1305||1
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|821|1185|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||821||821|1185||1
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|595|1903|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||595||595|1903||1
161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|4871|7753|lyfalmen|V0131|7753|1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4871||4871|7753||1
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|59167|77085|lyfalmen|V0452|42844|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||59167||59167|77085||1
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|12058|17015|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||12058||12058|17015||1
162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|153293|194265|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||153293||153293|194265||1
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|535587|674992|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||535587||535587|674992||1
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1884|3667|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1884||1884|3667||1
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5351|10447|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5351|10447||2
162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2801|2966|lyfalmen|V0041|2966|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíđ mónónítrat||1372||1372|2966||2
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|459|1691|lyfalmen|V0500|1691|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1691||2
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2108|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2108||2
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|2175|lyfalmen|V0502|2175|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||794||794|2175||2
162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1675|lyfalmen|V0108|1675|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1675||2
162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1803|lyfalmen|V0109|1803|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1803||2
162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2134|lyfalmen|V0110|2134|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2134||2
162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|1613|3229|lyfalmen|V0373|2442|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1564||1564|3229||1
162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1462|3089|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1462||1462|3089||1
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|1124|2627|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1124||1124|2627||1
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1532|3185|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1532||1532|3185||1
163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|1|0|0|0|G|0|AEA|0|0|0|100|XEU|199|1362|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||199|1362||1
163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12989|18184|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||12989||12989|18184||2
163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2551|4579|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2551||2551|4579||1
163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|566381|712691|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||566381||566381|712691||2
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|688|1760|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||490||490|1760||2
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1652|2701|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1178||1178|2701||2
163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|8140|12224|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12224||1
164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|317899|400846|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||317899||317899|400846||1
164125|R01AA0707|Otrivin Junior ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001|31.03.2014|R|0|0|0|0|G|0|APP|0|0|0|100|XEU|12658|18716|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||12658||12658|18716||1
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3813|5503|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3813||3813|5503||2
164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9436|18291|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||9436||9436|18291||1
164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóđur|QA07XA91|01.03.2014||R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|43245|83209|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||43245||43245|83209||2
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2920|5084|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2920|5084||2
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|9627|14259|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||9627||9627|14259||2
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1187|2713|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1187||1187|2713||2
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1404|3010|lyfalmen|V0314|3010|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1404||1404|3010||2
164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|7133|10847|lyfalmen|V0014|10309|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||7133|10847||2
165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|824|2217|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||824||824|2217||1
165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|24148|33136|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||24148||24148|33136||1
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6808|13245|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6808||6808|13245||2
165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4941|7848|lyfalmen|V0059|5872|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4941||4941|7848||1
165507|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|23566|31458|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||23566||23566|31458||1
165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3189|5452|lyfalmen|V0058|4887|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3189||3189|5452||1
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|181628|229826|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||181628||181628|229826||2
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33127|43457|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||33127||33127|43457||2
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|48233|62415|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||48233||48233|62415||2
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|684|2025|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||684||684|2025||1
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|198|1360|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||198||198|1360||1
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4029|5815|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4029||4029|5815||2
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|64346|82637|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||64346||64346|82637||2
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4598|9001|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4598|9001||1
166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|466001|587661|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||466001||466001|587661||2
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1689|3400|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1689||1689|3400||1
166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|14932|21570|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14932||14932|21570||1
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2164|4050|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||2164||2164|4050||2
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|4096|6692|lyfalmen|V0428|6692|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||4096||4096|6692||2
166496|J01CA0413|Amoxin|mixt.kyr|100|mg/ml|40|ml|1|glas||J01CA04|01.06.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1393|2995|lyfalmen|||2|40|0|4,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1393||1393|2995|28.2.2014|2
166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|4809|5554|lyfalmen|V0550|5554|2|90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||3264||3264|5554||1
166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|G|0|AUL|0|0|0|100|DKK|128480|164072|lyfalmen|V0140|164072|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Auxilium UK Limited|Clostridíum||128480||128480|164072||3
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1
167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|442|1694|lyfalmen|V0333|784|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||442||442|1694||1
168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|174690|221118|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og cobícístat||174690||174690|221118||2
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|526|1809|lyfalmen|V0119|1746|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||526|1809||1
168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|5255|lyfalmen|V0007|4285|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5255||1
168589|N02CC0402|Maxalt Smelt|frţ.tfl|10|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4401|7110|lyfalmen|V0621|1772|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4401||4401|7110||1
168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2410|4386|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2410||2410|4386||2
168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2582|4621|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2582||2582|4621||2
168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2836|4969|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2836||2836|4969||2
168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3206|5475|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3206||3206|5475||2
168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3377|5709|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3377||3377|5709||2
168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2999|5192|lyfalmen|V0240|5192|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2999||2999|5192||1
168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5536|8662|lyfalmen|V0433|8660|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5536||5536|8662||1
168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|52605|67902|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||52605||52605|67902||1
169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|228716|288921|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||228716||228716|288921||1
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|21324|28644|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21324||21324|28644||2
169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5287|8322|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5287||5287|8322||
169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|1407|2937|lyfalmen|V0124|2937|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2937||1
169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|2450|4307|lyfalmen|V0125|4307|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4307||1
169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2687|lyfalmen|V0411|2687|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2687||1
169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1974|lyfalmen|V0177|1974|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1974||1
169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1962|lyfalmen|V0418|1962|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1962||1
169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1627|lyfalmen|V0176|1627|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1627||1
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2878|5026|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2878||2878|5026||1
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3098|5327|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3098||3098|5327||1
170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|19658|26553|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||19658|26553||2
170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|48677|62972|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||48677|62972||2
170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|5684|8865|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5684||5684|8865||1
170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|97356|124064|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||97356||97356|124064||2
170489|G04BD0705|Tolterodine Sandoz|forđahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3396|5735|lyfalmen|V0618|5735|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||3396|5735||1
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|ţpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|15768|22619|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||15768||15768|22619||2
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996|28.02.2014|R|1|0|0|1|G|0|ABS|0|0|0|100|DKK|3908|6435|lyfalmen|||1|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3908||3908|6435||1
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996|28.02.2014|R|1|0|0|1|G|0|ABS|0|0|0|100|DKK|6840|10446|lyfalmen|||1|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6840||6840|10446||1
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2355|4311|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2355||2355|4311||1
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|11258|16011|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11258||11258|16011||1
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|27082|35870|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||27082||27082|35870||1
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|40622|52863|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||40622||40622|52863||1
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3306|3679|lyfalmen|V0203|3679|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1893||1893|3679||1
170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|12363|2315|lyfalmen|V0207|2315|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||896||896|2315||1
170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|56661|72992|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||56661||56661|72992||2
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|1|0|0|100|DKK|2691|5340|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2691||2691|5340||1
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3568|5970|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3568||3568|5970||1
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3602|6017|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3602||3602|6017||1
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005|28.02.2014|R|0|0|0|0|0|0|LDR|0|0|0|100|NOK|1426|3040|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1426||1426|3040||2
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2982|5169|lyfalmen|V0247|3139|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2982||2982|5169||1
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|5212|8219|lyfalmen|V0248|6102|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||5212||5212|8219||1
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|44019|57126|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||44019||44019|57126||2
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|29347|38713|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||29347||29347|38713||2
172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488||2
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|9510|14099|lyfalmen|V0249|7922|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9510||9510|14099||1
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|17357|24613|lyfalmen|V0252|19691|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||17357||17357|24613||1
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|67497|86591|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||67497||67497|86591||2
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33539|lyfalmen|V0346|33539|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33539||2
172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|47607|62577|lyfalmen|V0068|62577|1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||47607||47607|62577||1
172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|11335|16595|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11335||11335|16595||1
172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6253|9643|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6253||6253|9643||2
172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11616|16979|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11616||11616|16979||2
172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2999|2556|lyfalmen|V0284|2541|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1072||1072|2556||1
172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|20153|28122|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20153||20153|28122||2
172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|601612|757853|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||601612||601612|757853||1
172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|26281|35813|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26281||26281|35813||2
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|408|1647|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||408||408|1647||1
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10480|15425|lyfalmen|V0118|15425|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||10480||10480|15425||1
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3389|5725|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||3389||3389|5725||2
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3639||1
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|5996|9292|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||5996||5996|9292||2
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|16329|22251|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16230||16230|22251||1
173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|15593|21452|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||15593||15593|21452||1
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2488|3591|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||2488||2488|3591||1
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|658|1989|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||658||658|1989||1
174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1351|2937|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1351||1351|2937||1
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|672|2009|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||672||672|2009||1
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|1737|3465|lyfalmen|V0368|2686|1|5|0|25,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||1737||1737|3465||1
174522|N04BC0505|Oprymea|forđatfl|0,26|mg|30|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5056|lyfalmen|V0634|5056|2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5056||2
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|5094|8058|lyfalmen|V0368|8058|1|15|0|75,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||5094||5094|8058||1
175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5262|10276|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||5262||5262|10276||2
175600|G03AA0904|Denise|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1477|2320|lyfalmen|V0065|2320|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||900||900|2320||2
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|2514|2315|lyfalmen|V0033|2059|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||896||896|2315||1
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5
176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6530|5010|lyfalmen|V0278|1416|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2866||2866|5010||2
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|5815|9044|lyfalmen|V0429|9044|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||5815||5815|9044||2
176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2711|4798|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2711||2711|4798||1
176681|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|53743|69330|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||53743||53743|69330||1
177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8842|12761|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8842||8842|12761||2
177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1130|2635|lyfalmen|V0231|2635|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1130||1130|2635||1
177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4517|8846|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4517||4517|8846||2
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|2078|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|2078||1
178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|38395|51016|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||38395||38395|51016||2
178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5438|4783|lyfalmen|V0320|4783|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||2700||2700|4783||2
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|139366|176787|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||139366||139366|176787||1
179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10390|9925|lyfalmen|V0253|9925|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||6459||6459|9925||2
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10864|15951|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||10864|15951||2
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|128175|162742|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||128175||128175|162742||2
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5508|8624|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5508||5508|8624||1
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2563|3392|lyfalmen|V0148|3384|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1683||1683|3392||2
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|784|2162|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||784||784|2162||1
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7910|15361|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7910||7910|15361||2
181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9615|13877|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9615||9615|13877||1
181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6018|9322|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6018||6018|9322||1
182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|12738|18816|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12738||12738|18816||1
182502|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|17510|23858|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||17510||17510|23858||2
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5302|10353|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5302||5302|10353||1
183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1879|1963|lyfalmen|V0234|1963|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||639||639|1963||2
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5693|8877|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5693|8877||1
183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|1271596|1597735|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1271596||1271596|1597735||1
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|BRS|0|0|0|100|DKK|1169|2688|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1169||1169|2688||1
184014|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|ţpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|6651|10188|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||6651||6651|10188||1
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|482|1749|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||482||482|1749||1
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1603|2232|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2232||1
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4800|7656|lyfalmen|V0017|7333|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4800|7656||2
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|21370|29649|lyfalmen|V0170|7692|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||21370||21370|29649||1
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|54310|70989|lyfalmen|V0185|16040|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||54310||54310|70989||1
184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|ţpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1163|2680|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1163||1163|2680||1
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|5192|8192|lyfalmen|V0235|6524|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5192||5192|8192||1
186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|35725|22895|lyfalmen|V0607|22895|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Memantín||15988||15988|22895||2
187057|N07BB0501|Selincro|filmhtfl|18|mg|7|stk|1|ţpakki||N07BB05|01.06.2013|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|4207|6844|lyfalmen|||1|7|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||4207||4207|6844||1
187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|ţpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3192|3825|lyfalmen|V0462|3825|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3825||2
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|4480|7218|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||4480||4480|7218||1
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|WTE|0|0|0|100|DKK|75901|97138|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||75901||75901|97138||2
188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3317|3401|lyfalmen|V0621|1772|2|6|0|6,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||1690||1690|3401||1
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|G|0|DEA|0|0|0|100|XEU|2888|5040|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2888||2888|5040||1
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|3017|5216|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||3017||3017|5216||2
189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|9493|13701|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||9493||9493|13701||1
189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|47064|60948|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||47064||47064|60948||1
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|7041|10162|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||7041||7041|10162||1
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2453|4445|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2453||2453|4445||1
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1010|2471|lyfalmen|V0413|2471|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1010||1010|2471||1
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|489|1758|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||489||489|1758||1
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|453|654|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||453||453|654||1
190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|266|1453|lyfalmen|V0642|1453|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||266||266|1453||1
190425|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|7866|11850|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||7866|11850||2
190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|981|2431|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||981||981|2431||1
190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|867|2275|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||867||867|2275||1
191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3798|5481|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3798||3798|5481||2
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6899|10527|lyfalmen|V0117|10527|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||6899||6899|10527||1
191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3618|5222|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3618||3618|5222||2
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3733|5388|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3733||3733|5388||2
191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4375|7074|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4375||4375|7074||1
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|513|1791|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||513||513|1791||
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3774|6252|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3774||3774|6252||1
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1580|3251|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1580||1580|3251||1
192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8831|12745|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8831||8831|12745||2
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|0|0|100|SEK|181920|230192|lyfsjukr|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||181920||181920|230192||1
193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|ţpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|1006|2465|lyfalmen|V0447|2211|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1006||1006|2465||1
193583|L01XE1801|Jakavi|töflur|5|mg|60|stk|1|glas||L01XE18|01.11.2012|28.02.2014|R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|326243|411317|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||326243||326243|411317||1
193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2344||1
193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|43016|70181|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||43016||43016|70181||1
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1788|3535|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1788||1788|3535||2
195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.12.2013|31.03.2014|R|0|0|0|0|G|0|PCO|0|0|1|100|DKK|3338|5656|lyfalmen|||2|5|1|250,0000|Distica|Distica - óskráđ lyf|Cýanókóbalamíntannín-komplex||3338||3338|5656||1
195445|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|14099|20524|lyfalmen|V0609|20524|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||14099||14099|20524||1
195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|9142|8030|lyfalmen|V0012|5231|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||5074||5074|8030||1
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|60543|77864|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||60543||60543|77864||2
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|139366|176787|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||139366||139366|176787||1
195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|991|2445|lyfalmen|V0631|2445|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||991||991|2445||1
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|736|2096|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||736||736|2096||1
195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|377|1605|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||377||377|1605||1
195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|799|2182|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||799||799|2182||1
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2284|4214|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2284||2284|4214||2
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1512|3158|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1512||1512|3158||2
196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010|28.02.2014|L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|7855|11830|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||7852||7852|11830||1
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|21661|29067|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||21661|29067||1
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|2514|5000|vetalmen|||0|10|0||Vistor hf|Intervet International BV|||2514||2514|5000||1
197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|575|1746|lyfalmen|V0119|1746|2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||480||480|1746||2
197554|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|150|skammtar|1|fl|1 x 150 úđaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|837|2234|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||837||837|2234||1
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2740|4838|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2740||2740|4838||1
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2075|3928|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2075||2075|3928||1
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001|31.03.2014|R|0|0|0|1|G|0|APP|0|0|0|100|XEU|12870|18982|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||12870||12870|18982||1
198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|ţpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2212|3278|lyfalmen|V0069|3278|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Lósartan||1600||1600|3278||2
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7013|10122|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7013||7013|10122||1
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|35242|47059|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||35242||35242|47059||1
199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|8346|5264|lyfalmen|V0515|5264|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3052||3052|5264||1
199319|A10BG0304|Pioglitazone Accord|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|7171|5115|lyfalmen|V0572|5115|2|98|0|49,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||2943||2943|5115||1
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|618|1935|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||618||618|1935||1
199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|7641|5111|lyfalmen|||2|98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2940||2940|5111|28.2.2014|1
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|92033|117384|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||92033|117384||1
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4563|7331|lyfalmen|V0126|7331|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4563||4563|7331||1
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|55128|71068|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||55128||55128|71068||0
199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2673615|3357269|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2673615||2673615|3357269||1
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|ţpakki||A05AA02|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5304|8173|lyfalmen|||0|60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5178||5178|8173||1
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|659|951|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||659||659|951||2
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|30285|58324|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30285||30285|58324||1
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2746|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2746||2
370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|11531|5231|lyfalmen|V0012|5231|2|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3028||3028|5231||1
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|573|827|lyfsjukr|||1|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||573||573|827||2
371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|9728|14397|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||9728||9728|14397||1
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||9824||1
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|4289|6956|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||4289||4289|6956||1
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3575|5980|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3575||3575|5980||2
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372283|N06AB1006|Escitalopram Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4922|2311|lyfalmen|V0325|2243|2|100|0|100,0000|Portfarma ehf|Portfarma|Escítalópram||893||893|2311||1
373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2452|4444|lyfalmen|||1|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||2452||2452|4444||1
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|14376|20872|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||14376||14376|20872||1
373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4063|6647|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4063||4063|6647||1
373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6665|10207|lyfalmen|V0436|10205|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||6665||6665|10207||1
373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|8738|13042|lyfalmen|V0437|13041|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||8738||8738|13042||1
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|7289|4385|lyfalmen|V0420|4385|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||2409||2409|4385||2
373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|457|1615|lyfalmen|V0541|1615|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||384||384|1615||1
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1544|3201|lyfalmen|V0126|1833|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1544||1544|3201||1
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|378702|477154|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||378702||378702|477154||1
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|550|1842|lyfalmen|V0500|1691|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||550||550|1842||2
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5604|8088|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5604||5604|8088||2
374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6835|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6835||2
374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|21459|29761|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||21459||21459|29761||2
374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4507|7255|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4507||4507|7255||1
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|11333|16592|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11333||11333|16592||1
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7723|11654|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7723||7723|11654||1
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|9115|13558|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9115||9115|13558||1
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|10674|15691|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10674||10674|15691||1
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|30199|40730|lyfalmen|V0459|40730|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||30199||30199|40730||1
376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|0|0|GGL|0|0|0|100|GBP|7573|11449|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||7573||7573|11449||1
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|19416|27197|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||19416||19416|27197||1
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|91270|117374|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||91270||91270|117374||1
377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|12481|21772|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||12481||12481|21772||2
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|4191|6822|lyfalmen|||1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4191||4191|6822||1
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|10977|8795|lyfalmen|V0182|8022|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5633||5633|8795||1
378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2492|4498|lyfalmen|V0630|4498|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2492||2492|4498||1
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|16042|22963|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||16042||16042|22963||1
379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8144|14207|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||8144||8144|14207||2
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|154157|195350|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||154157|195350||1
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|97998|124870|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||97998||97998|124870||1
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|137892|174937|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||137892||137892|174937||1
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|177810|225034|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||177810||177810|225034||1
379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|148849|188688|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||148849||148849|188688||1
379796|N04BC0406|Ropinirole Portfarma|forđatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|9046|7598|lyfalmen|||2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||4758||4758|7598|31.3.2014|1
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1476|3108|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1476||1476|3108||1
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1824|3584|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1824||1824|3584||1
380162|H01BA0201|Minirin|nefúđi|0,1|mg/ml|5|ml|3|úđagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|20436|28477|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||20436||20436|28477||1
380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|8365|12532|lyfalmen|||2|100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||8365||8365|12532|28.2.2014|2
380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|11104|8331|lyfalmen|V0606|8331|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Memantín||5294||5294|8331||2
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|7465|6190|lyfalmen|V0143|6036|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3729||3729|6190||2
382162|N04BC0406|Ropinirole Portfarma|forđatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15987|13042|lyfalmen|||2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||8738||8738|13042|31.3.2014|1
382190|G04BE0307|Sildenafil Mylan|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4022|6216|lyfalmen|V0141|6216|2|4|0|2,0000|Icepharma hf|Mylan AB|Síldenafíl||3748||3748|6216||2
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|6799|10390|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6799||6799|10390||1
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1258|2195|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1258|2195||2
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7575|13214|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7575||7575|13214||2
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2165|4051|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2165||2165|4051||1
383445|J05AG0101|Viramune|forđatfl|400|mg|30|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|41652|54156|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||41652||41652|54156||1
383933|L01XE1801|Jakavi|töflur|15|mg|60|stk|1|glas||L01XE18|01.11.2012|28.02.2014|R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|652475|820739|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||652475||652475|820739||1
385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8256|12383|lyfalmen|V0616|12383|1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8256||8256|12383||1
386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|6037|5549|lyfalmen|V0144|4973|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3260||3260|5549||2
386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|56141|73287|lyfalmen|V0184|7234|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||56141||56141|73287||1
387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|910|2076|lyfalmen|V0308|2076|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||721||721|2076||2
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|0|0|0|0|0|0|ICE|0|0|0|100|XEU|717|1426|vetalmen|||0|100|0||Icepharma hf|Icepharma hf|||717||717|1426||2
387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|0|0|0|0|0|1|TBV|0|0|0|100|DKK|196555|248559|lyfsjukr|||1|200|0|28,5714|Vistor hf|Teva Pharma B.V.|Amfóterícín||196555||196555|248559||1
387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|126711|160905|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||126711||126711|160905||1
387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|13124|9289|lyfalmen|V0491|9289|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||5994||5994|9289||2
388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|159642|202233|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||159642||159642|202233||1
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3232|5511|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3232||3232|5511||1
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4074|6662|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4074||4074|6662||1
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1
388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.04.2013||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|13108|18333|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||13108||13108|18333||1
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|7905|11903|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||7905||7905|11903||1
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2383|1673|lyfalmen|V0466|1673|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||427||427|1673||1
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2739|4836|lyfalmen|V0410|4836|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2739||2739|4836||1
389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2057|3903|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2057||2057|3903||1
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|808|2195|lyfalmen|V0128|2195|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||808||808|2195||1
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|604|1916|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||604||604|1916||1
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|914|2340|lyfalmen|V0367|1736|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||914||914|2340||1
389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2641|2769|lyfalmen|V0143|2012|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1228||1228|2769||2
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|3814|5189|lyfalmen|V0267|5189|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2997||2997|5189||2
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|48474|63665|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||48474|63665||2
389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|ţpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|AGT|0|0|0|100|SEK|369|1359|lyfalmen|V0312|1359|2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Zópíklón||197||197|1359||1
389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|18155|25615|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18155||18155|25615||1
390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|80511|102924|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||80511||80511|102924||1
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2867|5011|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2867||2867|5011||1
390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|2987|2007|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||671||671|2007||2
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6870|10487|lyfalmen|V0429|9044|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6870||6870|10487||1
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2713|4801|lyfalmen|V0037|3980|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2713||2713|4801||1
391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|25242|34509|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||25242|34509||2
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|13239|19445|lyfalmen|V0196|16417|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13239||13239|19445||1
391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|339654|272332|lyfsjukr|||2|30|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||215498||215498|272332||1
391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2603|4650|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2603||2603|4650||1
391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2481|4483|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2481||2481|4483||2
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|218125|275629|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||218125||218125|275629||2
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4485|5889|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3509||3509|5889||1
392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|9999|14767|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9999||9999|14767||1
393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|20927|11170|lyfalmen|V0286|10480|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||7369||7369|11170||1
393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|VIO|0|0|1|100|DKK|84264|108581|lyfalmen|||1|50|0|33,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||84264||84264|108581||2
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5517|10766|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5517||5517|10766||2
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|2311|lyfalmen|V0327|2311|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||893||893|2311||2
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
394357|A10BX0205|Repaglinide Accord|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.04.2014||R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|1463|3091|lyfalmen|V0471|2869|2|90|0|22,5000|Portfarma ehf|Accord Healthcare Limited|Repaglíníđ||1463||1463|3091||1
395372|L01XA0303|Oxaliplatin Actavis|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.05.2013||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|26237|8397|lyfsjukr|||2|20|0||Actavis Group hf|Actavis Group PTC ehf|Oxalíplatín||5818||5818|8397||1
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|145959|183920|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||145050||145050|183920||1
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|25536|34878|lyfalmen|V0356|34878|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||25536||25536|34878||
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|176080|222863|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||176080||176080|222863||2
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3976|6528|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3976||3976|6528||1
396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|20909|40321|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||20909||20909|40321||2
396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5523|10778|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5523||5523|10778||1
397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1243|2790|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1243||1243|2790||1
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|29189|38515|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||29189||29189|38515||2
397567|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1249|1803|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1249||1249|1803||1
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|9718|14026|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||9718||9718|14026||2
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|51299|66263|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||51299||51299|66263||2
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||5393||1
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3825|lyfalmen|V0012|2989|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3825||2
399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3464|3801|lyfalmen|V0009|3664|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||1982||1982|3801||2
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|384|1615|lyfalmen|V0225|1605|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||384||384|1615||1
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2049|2315|lyfalmen|V0244|2139|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||896||896|2315||1
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8858|13207|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8858||8858|13207||1
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1
399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|111967|142401|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||111967||111967|142401||2
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1364|2955|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1364||1364|2955||1
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5059|8010|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5059||5059|8010||1
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|219|1389|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||219||219|1389||1
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|398|1634|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||398||398|1634||1
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|190|1349|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||190||190|1349||1
400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5293|8330|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5293||5293|8330||1
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2296|3980|lyfalmen|V0037|3980|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2113||2113|3980||2
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|10434|15363|lyfalmen|V0459|13577|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10434||10434|15363||1
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|744|2107|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||744||744|2107||1
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1191|2719|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1191||1191|2719||1
402203|D07AC1302|Ovixan|húđlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2745|4844|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||||2745|4844||1
402395|N06DX0103|Nemdatine|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|39241|23096|lyfalmen|V0607|22437|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||16148||16148|23096||1
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1951|3881|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1951||1951|3881||1
402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|14820|19923|lyfalmen|V0349|19923|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||13620||13620|19923||3
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5045|9860|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5045||5045|9860||1
403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5761|8970|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||5761||5761|8970||1
403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|36296|47434|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||36296|47434||1
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1301|2869|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1301||1301|2869||1
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1953||2
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|63929|82113|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||63929||63929|82113||1
404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1171|2691|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||1171||1171|2691||1
404832|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||36|stk|1|ţpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|672|970|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||672||672|970||2
404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|11547|16885|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Lixisenatíd||11547||11547|16885||1
405019|C03CA0110|Impugan|töflur|40|mg|250|stk|1|glas||C03CA01|01.11.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|1014|2476|lyfalmen|||2|250|0|250,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||1014||1014|2476||1
405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|ţpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1398|2320|lyfalmen|V0559|2300|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||900||900|2320||2
405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7995|15524|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7995||7995|15524||2
405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1765|3504|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1765||1765|3504||1
405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|18808|26434|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||18808||18808|26434||1
405677|J01DD0401|Rocephalin|irţ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4146|5984|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||4146||4146|5984||2
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17818|25192|lyfalmen|||1|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17818||17818|25192||1
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20328|28342|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20328||20328|28342||1
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|22280|30791|lyfalmen|||1|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22280||22280|30791||1
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20070|28018|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20070||20070|28018||1
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|60512|78773|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||60512||60512|78773||1
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|71035|91979|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||71035||71035|91979||1
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|80652|104048|lyfalmen|||1|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||80652||80652|104048||1
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006|30.04.2014|R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6150|9502|lyfalmen|||1|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6150||6150|9502||1
406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|76647|98074|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||76647||76647|98074||1
407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3283|3099|lyfalmen|V0072|3099|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||1469||1469|3099||2
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|165|1315|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||165||165|1315||1
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|357|1578|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||357||357|1578||1
408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1923|3011|lyfalmen|V0310|3011|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1405||1405|3011||2
408453|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013|30.04.2014|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|107639|136969|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||107639||107639|136969||1
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2819|4946|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2819||2819|4946||1
408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2210|4113|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2210||2210|4113||1
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|4193|6825|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4193||4193|6825||1
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008|31.03.2014|R|0|0|0|0|0|0|BII|0|0|0|100|DKK|3669|6108|lyfalmen|||1|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3669||3669|6108||1
409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|4127|6735|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4127||4127|6735||1
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12213|18157|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12213||12213|18157||1
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008|31.03.2014|R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2969|5151|lyfalmen|||1|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2969||2969|5151||1
409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|75827|97993|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||75827||75827|97993||1
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9896|14627|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9896||9896|14627||1
409927|G04BD1201|Betmiga|forđatfl|50|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|17034|24208|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||17034||17034|24208||1
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|11205|16417|lyfalmen|V0196|16417|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||11205||11205|16417||2
410077|N02CC0402|Maxalt Smelt|frţ.tfl|5|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5359|8420|lyfalmen|V0620|8420|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5359||5359|8420||1
410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3842|5378|lyfalmen|V0093|5378|2|100|0|133,3300|Portfarma ehf|Orion Corporation|Spírónólaktón||3135||3135|5378||1
410469|L04AB0202|Remsima|irţ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|62408|80205|lyfsjukr|||2|1|0|26,6700|Portfarma ehf|Celltrion Healthcare Hungary Kft.|Infliximab||62408||62408|80205||2
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1107|2604|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1107||1107|2604||1
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|662|1995|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||662||662|1995||2
411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|475|1661|lyfalmen|V0230|1652|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Paracetamól||418||418|1661||2
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4784|6905|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4784||4784|6905||2
411616|N06BA0404|Methylphenidate Sandoz|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|6610|10131|lyfalmen|V0624|10059|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||6610||6610|10131||1
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|24999|33256|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||24999||24999|33256||1
411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1879|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1879||1
411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7313|11093|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7313||7313|11093||1
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|21298|29559|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||21298||21298|29559||1
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3421|4937|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3421||3421|4937||1
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|6115|11914|vetalmen|||0|100|0||Vistor hf|Merial|||6115||6115|11914||1
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|120656|153306|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||120656||120656|153306||2
412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|58973|76841|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||58973||58973|76841||1
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|3324|5636|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||3324||3324|5636||2
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3430|5781|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3430||3430|5781||2
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|890|1842|lyfalmen|V0062|1842|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||550||550|1842||2
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|18462|7861|lyfalmen|V0342|7839|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4950||4950|7861||2
414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|4222|6865|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4222||4222|6865||2
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1297|2864|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1297||1297|2864||1
415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1880|3661|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1880||1880|3661||1
415556|B03AC0003|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC|01.03.2011||R|0|0|0|0|G|0|DAC|0|0|1|100|CHF|14653|18917|lyfalmen|||3|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járn, stungulyf||12818||12818|18917|30.4.2014|2
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995|31.03.2014|R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1874|3653|lyfalmen|||1|15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1874||1874|3653||1
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|10390|11292|lyfalmen|V0253|9925|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||7458||7458|11292||1
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9318|9495|lyfalmen|V0088|2456|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6145||6145|9495||1
416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2576|lyfalmen|V0005|2389|2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2576||1
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4569|7340|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||4569||4569|7340||1
416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2844|4980|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2844||2844|4980||2
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1274|2832|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1274||1274|2832||2
417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|10510|5080|lyfalmen|V0285|5080|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||2917||2917|5080||1
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|40917|53233|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||40917||40917|53233||1
417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|97542|124298|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||97542||97542|124298||1
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|33618|45021|lyfalmen|V0460|45021|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||33618|45021||1
418122|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|4291|6959|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||4291||4291|6959||2
418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|ABP|0|0|0|100|DKK|132182|167771|lyfsjukr|||1|18,76|0|28,0000|Vistor hf|Swedish Orphan Biovitrum AB (publ)|Anakinra||132182||132182|167771||1
418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1571|3238|lyfalmen|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1571||1571|3238||1
418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|6740|10309|lyfalmen|V0014|10309|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||6740||6740|10309||1
418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|2308|3731|lyfalmen|V0458|3731|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1931||1931|3731||1
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2008|3994|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2008||2008|3994||1
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2606|5176|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2606||2606|5176||1
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2709|4795|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2709||2709|4795||1
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6982|10640|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6982||6982|10640||1
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|51265|66220|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||51265||51265|66220||1
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|38901|50703|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||38901||38901|50703||3
419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|827|2221|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||827||827|2221||1
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|11836|17280|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11836||11836|17280||1
420197|N05AH0314|Olanzapine Mylan|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1600|1548|lyfalmen|V0279|1548|2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Olanzapín||335||335|1548||2
420678|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4811|6943|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4811||4811|6943||1
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1099|2593|lyfalmen|V0036|2591|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1099||1099|2593||1
421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|ţpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|33216|63952|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||33216||33216|63952||1
421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|2309|4248|lyfalmen|V0458|3731|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||2309||2309|4248||2
422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1474|3106|lyfalmen|V0051|2184|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1474||1474|3106||1
422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3311|5619|lyfalmen|V0049|4233|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3311||3311|5619||1
422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5443|8535|lyfalmen|V0054|7340|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5443||5443|8535||1
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|69344|88909|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||69344||69344|88909||2
423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3269|5561|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3269|5561||2
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3825|lyfalmen|V0011|3061|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3825||2
423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|DKK|748|2113|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum međ öđrum efnum||748||748|2113||1
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|21519|28889|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||21519||21519|28889||1
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1592|2777|vetorma|||0|24|0||Vistor hf|Intervet International BV|||1592||1592|2777||1
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|1049|2524|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||1049||1049|2524||2
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4685|6715|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4653||4653|6715||1
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|3995|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||2124||2124|3995||1
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|658|1989|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||658||658|1989||1
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|859|2264|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||859||859|2264||1
427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|ţpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2
427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8805|13134|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8805||8805|13134||1
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2849||1
427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|21028|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|21028||2
428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0136|1821|0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1821||1
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|844|2244|lyfalmen|V0629|2244|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||844||844|2244||1
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|991|2445|lyfalmen|V0631|2445|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||991||991|2445||1
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|28356|31426|lyfalmen|V0344|31426|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31426||2
429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3848|5554|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3848||3848|5554||2
429703|A02BC0508|Esomeprazol Actavis|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.04.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6399|5394|lyfalmen|V0012|5338|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3147||3147|5394||1
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4010|6575|lyfalmen|V0093|5378|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4010||4010|6575||1
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|1658|2393|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1658||1658|2393||1
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1416|2044|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1416||1416|2044||2
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4392|8606|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4392||4392|8606||1
430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|107487|136779|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||107487||107487|136779||1
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|28811|7925|lyfalmen|V0184|7234|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||4997||4997|7925||2
430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2915|2970|lyfalmen|V0144|2486|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1375||1375|2970||2
430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2411|4387|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2411||2411|4387||2
430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|ţpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|1076|2561|lyfalmen|V0173|2561|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||1076||1076|2561||1
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|747|2111|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||747||747|2111||1
431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|153656|194721|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||153656||153656|194721||1
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1388|2988|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1388|2988||1
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|4304|6977|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4304||4304|6977||1
431985|D07XC0101|Diprosalic|húđlausn|||100|ml|1|glas||D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2228|4137|lyfalmen|V0640|4137|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2228||2228|4137||1
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|32413|43508|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||32413|43508||1
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3647|7175|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3647||3647|7175||2
433126|N02BE0102|Panodil Brus|freyđit|500|mg|20|stk|1|ţpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
433194|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1737|3465|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1737||1737|3465||1
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10854|15937|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10854||10854|15937||1
433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2539|4563|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2539||2539|4563||1
433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5557|8691|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5557||5557|8691||1
433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011|28.02.2014|R|1|0|0|0|0|0|POF|0|0|0|100|IKR|581|1884|lyfalmen|||2|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||581||581|1884||1
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|194274|245696|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||194274||194274|245696||2
434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|18058|11898|lyfalmen|V0605|10746|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||7901||7901|11898||1
434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|6865|4967|lyfalmen|V0490|4037|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||2835||2835|4967||2
434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|87085|134884|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||82675||82675|134884||1
434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|9124|13571|lyfalmen|V0139|13571|1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9124||9124|13571||1
434576|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|4021|4099|lyfalmen|V0010|4077|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||2200||2200|4099||2
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1115|1945|vetorma|||0|10|0||Vistor hf|Intervet International BV|||||1115|1945||1
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|874|2285|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||874||874|2285||1
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5509|8625|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5509||5509|8625||1
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5509|8625|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5509||5509|8625||1
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|10108|14917|lyfalmen|V0315|5944|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10108||10108|14917||2
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|6541|10037|lyfalmen|||1|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6541||6541|10037||1
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998|31.03.2014|R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|4268|6928|lyfalmen|||1|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4268||4268|6928||1
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|8072|10718|lyfalmen|V0284|2541|1|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7039||7039|10718||1
435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8713|lyfalmen|V0304|8713|2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8713||2
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004|31.03.2014|R|1|0|0|0|G|0|REP|0|0|0|100|SEK|2786|4900|lyfalmen|||1|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2786||2786|4900||1
436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|228786|289009|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||228786||228786|289009||2
436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3472|5839|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||3472||3472|5839||1
436042|R03DC0305|Montelukast Navamedic|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|7001|9768|lyfalmen|V0491|9289|2|98|0|49,0000|Artasan ehf|Navamedic ASA|Montelúkast||6344||6344|9768||1
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2
436394|H01BA0202|Octostim|nefúđi|0,15|mg/sk|2,5|ml|1|úđagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|42336|55014|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||42336||42336|55014||1
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|727|2084|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||727||727|2084||1
436471|N06DX0105|Memantine Mylan|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|17405|10847|lyfalmen|V0605|10531|2|98|0|49,0000|Icepharma hf|Generics UK Ltd|Memantín||7133||7133|10847||2
436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|237658|300143|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||237658||237658|300143||2
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|933|2366|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||933||933|2366||1
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3411|5755|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3411||3411|5755||1
437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|8220|6915|lyfalmen|V0029|6915|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4259||4259|6915||2
437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|ţpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Medical ehf|ratiopharm GmbH|Deslóratadín|||||||2
437774|N06DX0103|Nemdatine|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18350|10821|lyfalmen|V0605|10531|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||7114||7114|10821||1
437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|66613|85482|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||66613||66613|85482||2
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1144|2654|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1144||1144|2654||1
438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10898|15997|lyfalmen|V0334|4218|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10898||10898|15997||1
438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10646|10885|lyfalmen|V0605|10531|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||7161||7161|10885||2
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|326532|411680|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||326532||326532|411680||2
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|G|0|MBV|0|0|1|100|DKK|||lyfalmen|V0362|2103|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||9041||1
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|161512|204580|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||161512||161512|204580||1
439198|N04BC0505|Oprymea|forđatfl|0,26|mg|10|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|1300|2868|lyfalmen|V0634|1685|2|10|0|1,0400|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||1300||1300|2868||2
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2598|4643|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2598||2598|4643||1
439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8339|12497|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8339||8339|12497||1
439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|21687|30047|lyfalmen|V0615|30047|1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||21687||21687|30047||1
439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
439908|G03AA0904|Denise|töflur|||126|stk|1|ţpakki|150/20 mcg|G03AA09|01.05.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|2900|5056|lyfalmen|V0065|4640|2|126|0|168,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||2900||2900|5056||2
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2319|lyfalmen|V0163|1864|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2319||1
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1539|2221|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1539||1539|2221||1
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2429|3506|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2429||2429|3506||1
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|908|2331|lyfalmen|V0046|2041|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||908||908|2331||1
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1193|2721|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1193||1193|2721||1
441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1032|2501|lyfalmen|V0046|2041|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1032||1032|2501||1
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|123006|156255|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||123006||123006|156255||2
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|ţpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|1033|2502|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1033||1033|2502||2
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|14209|1637|lyfalmen|V0283|1637|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||400||400|1637||2
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11206|16419|lyfalmen|V0460|15007|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11206|16419||1
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3384|5718|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3384||3384|5718||1
443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|25800|35209|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||25800||25800|35209||1
443500|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|4555|6574|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||4555||4555|6574||1
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7470|11308|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7470||7470|11308||1
444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|985|2437|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||985||985|2437||2
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|3067|5285|lyfalmen|V0061|3394|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3067||3067|5285||2
444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|24831|33045|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||24831||24831|33045||2
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2233|4144|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2233||2233|4144||2
444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|ţpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|2250|4167|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm Oy|Betahistín||2250||2250|4167||2
445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|0|0|GGL|0|0|0|100|GBP|5918|9185|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||5918||5918|9185||1
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1558|3221|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1558||1558|3221||1
445479|N04BC0407|Ropinirol Actavis|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8476|6642|lyfalmen|V0532|6642|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||4059||4059|6642||1
446268|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|6649|10185|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||6649|10185||2
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|18980|26650|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||18980||18980|26650||1
446856|B03BA0202|Vitamin B12|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.02.2014|31.03.2014|R|0|0|0|0|G|0|PCO|0|0|1|100|IKR|3330|5645|lyfalmen|||2|5|1|250,0000|Distica|Distica - óskráđ lyf|Cýanókóbalamíntannín-komplex||3330||3330|5645||1
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|10390|15302|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10390||10390|15302||1
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|5921|9189|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5921||5921|9189||1
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|7329|11115|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7329||7329|11115||1
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8721|13019|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8721||8721|13019||1
447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|1262|2389|lyfalmen|V0330|2389|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||950||950|2389||2
448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2938|5108|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2938|5108||2
448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|654|1984|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||654||654|1984||2
448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1278|2838|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1278||1278|2838||2
448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2077|3931|lyfalmen|V0202|3612|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||2077||2077|3931||1
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1128|1628|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1128||1128|1628||1
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1359|2948|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1359||1359|2948||2
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|5758|8310|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5758||5758|8310||1
449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|3855|6363|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||3855||3855|6363||2
449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|5296|8334|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5296||5296|8334||2
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4592|8990|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4592||4592|8990||2
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|ţpakki|875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2319|lyfalmen|V0169|1730|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2319||1
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2784|3935|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2080||2080|3935||1
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7328|12783|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7328||7328|12783||2
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|50169|64845|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||50169||50169|64845||2
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|48502|62753|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||48502||48502|62753||2
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|64671|83045|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||64671||64671|83045||2
451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|47607|62577|lyfalmen|V0068|62577|1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||47607||47607|62577||1
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5617|8007|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5057||5057|8007||1
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14835|21448|lyfalmen|||1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||14835||14835|21448||1
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1
452258|R03AK1101|Flutiform|innúđal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|8077|12138|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||8077||8077|12138||2
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1140|2649|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1140||1140|2649||2
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|10979|19152|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10979||10979|19152||2
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
452594|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2457|lyfalmen|V0010|2330|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2457||2
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|11600|16958|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||11600||11600|16958||1
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|8484|12245|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||8484||8484|12245||2
452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2300|4236|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2300||2300|4236||1
452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1516|3163|lyfalmen|V0597|2498|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1516||1516|3163||2
452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|4090|6684|lyfalmen|V0598|5118|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||4090||4090|6684||2
452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2884|5035|lyfalmen|V0584|4646|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2884||2884|5035||2
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1450|2529|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1450||1450|2529||1
453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7849|11826|lyfalmen|V0585|10261|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7849||7849|11826||2
453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5558|8692|lyfalmen|V0586|7450|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||5558||5558|8692||2
453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|15490|22270|lyfalmen|V0587|19711|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||15490||15490|22270||2
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2702|3900|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2702||2702|3900||1
454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|3139|5383|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3139||3139|5383||1
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|15057|21727|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15057||15057|21727||1
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|42717|38595|lyfalmen|V0341|7839|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||28498||28498|38595||1
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16902|24042|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||16902||16902|24042||1
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|47064|42970|lyfalmen|V0342|7839|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||31984||31984|42970||1
454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|52722|68049|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||52722||52722|68049||1
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1127|2242|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1127||1127|2242||1
454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1697|3411|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1697||1697|3411||1
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1054|2531|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||1054||1054|2531||2
455406|L01XA0101|Cisplatin Strides|irţ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013||R|0|0|0|1|0|1|SAI|0|0|0|100|IKR|8350|12051|lyfsjukr|||2|100|0||LYFIS ehf|Strides Arcolab International Limited|Cisplatín||8350||8350|12051||2
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|21527|29846|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||21527||21527|29846||1
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|541|1829|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||541||541|1829||1
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1003|2461|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1003||1003|2461||1
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1965|3777|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1965||1965|3777||1
456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|26688|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|26688||2
457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|GSB|0|0|0|100|GBP|7449|11279|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals|Hreinsađir fjórgildi A,C,Y,W-135 og fl.||7449||7449|11279||1
457615|N06AB1006|Escitalopram Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4787|2311|lyfalmen|||2|100|0|200,0000|Portfarma ehf|Portfarma|Escítalópram||893||893|2311|30.4.2014|1
457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3430|5781|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3430||3430|5781||2
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2677|1673|lyfalmen|V0003|1673|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||427||427|1673||1
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|SEK|1135|2642|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1135||1135|2642||1
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1415|3025|lyfalmen|V0577|2389|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1415||1415|3025||1
459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|0|0|100|GBP|1136881|1428668|lyfsjukr|||1|120|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||1136881||1136881|1428668||1
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|841|1214|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||841||841|1214||1
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1540|2223|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1540||1540|2223||1
459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7470|11308|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7470||7470|11308||1
459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010|30.04.2014|L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|2137|4013|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2137||2137|4013||1
460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3956|6501|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3956||3956|6501||2
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|8082|12145|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8082||8082|12145||2
460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|239198|302076|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||239198||239198|302076||2
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7010|13633|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7010||7010|13633||2
461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|85655|109380|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||85655||85655|109380||1
461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|548730|690539|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||548730||548730|690539||1
461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyfalmen|V0554|1879|2|1|0|0,7500|Medical ehf|ratiopharm GmbH|Flúkónazól|||||1879||2
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|203|1367|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||203||203|1367||1
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|518|1798|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||518||518|1798||1
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|572|1872|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||572||572|1872||1
462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|3691|6138|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||3691|6138||2
462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6736|10304|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6736||6736|10304||1
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|11871|17328|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||11871||11871|17328||1
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6582|12811|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||6582|12811||2
463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|17573|10746|lyfalmen|V0605|10746|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Memantín||7059||7059|10746||2
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5251|10255|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||5251||5251|10255||2
463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|788|1137|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||788||788|1137||1
463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|62967|80906|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||62967|80906||1
463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2928|5095|lyfalmen|V0632|5095|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2928||2928|5095||1
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|2938|5108|lyfalmen|V0376|5108|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||2938||2938|5108||1
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1166|2319|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1166||1166|2319||1
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1181|2349|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1181||1181|2349||1
465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3763|6237|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3763||3763|6237||2
465472|M05BA0803|Zoledronic acid Actavis|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.06.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|32909|43183|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||32909||32909|43183||1
465932|L04AA1303|Leflunomide ratiopharm|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.05.2013||R|0|1|0|1|G|0|RGM|0|0|0|100|XEU|27162|19370|lyfalmen|V0454|19370|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Leflúnómíđ||13179||13179|19370||2
466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1601|2184|lyfalmen|V0038|2184|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||800||800|2184||2
466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4767|3825|lyfalmen|V0039|3825|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||2000||2000|3825||2
466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|655|1985|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||655||655|1985||1
466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2407|4382|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2407||2407|4382||1
466122|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1269|2825|lyfalmen|V0545|2820|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1269|2825||2
466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1451|3074|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1451||1451|3074||1
466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5029|7969|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5029||5029|7969||1
466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|21398|29685|lyfalmen|V0138|29685|1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||21398||21398|29685||1
466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2698|4780|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2698||2698|4780||1
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7772|11721|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7772||7772|11721||1
466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4439|7162|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4439||4439|7162||1
466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|4059|6642|lyfalmen|V0063|5051|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4059||4059|6642||1
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|14993|20699|lyfsjukr|||1|0,5|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||14993||14993|20699||1
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|22976|30717|lyfsjukr|||1|0,5|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||22976||22976|30717||1
467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7006|10111|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7006||7006|10111||2
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|18147|23905|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17548||17548|23905||1
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|15162|21858|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||15162||15162|21858||1
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|54437|67938|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||52634||52634|67938||1
467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|7361|11159|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7361||7361|11159||2
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|28870|39062|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28870||28870|39062||1
467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|11547|16885|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Lixisenatíd||11547||11547|16885||1
467810|J01DI0201|Zinforo|irţ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|91764|117046|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||91764||91764|117046||1
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|493|712|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||493||493|712||1
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6292|6666|lyfalmen|V0317|3004|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4077||4077|6666||1
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|375|541|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||375||375|541||1
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|9162|6357|lyfalmen|V0318|3141|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3851||3851|6357||1
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|23149|12670|lyfalmen|V0320|4783|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8466||8466|12670||1
468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|395|570|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||395||395|570||1
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2315|lyfalmen|V0207|2315|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||896||896|2315||1
468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|6133|11949|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||6133||6133|11949||2
468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5188|lyfalmen|V0467|4388|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5188||1
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5532|8657|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5532||5532|8657||1
469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11900|13172|lyfalmen|V0253|9925|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8833||8833|13172||1
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7449|10751|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7449||7449|10751||2
469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|6195|9564|lyfalmen|V0228|9144|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6195||6195|9564||2
469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5037|7980|lyfalmen|V0227|7199|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5037||5037|7980||2
469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3288|5587|lyfalmen|V0226|4936|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3288||3288|5587||2
470148|N06BA0404|Methylphenidate Sandoz|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|8862|11203|lyfalmen|V0622|11203|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7393||7393|11203||1
470352|M05BA0804|Zoledronic acid medac|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|28414|37542|lyfsjukr|||2|5|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||28414||28414|37542||2
470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4646|7445|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||4646||4646|7445||1
470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|30347|39968|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||30347||30347|39968||1
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1196|2725|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1196||1196|2725||1
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2086|3639|vetorma|||0|20|0||Vistor hf|Intervet International BV|||||2086|3639||1
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|6056|9374|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||6056||6056|9374||2
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4674|9147|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4674||4674|9147||1
472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2040|3880|lyfalmen|V0048|2840|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2040||2040|3880||1
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3102|5333|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3102||3102|5333||1
472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|12821|17973|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||12821||12821|17973||1
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|9141|5357|lyfalmen|V0012|5231|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5357||2
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4510|7259|lyfalmen|V0458|3731|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4510||4510|7259||1
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|15106|20841|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||15106||15106|20841||1
474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|5190|7490|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5190||5190|7490||1
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474252|A10BX1001|Lyxumia|stl|10|mcg|1|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|5749|8954|lyfalmen|||1|1|0||Vistor hf|Sanofi-aventis groupe|Lixisenatíd||5749||5749|8954||1
474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1732|3459|lyfalmen|||1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1732||1732|3459||1
474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|29848|57485|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||29848||29848|57485||2
474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|31570|12494|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||8337||8337|12494||1
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|786|2165|lyfalmen|V0266|2165|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||786||786|2165||2
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1100|2594|lyfalmen|||2|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||1100||1100|2594||1
475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2992|5182|lyfalmen|V0130|5182|1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||2992||2992|5182||1
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|495|1766|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||495||495|1766||1
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|625|1944|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||625||625|1944||1
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|NOK|1480|3114|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1480||1480|3114||1
475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2978|5163|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2978||2978|5163||1
475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3885|6404|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3885||3885|6404||1
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|64984|83437|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||64984|83437||1
476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1146|2657|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1146||1146|2657||1
476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|10681|5245|lyfalmen|||2|56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||3038||3038|5245|28.2.2014|1
477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18021|25446|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||18021||18021|25446||1
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|ţpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5109|8078|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5109||5109|8078||1
477382|N05AH0410|Quetiapin Actavis|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|35687|47617|lyfalmen|V0272|47448|2|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||35687||35687|47617||1
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|942|2378|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||||942|2378||1
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477941|L01XX4401|Zaltrap|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|52057|67214|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||52057||52057|67214||1
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|471|1734|lyfalmen|V0500|1691|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||471||471|1734||1
478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|7468|14512|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||7468||7468|14512||2
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|27162|24297|lyfalmen|V0454|19370|2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||17105||17105|24297||2
479564|N01AB0701|Suprane|innönd.l|||240|ml|1|glas||N01AB07|01.01.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|13302|18577|lyfsjukr|||1|240|0||Icepharma hf|Baxter Medical AB|Desflúran||13302||13302|18577||2
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|16081|7861|lyfalmen|V0341|7839|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4950||4950|7861||2
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999|30.04.2014|R|0|0|0|0|G|0|DAI|0|0|0|100|SEK|12467|18476|lyfalmen|||1|84|0|84,0000|Daiichi Sankyo Europe GmbH|Daiichi Sankyo Europe GmbH|Raloxífen||12467||12467|18476||1
480932|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|ţpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|21491|29801|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||21491||21491|29801||1
481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|13772|20114|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||13772||13772|20114||1
481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|807|2193|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||807||807|2193||1
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|324|1533|lyfalmen|||1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||324||324|1533||1
482183|G03BA0307|Nebido|stl|1000|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15993|22901|lyfalmen|V0641|22901|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15993||15993|22901||2
482457|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
483104|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|75893|97128|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||75893||75893|97128||1
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|37880|50369|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||37880|50369||2
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|6788|9797|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||6788||6788|9797||2
483477|A02BC0403|Rabeprazol Krka|sţ-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1800|2457|lyfalmen|V0467|2457|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2457||2
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2722|3929|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2722||2722|3929||1
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|3469|5835|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3469||3469|5835||1
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4697|6779|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4697||4697|6779||1
483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2379|4344|lyfalmen|V0374|4344|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2379||2379|4344||1
483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|941|2377|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||941||941|2377||1
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|287|1374|lyfalmen|||2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||287||208|1374|30.4.2014|1
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|56140|72338|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||56140||56140|72338||1
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5834|9070|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5834||5834|9070||1
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|142680|180946|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||142680||142680|180946||1
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1342|2925|lyfalmen|||1|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1342||1342|2925||1
484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|11564|16908|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||11564||11564|16908||2
484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|53884|70454|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||53884||53884|70454||1
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1222|2761|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1222||1222|2761||1
485252|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|8766|12652|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||8766||8766|12652||1
485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|86141|109989|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Dolutegravír||86141||86141|109989||1
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|437|1687|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||437||437|1687||1
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|623|1942|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||623||623|1942||1
487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|19351|17479|lyfalmen|V0573|17479|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||11981||11981|17479||1
487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|2526|lyfalmen|V0326|2526|2|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1050||1050|2526||2
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|32704|42926|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||32704||32704|42926||1
487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|54437|70201|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||54437||54437|70201||1
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|32257|43313|lyfalmen|V0453|43313|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||32257||32257|43313||2
487827|M01AB0517|Diclomex|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|1910|lyfalmen|V0469|1910|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||600||600|1910||2
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|928|2359|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||928||928|2359||1
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2580|4619|lyfalmen|V0198|2993|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2580||2580|4619||1
488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|275923|348166|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||275923||275923|348166||1
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|5795|9017|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5795||5795|9017||1
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|11092|16263|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11092||11092|16263||1
489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|3552|lyfalmen|V0331|3552|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1800||1800|3552||2
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|101388|129124|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||101388|129124||1
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|HES|0|0|1|100|IKR|338|1352|lyfalmen|V0188|509|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||192||192|1352||1
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|IKR|882|1728|lyfalmen|V0188|1526|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||467||467|1728||1
490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2322|4266|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2322||2322|4266||1
490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2306|4244|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2306||2306|4244||1
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3883|6401|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3883||3883|6401||1
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10629|10516|lyfalmen|V0112|10516|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6891||6891|10516||1
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5163|8152|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5163||5163|8152||1
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14027|14211|lyfalmen|V0113|3896|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9592||9592|14211||1
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16020|18021|lyfalmen|V0114|3899|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12104||12104|18021||1
491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|24148|33136|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||24148||24148|33136||1
491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|37624|49101|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||37624|49101||1
491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|134049|170114|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||134049|170114||1
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|48467|62709|lyfsjukr|||1|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||48467||48467|62709||1
492270|N05AH0314|Olanzapine Mylan|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1318|1416|lyfalmen|V0278|1416|2|28|0|7,0000|Icepharma hf|Generics UK Ltd|Olanzapín||239||239|1416||2
492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3222|5497|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3222||3222|5497||2
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12267|18225|lyfalmen|V0002|5357|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12267||12267|18225||1
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|27421|37243|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||27421||27421|37243||1
493313|G04BD0704|Tolterodin Actavis|forđahlk|2|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11770|17190|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||11770||11770|17190||1
493401|R03DC0305|Montelukast Navamedic|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6958|8074|lyfalmen|V0492|8074|2|98|0|39,2000|Artasan ehf|Navamedic ASA|Montelúkast||5106||5106|8074||1
493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|18620|11159|lyfalmen|V0516|8565|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||7361||7361|11159||1
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1244|2791|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1244||1244|2791||1
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2422|4403|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2422||2422|4403||1
494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|72740|93171|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||72740||72740|93171||2
494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|181851|230106|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||181851||181851|230106||2
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1977|3794|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1977||1977|3794||1
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2217|4122|lyfalmen|V0128|2195|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2217||2217|4122||1
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3222|5497|lyfalmen|V0410|4836|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3222||3222|5497||1
494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2168|4313|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|||2168||2168|4313||2
494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1792|3541|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1792||1792|3541||1
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|18360|6345|lyfalmen|V0384|5361|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3842||3842|6345||1
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|7141|6456|lyfalmen|V0382|6387|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3923||3923|6456||1
495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2802|4922|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2802||2802|4922||1
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33539|lyfalmen|V0345|33539|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33539||2
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4492|8798|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4492||4492|8798||2
496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|12511|5118|lyfalmen|V0572|5115|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||2945||2945|5118||1
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985|31.03.2014|R|0|0|0|0|G|0|APP|0|0|0|100|GBP|7936|11945|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||7936||7936|11945||1
496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982|31.03.2014|R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1366|2958|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1366||1366|2958||1
496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|1|0|100|DKK|84376|107774|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||84376||84376|107774||3
496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|513|1791|lyfalmen|V0643|1791|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||513||513|1791||1
496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986|31.03.2014|R|1|0|0|0|G|0|APP|0|0|0|100|GBP|3239|5520|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||3239||3239|5520||1
496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|460|1719|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||460||460|1719||1
496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|831|2226|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||831||831|2226||1
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|243586|307583|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||243586||243586|307583||1
497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1826|3587|lyfalmen|V0127|3587|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1826||1826|3587||1
497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3168|5423|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3168||3168|5423||1
497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|905|2327|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||905||905|2327||1
497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|334|1546|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||334||334|1546||1
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|495|1766|lyfalmen|V0448|1678|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||495||495|1766||1
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1030|2498|lyfalmen|V0449|1920|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1030||1030|2498||1
497983|N04BC0407|Ropinirol Actavis|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14811|11286|lyfalmen|V0533|11286|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||7454||7454|11286||1
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1480|3056|lyfalmen|V0369|3056|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1438||1438|3056||1
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1336|2917|lyfalmen|||1|2|0|9,3300|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1336||1336|2917||1
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16643|23717|lyfalmen|V0608|16715|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16643||16643|23717||1
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17754|25111|lyfalmen|V0609|20524|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17754||17754|25111||1
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22115|30584|lyfalmen|V0610|20313|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22115||22115|30584||1
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|26717|36360|lyfalmen|V0611|26759|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||26717||26717|36360||1
499070|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1143|2653|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1143||1143|2653||1
499109|N05AH0410|Quetiapin Actavis|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12581|18619|lyfalmen|V0275|18559|2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||12581||12581|18619||1
499142|C09CA0603|Candesartan Aspen|töflur|4|mg|100|stk|1|ţpakki||C09CA06|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|1573|3241|lyfalmen|V0102|3241|2|100|0|50,0000|Artasan ehf|Navamedic ASA|Candesartan||1573||1573|3241||1
499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|24148|33136|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||24148||24148|33136||1
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10864|15951|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||10864|15951||2
499436|R03AK1101|Flutiform|innúđal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|6157|9512|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||6157||6157|9512||2
501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3857|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2023||2023|3857||2
501278|G04BD1201|Betmiga|forđatfl|25|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|6044|9357|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||6044||6044|9357||1
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3004|5199|lyfalmen|V0434|4493|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3004||3004|5199||2
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|2929|5096|lyfalmen|||1|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||2929||2929|5096||1
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|20545|27666|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||20545||20545|27666||1
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6799|8282|lyfalmen|V0354|8282|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8282||2
503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
504014|N04BC0407|Ropinirol Actavis|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|29013|21745|lyfalmen|V0534|21745|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||15072||15072|21745||1
504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|4230|6105|lyfsjukr|||1|250|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||4230||4230|6105||2
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1627|2762|lyfalmen|V0494|2762|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1223||1223|2762||1
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|2004|3831|lyfalmen|||1|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2004||2004|3831||1
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|ţpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1139|2647|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1139||1139|2647||2
504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|ţpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13743|26561|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||13743||13743|26561||1
505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|8058|12112|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8058||8058|12112||1
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1771|2556|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1771||1771|2556||1
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3537|5105|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3537||3537|5105||1
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8072|11650|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8072||8072|11650||1
506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2559|4590|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2559||2559|4590||2
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2419|4398|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2419||2419|4398||1
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|393|1627|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||393||393|1627||1
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|647|1129|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||||647|1129||2
507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|126711|160905|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||126711||126711|160905||1
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|15782|27531|vetorma|||0|1000|0||Vistor hf|Intervet International BV|||15782||15782|27531||1
507367|A10BX0205|Repaglinide Accord|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.04.2014||R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|1463|3091|lyfalmen|V0462|2869|2|90|0|11,2500|Portfarma ehf|Accord Healthcare Limited|Repaglíníđ||1463||1463|3091||1
507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9707|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9707||2
507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|ţpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|3105|5337|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Betahistín||3105||3105|5337||2
507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1980|3798|lyfalmen|V0092|3798|2|100|0|66,6600|Portfarma ehf|Orion Corporation|Spírónólaktón||1980||1980|3798||1
508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2510|4523|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2510||2510|4523||1
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5015|9802|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5015|9802||2
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4518|8848|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4518||4518|8848||2
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13386|25876|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||13386||13386|25876||2
508921|L01CD0401|Jevtana|irţ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|656971|826381|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||656971||656971|826381||1
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8925|13298|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8925||8925|13298||1
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|G|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2896||1
509577|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.06.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2159|4043|lyfalmen|V0134|3197|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||2159||2159|4043||2
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|47487|61479|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||47487||47487|61479||1
509696|N05AH0314|Olanzapine Mylan|filmhtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1977|1824|lyfalmen|||2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Olanzapín||537||537|1824||2
510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|89939|114756|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||89939|114756||2
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|16330|22377|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||16330||16330|22377||2
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|24445|32561|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||24445||24445|32561||2
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|40097|52204|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||40097||40097|52204||2
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|71330|91402|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||71330||71330|91402||2
510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|472|1735|lyfalmen|V0601|1589|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||472||472|1735||1
510608|L01XX4401|Zaltrap|irţ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|104114|132546|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||104114||104114|132546||1
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|161957|205139|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||161957|205139||1
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4099|4404|lyfalmen|V0445|3401|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||2423||2423|4404||1
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008|31.03.2014|R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2675|4749|lyfalmen|||1|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2675||2675|4749||1
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2642|4703|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2642||2642|4703||1
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|22724|30401|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||22724||22724|30401||1
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|14215|19722|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||14215||14215|19722||1
511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|ţpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|16797|23910|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) međ prógestógen||16797||16797|23910||2
512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|2311|lyfalmen|V0325|2243|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||893||893|2311||2
512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5157|7443|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5157||5157|7443||2
513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1803|lyfalmen|V0109|1803|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1803||2
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1
513401|N06DX0104|Memantine LEK|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.08.2013|30.04.2014|R|1|0|0|0|G|0|SHR|0|0|0|100|DKK|38694|27822|lyfalmen|||2|98|0|98,0000|Artasan ehf|Pharmathen S.A.|Memantín||19914||19914|27822||1
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|22410|30955|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22410||22410|30955||1
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|2084|4145|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2084||2084|4145||2
514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1783|3528|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1783||1783|3528||1
514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|3818|6312|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3818||3818|6312||1
514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|ţpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|20147|28115|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||20147|28115||2
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4333|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4333||1
515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2650||1
515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2662||1
516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|5274|6552|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4540||4540|6552||1
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2899|5055|lyfalmen|V0462|2869|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2899||2899|5055||1
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3157|5408|lyfalmen|V0471|2869|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3157||3157|5408||1
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3394|5732|lyfalmen|V0472|3552|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3394||3394|5732||1
517824|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|35019|45831|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||35019||35019|45831||2
517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|1068|2550|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||1068||1068|2550||1
518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3391|5728|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3391||3391|5728||1
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2046|3888|lyfalmen|V0590|2320|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2046||2046|3888||1
518660|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013|30.04.2014|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|85775|109530|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||85775||85775|109530||1
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|18900|26550|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||18900||18900|26550||1
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1076|2561|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1076||1076|2561||1
519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3921|6453|lyfalmen|V0644|6453|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||3921||3921|6453||1
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1612|3294|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1612||1612|3294||1
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|7125|10836|lyfalmen|||2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7125||7125|10836||1
520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|24371|33416|lyfalmen|V0646|33416|1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||24371|33416||1
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4724|7552|lyfalmen|V0141|6216|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4724||4724|7552||1
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5334|8386|lyfalmen|V0143|2012|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5334||5334|8386||1
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15031|21694|lyfalmen|V0143|6036|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15031||15031|21694||1
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5721|8915|lyfalmen|V0144|2486|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5721||5721|8915||1
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15829|22695|lyfalmen|V0144|7459|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15829||15829|22695||1
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2047|lyfalmen|V0056|1999|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2047||1
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2047|lyfalmen|V0057|1999|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2047||1
520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|347|1564|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||347||347|1564||1
520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0135|1810|0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1810||1
520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0136|1821|0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1821||1
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|31464|42317|lyfalmen|V0269|14297|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||31464||31464|42317||1
522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8232|15979|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|||8232||8232|15979||1
522399|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11423|16715|lyfalmen|V0608|16715|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||11423||11423|16715||1
522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2247|4163|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2247||2247|4163||2
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|182503|230924|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||182503||182503|230924||1
522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2717|4806|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2717||2717|4806||1
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|0|0|1|0|G|0|GLP|0|0|1|100|DKK|387|1619|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||387||387|1619||1
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|977|2426|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||977||977|2426||1
523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5727|5490|lyfalmen|V0285|5080|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3217||3217|5490||1
523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1505||1
523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|ţpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|385192|485298|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||385192||385192|485298||1
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1152|2665|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1152||1152|2665||1
524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|434|1683|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||434||434|1683||1
524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2496|4504|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2496||2496|4504||1
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6062|lyfalmen|V0010|4077|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6062||1
524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1864|3708|vetalmen|||0|1|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1864||1864|3708||2
525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|716|2069|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||716||716|2069||1
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|759|2128|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||759||759|2128||1
525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1687|3397|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1687||1687|3397||1
525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4889|7777|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4889||4889|7777||1
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|0|0|0|TBP|0|0|0|100|DKK|7335|11123|lyfalmen|||1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||7335||7335|11123||1
525593|N06DX0103|Nemdatine|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18640|11018|lyfalmen|V0605|10746|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||7258||7258|11018||1
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38652|51338|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||38652|51338||2
525757|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|glas||C10AA07|01.03.2014||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14342|20829|lyfalmen|V0117|10742|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14342||14342|20829||1
525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5332|7695|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5332||5332|7695||1
525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4855|7007|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||4855||4855|7007||1
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4372|7070|lyfalmen|V0435|7070|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4372||4372|7070||2
526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|4082|6673|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4082||4082|6673||1
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3492|5866|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3492||3492|5866||1
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|13926|19360|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||13926||13926|19360||1
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1154|2668|lyfalmen|||0|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1154||1154|2668||1
528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1040|2041|lyfalmen|V0046|2041|2|100|0|33,3333|Portfarma ehf|Orion Corporation|Spírónólaktón||696||696|2041||1
528214|N04BC0505|Oprymea|forđatfl|0,52|mg|100|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|16800|20651|lyfalmen|V0635|20651|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||14200||14200|20651||2
528267|A02BC0501|Nexium|sţ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11743|7047|lyfalmen|V0011|5466|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4355||4355|7047||1
528374|G03BA0307|Nebido|stl|1000|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|16624|23693|lyfalmen|V0641|22901|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||16624||16624|23693||2
528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2318|4260|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||2318||2318|4260||1
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|8511|12732|lyfalmen|V0356|11626|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||8511||8511|12732||3
528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6742|10312|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6742||6742|10312||1
528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|9310|9612|lyfalmen|V0621|5316|2|18|0|18,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||6230||6230|9612||2
529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4406|8633|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4406||4406|8633||2
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4684|9167|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4684||4684|9167||2
529449|A02BC0112|Omezolmyl|sţ-hylki|40|mg|98|stk|1|ţpakki||A02BC01|01.09.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|10121|3905|lyfalmen|V0001|3905|2|98|0|196,0000|Icepharma hf|Mylan AB|Ómeprazól||2058||2058|3905||2
529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|67250|86281|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||67250||67250|86281||1
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6635|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6858||1
530322|B01AC0602|Hjarta-Aspirín|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2
530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|11548|2382|lyfalmen|V0186|2382|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||945||945|2382||2
530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1603|3189|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1603||1603|3189||2
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2953|5129|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2953||2953|5129||1
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5846|8437|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5846||5846|8437||2
531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2893|5047|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2893||2893|5047||1
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|640|1965|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||640||640|1965||1
532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|338|1552|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||338||338|1552||1
532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|982|2433|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||982||982|2433||1
532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|272|1461|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||272||272|1461||1
532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1730|3456|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1730||1730|3456||1
532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2242|3236|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2242||2242|3236||2
533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1961|3772|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1961||1961|3772||1
533779|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3
534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|18337|25843|lyfalmen|V0639|25843|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||18337||18337|25843||1
534183|N05AH0308|Lazapix|filmhtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|14927|21563|lyfalmen|||2|28|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||14927||14927|21563||1
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|57563|75072|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||57563||57563|75072||1
534652|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|ţpakki||G03XB01|01.05.2014||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3178|4582|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3175||3175|4582||1
534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6012|8677|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||6012||6012|8677||2
535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|2645|4708|lyfalmen|V0092|3798|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2645||2645|4708||1
535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|407|1646|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||407||407|1646||1
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|519|1799|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||519||519|1799||1
536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|398|1602|lyfalmen|V0502|1088|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||375||375|1602||1
536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|29270|38616|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||29270||29270|38616||1
536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|105151|134795|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||105151||105151|134795||1
536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3006|4338|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||3006||3006|4338||2
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6192|8937|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6192||6192|8937||2
537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|G|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2493||1
537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0135|1810|0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1810||1
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|131375|166758|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||131375||131375|166758||2
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|7958|11975|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7958||7958|11975||1
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|216|1385|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||216||216|1385||1
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|628|1948|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||628||628|1948||1
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1761|3498|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1761||1761|3498||1
540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22813|30513|lyfsjukr|||1|2958|0||Icepharma hf|Fresenius Kabi|Blöndur||22813||22813|30513||2
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2734|4829|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2734||2734|4829||2
540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|3354|1772|lyfalmen|V0621|1772|2|6|0|6,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||499||499|1772||2
540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2536|4424|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2536||2536|4424||2
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5769|8981|lyfalmen|V0373|7327|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5769||5769|8981||1
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|9327|13848|lyfalmen|V0199|13848|1|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9327||9327|13848||3
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|01.10.2004||R|1|0|0|0|G|0|SGM|0|0|0|100|DKK|15108|21791|lyfalmen|V0200|21791|1|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15108||15108|21791||3
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
541834|N06DA0207|Donepezil Bluefish|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12845|7861|lyfalmen|V0341|7839|2|98|0|65,3300|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4950||4950|7861||2
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5775|8335|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5775||5775|8335||1
542937|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|13931|20313|lyfalmen|V0610|20313|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13931||13931|20313||1
543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|642|1968|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||642||642|1968||1
543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|16900|24040|lyfalmen|V0645|24040|1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||16900|24040||1
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2851|4989|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2851||2851|4989||1
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2177|3229|lyfalmen|V0373|2442|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1564||1564|3229||1
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1
543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
543755|R03DC0305|Montelukast Navamedic|töflur|10|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|7158|4037|lyfalmen|V0490|4037|2|98|0|98,0000|Artasan ehf|Navamedic ASA|Montelúkast||2155||2155|4037||1
543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|503815|634170|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||503815||503815|634170||1
544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4482|6036|lyfalmen|V0143|6036|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||3616||3616|6036||2
544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|277756|350466|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||277756||277756|350466||2
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12782|18871|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12782||12782|18871||1
545090|N04BC0505|Oprymea|forđatfl|2,1|mg|100|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|50000|60560|lyfalmen|V0636|60560|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||46000||46000|60560||2
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1898|3197|lyfalmen|V0134|3197|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1541||1541|3197||2
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|967|2412|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||967||967|2412||1
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|888|2304|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||888||888|2304||1
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2190|4085|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2190||2190|4085||1
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|29647|40037|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||29647||29647|40037||1
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23903|32828|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||23903||23903|32828||1
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|29821|40255|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||29821||29821|40255||1
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|25335|34625|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||25335||25335|34625||1
546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1
546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1351|2937|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1351||1351|2937||1
546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2457|lyfalmen|V0580|2457|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1000||1000|2457||2
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4021|4160|lyfalmen|V0010|4160|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2245||2245|4160||1
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4902||1
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2457|lyfalmen|V0004|2457|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2457||2
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|10140|14608|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10140||10140|14608||1
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3342|4823|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3342||3342|4823||1
548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|562|1277|lyfalmen|V0542|1277|2|100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||137||137|1277||2
548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|SAG|0|0|0|100|DKK|128461|163101|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||128461||128461|163101||2
548154|N06DX0103|Nemdatine|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|38021|23510|lyfalmen|V0607|22895|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||16478||16478|23510||1
548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
548506|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1138|2646|lyfalmen|V0627|2646|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1138||1138|2646||1
548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|međ rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og ađrar óvirkar samsetningar|||||1772||1
548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|172252|218059|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||172252||172252|218059||2
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004|30.04.2014|R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|92870|118434|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||92870||92870|118434||1
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|9242|13732|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9242||9242|13732||1
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004|30.04.2014|R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|137522|174473|lyfsjukr|||1|1|0||Vistor hf|AbbVie Ltd.|Palivisumab||137522||137522|174473||1
549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|12478|8889|lyfalmen|V0606|7776|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||5702||5702|8889||1
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|37880|50369|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||37880|50369||2
550020|J07AP0302|Typherix|bóluefni|||0,5|ml|1|spr|m/ ađsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2312|3816|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir  mótefnavakar||1993||1993|3816||1
550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1702||1
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|ţpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3475|3825|lyfalmen|V0471|3825|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3825||2
551043|B01AC0701|Persantin|húđuđtfl|100|mg|100|stk|1|ţpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2362|4320|lyfalmen|V0122|4320|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2362||2362|4320||1
551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10188|14668|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||10188||10188|14668||2
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|8742|13048|lyfalmen|V0235|13048|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||8742||8742|13048||1
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1781|3526|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1781||1781|3526||1
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2851|4989|lyfalmen|V0198|4989|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2851||2851|4989||1
551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|2099|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|2099||2
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1862|lyfalmen|V0466|1673|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1862||1
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3542|lyfalmen|V0467|2457|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3542||1
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1118|lyfalmen|V0003|837|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1118||1
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1862|lyfalmen|V0003|1673|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1862||1
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3542|lyfalmen|V0010|2330|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3542||1
551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|18620|8565|lyfalmen|V0516|8565|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||5465||5465|8565||2
552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1764|2546|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1764||1764|2546||2
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|17345|28298|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||17345||17345|28298||1
552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|5002|5638|lyfalmen|||2|500|0|500,0000|Icepharma hf|Mylan AB|Zópíklón||3325||3325|5638|31.3.2014|2
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3227|5504|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3227||3227|5504||1
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11773|17194|lyfalmen|V0237|17194|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11773|17194||1
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4026|6597|lyfalmen|V0237|5731|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4026||4026|6597||1
553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|548730|690539|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||548730||548730|690539||1
553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|45844|59417|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||45844|59417||2
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|10181|19722|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||10181||10181|19722||1
554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8220|6915|lyfalmen|V0029|6915|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||4259||4259|6915||1
555235|N05AB0303|Peratsin|húđuđtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2229|4139|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2229||2229|4139||1
555268|N05AB0303|Peratsin|húđuđtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2540|4564|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2540||2540|4564||1
555292|N05AB0303|Peratsin|húđuđtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1917|3712|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1917||1917|3712||1
555836|N05AH0314|Olanzapine Mylan|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|4330|2858|lyfalmen|V0280|1637|2|56|0|42,0000|Icepharma hf|Generics UK Ltd|Olanzapín||1293||1293|2858||2
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|25987|34496|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||25987||25987|34496||2
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4782|7631|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4782||4782|7631||1
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|9323|13843|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||9323||9323|13843||1
557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1570|3237|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1570||1570|3237||1
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2822|4950|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2822||2822|4950||2
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|244865|309188|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||244865|309188||1
559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995|28.02.2014|R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|847|2248|lyfalmen|||1|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||847||847|2248||1
559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1906|3697|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1906||1906|3697||1
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1536|3191|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1536||1536|3191||2
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5615|8770|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5615||5615|8770||1
559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|3403|5744|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3403||3403|5744||1
559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|13302|18577|lyfsjukr|||1|240|0||Icepharma hf|Baxter|Desflúran||13302||13302|18577||2
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1524||1
560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|791|1842|lyfalmen|V0067|1842|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||550||550|1842||2
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|1431|2716|lyfalmen|V0044|2366|1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1189||1189|2716||1
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1504|3147|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1504||1504|3147||1
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|5758|8966|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5758||5758|8966||1
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6243|9629|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6243||6243|9629||1
560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|98308|125259|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||98308||98308|125259||1
560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|454643|572459|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||454643||454643|572459||1
560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|167380|149400|lyfsjukr|||2|60|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||117544||117544|149400||1
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1687|3397|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1687||1687|3397||2
562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1935|3362|lyfalmen|V0098|2450|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||1661||1661|3362||1
562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|48842|63179|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||48842||48842|63179||1
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4837|7706|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4837||4837|7706||1
562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|238967|301786|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||238967||238967|301786||2
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|100368|127844|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||100368||100368|127844||1
563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|112572|144108|lyfalmen|||1|63|0|7,0000|Vistor hf|InterMune Europe Ltd.|Pírfenidon||112572||112572|144108||1
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|695|2040|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||695||695|2040||1
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|672|2009|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||672||672|2009||1
563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1355|2943|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1355||1355|2943||1
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|201890|256202|lyfalmen|||2|60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||201890||201890|256202||1
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3519|5903|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3519||3519|5903||2
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3649|6081|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3649||3649|6081||2
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|455249|574168|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||455249||455249|574168||1
563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2323|2316|lyfalmen|V0207|2315|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||897||897|2316||2
563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11171|19487|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11171||11171|19487||2
563918|N02AA0505|Oxycodone ratiopharm|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1470|2712|lyfalmen|V0596|2712|2|28|0|1,8600|Medical ehf|ratiopharm GmbH|Oxýcódon||1186||1186|2712||2
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|80304|102664|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||80304||80304|102664||1
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1083|2571|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1083||1083|2571||1
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11328|16585|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11328||11328|16585||1
565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|35599|46559|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||35599||35599|46559||1
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1289|2853|lyfalmen|V0444|2098|0|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||1289||1289|2853||1
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|204117|258049|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||204117||204117|258049||1
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5693|8877|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5693|8877||1
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3269|5561|lyfalmen|V0291|3004|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3269||3269|5561||1
567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|3206|5475|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||3206||3206|5475||1
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|6615|10138|lyfalmen|V0292|4783|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6615||6615|10138||1
567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1080|2567|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1080||1080|2567||1
568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2853|4987|lyfalmen|V0058|4987|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||2849||2849|4987||1
568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3590|5992|lyfalmen|V0059|5992|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3584||3584|5992||1
569041|C09CA0603|Candesartan Aspen|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3140|4914|lyfalmen|V0081|4914|2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan||2796||2796|4914||1
569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|12061|17019|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||12061||12061|17019||2
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|16859|23041|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||16859||16859|23041||1
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|19385|26211|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||19385||19385|26211||1
571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|45844|59417|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||45844|59417||3
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|82612|106508|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||82612||82612|106508||1
572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10390|13172|lyfalmen|V0253|9925|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||8833||8833|13172||1
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8127|5357|lyfalmen|V0011|5357|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5357||2
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3502|lyfalmen|V0245|3481|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3502||1
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3307|5613|lyfalmen|V0464|4411|0|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3307||3307|5613||1
573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|3153|5402|lyfalmen|V0129|5402|1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3153||3153|5402||1
573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|36693|24156|lyfalmen|V0607|22437|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||16993||16993|24156||1
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|84912|108447|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||84912||84912|108447||2
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|23304|31129|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||23304||23304|31129||1
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|28425|37556|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||28425||28425|37556||1
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|IKR|2477|2769|lyfalmen|V0189|2056|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1228||1228|2769||1
573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|5947|7459|lyfalmen|V0144|7459|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||4656||4656|7459||2
574377|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.09.2013||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|41810|54354|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||41810|54354||1
574423|L01XC1301|Perjeta|irţ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|443822|558879|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||443822||443822|558879||2
574900|N05AH0410|Quetiapin Actavis|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.09.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|22236|30736|lyfalmen|V0273|30631|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||22236||22236|30736||1
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2426|2195|lyfalmen|V0151|1617|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||808||808|2195||1
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|7559|6930|lyfalmen|V0322|2542|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4270||4270|6930||1
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4475|2195|lyfalmen|V0152|2082|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||808||808|2195||1
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|13622|6930|lyfalmen|V0323|3883|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4270||4270|6930||1
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|40|0||Icepharma hf|Norpharma |Malatíón|||||||2
575555|J01CA0413|Amoxin|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.06.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1201|2732|lyfalmen|||2|60|0|3,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1201||1201|2732|28.2.2014|2
575563|J01CA0413|Amoxin|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.05.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1519|3167|lyfalmen|||2|100|0|5,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1519||1519|3167|28.2.2014|2
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1541|2530|lyfalmen|||2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1053||1053|2530||2
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1648|3081|lyfalmen|V0160|3040|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1456||1456|3081||2
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1556|2634|lyfalmen|V0158|2604|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1129||1129|2634||2
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1150|1549|lyfalmen|V0243|1375|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1549||1
576122|L01XE1801|Jakavi|töflur|20|mg|60|stk|1|glas||L01XE18|01.11.2012|28.02.2014|R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|652475|820739|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||652475||652475|820739||1
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|12588|18628|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||12588||12588|18628||1
577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12989|18184|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||12989||12989|18184||2
578259|A04AA0106|Ondansetron Mylan|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3600|3576|lyfalmen|V0384|3574|2|10|0|5,0000|Icepharma hf|Mylan AB|Ondansetrón||1818||1818|3576||2
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5300|9246|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5300||5300|9246||2
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1256|2807|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1256||1256|2807||1
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4212|2457|lyfalmen|V0005|2389|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2457||2
579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|358|1579|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||358||358|1579||1
580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|ţpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8402|12583|lyfalmen|||1|14|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8402||8402|12583||1
580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2800|1773|lyfalmen|V0324|1773|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||500||500|1773||2
580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2071|2989|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2071||2071|2989||2
581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2801|3552|lyfalmen|V0472|3552|3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1800||1800|3552||2
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|14147|27337|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14147||14147|27337||2
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2152|4033|lyfalmen|||0|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Cýklópentólat||2152||2152|4033||1
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|27640|36571|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||27640||27640|36571||2
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|53341|68825|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||53341||53341|68825||2
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|106682|135768|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||106682||106682|135768||2
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|60184|77413|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||60184||60184|77413||2
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|4725|8243|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||4725||4725|8243||2
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|18356|32021|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||18356||18356|32021||2
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40469|52671|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||40469||40469|52671||2
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|74705|95637|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||74705||74705|95637||2
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44611|57869|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||44611||44611|57869||2
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|36325|47470|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||36325||36325|47470||2
583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2498|3828|lyfalmen|V0376|1703|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2002||2002|3828||1
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|88715|113220|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||88715||88715|113220||2
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1070|2553|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1070||1070|2553||2
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|105889|134773|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||105889||105889|134773||2
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|31876|41887|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||31876||31876|41887||2
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51002|65890|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||51002||51002|65890||2
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|95629|121897|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||95629||95629|121897||2
583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|0|0|100|GBP|175959|222711|lyfsjukr|||1|28|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||175959||175959|222711||1
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3729|5382|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3729||3729|5382||2
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2259|3260|lyfsjukr|||2|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2259||2259|3260||2
584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|18147|24657|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||18147||18147|24657||1
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|1800|3552|lyfalmen|V0064|2870|1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1800||1800|3552||1
584479|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|4|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1764|2647|lyfalmen|V0143|2012|2|4|0|4,0000|Icepharma hf|Mylan AB|Síldenafíl||1139||1139|2647||2
585130|N06DA0301|Exelon|forđapl|13,3|mg/sólh|60|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|42250|55854|lyfalmen|||1|60|0|84,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||42250||42250|55854||1
585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5951|9230|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5951||5951|9230||1
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4483|6470|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4483||4483|6470||1
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4377|7077|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4377||4377|7077||1
585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|460|1719|lyfalmen|V0541|1615|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||460||460|1719||2
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|31865|42821|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||31865||31865|42821||1
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1703|3419|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1703||1703|3419||1
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|13893|19318|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13893||13893|19318||1
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|370512|466875|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||370512||370512|466875||1
586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11936|8103|lyfalmen|V0606|7776|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||5127||5127|8103||1
587141|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|19097|26797|lyfalmen|V0611|26759|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||19097||19097|26797||1
587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5216|4468|lyfalmen|V0604|4269|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||2470||2470|4468||1
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9916|6694|lyfalmen|V0095|5602|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||4097||4097|6694||1
588457|N06DX0105|Memantine Mylan|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|35362|22722|lyfalmen|V0607|22437|2|98|0|98,0000|Icepharma hf|Generics UK Ltd|Memantín||15850||15850|22722||2
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2140|4017|lyfalmen|V0461|4015|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2140||2140|4017||1
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|8732|13034|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||8732||8732|13034||1
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|9190|5475|lyfalmen|V0282|4280|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3206||3206|5475||1
588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7656|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7656||2
589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|0|0|100|GBP|761312|957329|lyfsjukr|||1|120|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||761312||761312|957329||1
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5966|10407|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5966||5966|10407||2
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2312|4033|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2312||2312|4033||2
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5756|10041|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5756||5756|10041||2
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3109|5423|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3109||3109|5423||2
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3229|5633|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3229||3229|5633||2
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|3106|5418|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3106||3106|5418||2
589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12724|17851|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||12724||12724|17851||2
590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|134590|170793|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||134590||134590|170793||1
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2
590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3009|3340|lyfalmen|V0041|2907|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||1645||1645|3340||1
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|176065|222844|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||176065||176065|222844||1
591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12683|18747|lyfalmen|V0347|18747|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12683||12683|18747||3
591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|9574|14186|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||9574||9574|14186||2
592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14085|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14085||2
592687|A02BC0112|Omezolmyl|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC01|01.09.2013||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2762|2951|lyfalmen|||2|28|0|56,0000|Icepharma hf|Mylan AB|Ómeprazól||1361||1361|2951||2
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|772718|971644|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||772718||772718|971644||1
593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|24207|32262|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||24207|32262||3
593379|A10BG0304|Pioglitazone Accord|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|12502|17479|lyfalmen|V0573|17479|2|98|0|98,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||11981||11981|17479||1
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|506|1782|lyfalmen|V0238|772|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||506||506|1782||2
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|896|2315|lyfalmen|V0238|2315|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||896||896|2315||2
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1321|2896|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1321||1321|2896||2
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|20085|28037|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||20085||20085|28037||1
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|331|577|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||||331|577||2
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5835|8421|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||5835||5835|8421||1
595198|G04BD1201|Betmiga|forđatfl|25|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|17034|24208|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||17034||17034|24208||1
595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|611|1925|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||611||611|1925||1
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|54154|69846|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||54154|69846||1
596196|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|4|stk|1|ţpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|2915|2970|lyfalmen|V0144|2486|2|4|0|8,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||1375||1375|2970||1
596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|18967|25686|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||18967||18967|25686||1
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2286|4216|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2286||2286|4216||1
597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|668409|840736|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||668409||668409|840736||1
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|413|1654|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||413||413|1654||1
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1836||1
599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|603994|759895|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||603994||603994|759895||1
599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4441|8700|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4441||4441|8700||2
599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og ađrar óvirkar samsetningar|||||2143||1
599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|31363|42191|lyfalmen|V0647|42191|1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||31363|42191||1
692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|4026|6597|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4026|6597||1
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|ţpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2689|4768|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2689||2689|4768||1
923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1746|lyfalmen|||0|3,5|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1746||1
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6091|9422|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6091||6091|9422||2
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|17500|24793|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||17500||17500|24793||2
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|2855|4995|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||2855||2855|4995||1
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5290|8326|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5290||5290|8326||1
944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|342|1557|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1557||2
944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1998|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1998||2
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4226|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4226||1
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|7974|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7974||2
951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5290|8326|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5290||5290|8326||1
954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4571|7342|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||4571||4571|7342||2
954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|143829|182388|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||143829||143829|182388||2
957657|A12BA0201|Polycítra|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21806|lyfalmen|||0|500|1|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21806||2
957665|A12BA0102|Kalíum Klóriđ|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4660|lyfalmen|||0|300|1|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríđ||2610||2610|4660||2
961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|ţpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1257|2809|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1257||1257|2809||2
961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|ţpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1430|3046|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1430||1430|3046||2
961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9613|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||6231||6231|9613||2
962234|R05DA2001|SEM mixtúra|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1610|3292|lyfalmen|||0|300|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3292||2
962242|R05DA2001|SEM mixtúra|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1030|2498|lyfalmen|||0|100|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2498||2
962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3961|6508|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||3961||3961|6508||2
965171|D08AX0001|Bórsýruslím|lausn|2|%|500|ml|1|fl||D08AX|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2340|4290|lyfalmen|||0|500|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis sótthreinsandi lyf||2340||2340|4290||2
967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1200|2184|lyfalmen|V0284|1525|2|60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2184||2
967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|6800|3483|lyfalmen|V0285|3048|2|60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||1750||1750|3483||2
967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|12500|6288|lyfalmen|V0286|6288|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||3800||3800|6288||2
967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|27052|lyfalmen|V0287|27052|2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|27052||2
968365|D07CB0101|TNG-smyrsl|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1522|3171|lyfalmen|||0|15|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3171||2
968373|V03AB1505|Naloxonhydrochlorid|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|18870|26512|lyfalmen|||0|500|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|26512||2
968399|A03AA0704|Dicykloverine hydrochloride|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10755|lyfalmen|||0|100|1|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10755||2
968406|D05AA0001|Tjara 26 / ASVEP|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5096|lyfalmen|||0|100|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5096||2
968414|D05AA0002|Koltjörusmyrsl|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6082|lyfalmen|||0|100|1||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6082||2
969115|L02BA0108|Tamoxifen Aliud|töflur|20|mg|100|stk|1|ţpakki||L02BA01|01.03.2014||R|0|0|0|0|G|0|LDR|0|0|0|100|XEU|3616|6036|lyfalmen|||2|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Tamoxífen||3616||3616|6036||2
969123|L02BA0108|Tamoxifen Aliud|töflur|10|mg|100|stk|1|ţpakki||L02BA01|01.03.2014||R|0|0|0|0|G|0|LDR|0|0|0|100|XEU|3504|5883|lyfalmen|||2|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Tamoxífen||||3504|5883||2
969149|H03BB0102|Carbimazol|töflur|5|mg|100|stk|1|ţpakki||H03BB01|01.02.2014||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1380|2977|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1380||1380|2977||2
969181|N02AA0111|Morfin "DAK"|töflur|10|mg|100|stk|1|pakki||N02AA01|01.05.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|2948|5122|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||2948||2948|5122||2